text
stringlengths 102
99.6k
| url
stringlengths 31
426
| crawl_date
timestamp[us, tz=UTC]date 2022-04-01 00:29:49
2022-09-19 04:34:15
|
|---|---|---|
Convicted murderer in 11-year-old’s stabbing sentenced to life in prison
By Mycah Hatfield and Jeff Ehling
Click here for updates on this story
HOUSTON, Texas (KTRK) — A judge has sentenced Andre Jackson, who was convicted of murdering 11-year-old Josue Flores in 2016, to life in prison.
Jackson testified during Wednesday’s proceedings ahead of Judge Denise Collins’ decision. He could have been given a minimum of just five years, but Judge Collins instead decided on the maximum term possible.
Before learning his sentence, Jackson, who was convicted just the day before, remained defiant of the guilty verdict from a jury of his peers.
“I worked very hard in my life. I will always have self-respect and defend my character,” Jackson read from a lengthy, prepared statement.
In his presentation, he insisted that prison “is not where I belong,” and that his DNA was not on the clothing worn on that day.
He then talked about Josue and the doubt of whether he was indeed the killer.
“I can’t say much to Josue and his family. At this point, they have a guilty verdict. I’m not sure if they believe they have the right guy,” Jackson said before invoking race. “This is about Black men in America.”
He concluded with some self-awareness and continued defiance.
“I don’t want to be inflammatory. I give my condolences to the family (but) people may fault me for not being remorseful,” Jackson said.
Jackson’s demeanor Wednesday greatly differed from the day before when a jury read the guilty verdict for the Houston boy’s 2016 stabbing. He smiled and was talking with his attorney remarkably more than he was seen at any other point in the past seven days of his trial. This was in contrast to the tearful breakdown he had Tuesday afternoon.
Jackson decided to have Judge Collins sentence him as opposed to jurors.
The prosecution had Josue’s father and sister take the stand and face Jackson during Wednesday’s proceedings. Both explained the positive and negative impacts Josue’s passing had on them.
Through a Spanish-language translator, Juan Flores explained the difficulty his family had trying to move forward, to the extent that they moved away from the neighborhood where Josue was killed so his other children didn’t have to constantly be reminded of what happened.
Josue’s sister, Guadalupe, revealed he inspired her nursing career path from the start of his life.
“A lot was taken away from us as a family. We didn’t get to say goodbye. I didn’t get to give him a goodbye hug or kiss,” Guadalupe said.
Heart wrenching of all, as she mentioned several times, was that Josue died alone.
“We were robbed of the opportunity to give him comfort,” she said. “I can only do the next best thing. Nursing is the next best thing. I can bring comfort to people when they are alone.”
The state’s last witness was Josue’s best friend, Angel Nario, who was likely the last person to see him alive. He recalled leaving school with Josue the day he was killed, later parting ways with a handshake and a hug.
“To this day, I have not had a best friend like Josue,” Nario said, adding that both he and Josue should be graduating high school together this month.
Then, Jackson’s attorneys got their turn to call character witnesses, beginning with Jackson’s stepfather who described his stepson as a role model to his siblings.
The stepfather also mentioned Jackson’s accomplishment as a Marine, who was honorably discharged. Jackson had no disciplinary issues in school, but after the murder charges were previously dismissed in 2017, they called it a bump in the road.
Jackson’s younger brother was next to take the stand. He described the man who would be convicted of murder a father figure to him and his sibling.
Defense lawyers moved on to Jackson’s mother, who said her son, born during her U.S. Navy service, was a model student and top of the class. Still, Jackson had transitional issues when he left the military, his mom said, noticing behavioral changes including isolation and anti-social traits.
She said she wanted him to get help for anxiety and PTSD, but admitted she later lost touch with him after he moved away from her.
When she first learned her son was accused of the heinous act, she believed it to be a mistake.
Just the day before, the Flores family sat in silence as the verdict was read by a jury that deliberated for less than three hours.
“We the jury, find the defendant, Andre Timothy Jackson, guilty of murder as charged in the indictment,” said a member of the jury.
The Flores family waited six years for a guilty verdict.
During the trial, the defense team tried to convince the jury this was a botched investigation, but prosecutors said Jackson was seen running from the area after the murder. Josue’s DNA was also found on Jackson’s coat.
Prosecutors also told jurors the only way the boy’s DNA could have been on his coat is if Jackson killed him.
Ever since the murder six years ago, a memorial on the north side demanded justice for Josue. ABC13 was told that with the guilty verdict, the demand has been met and the memorial will be dismantled.
Please note: This content carries a strict local market embargo. If you share the same market as the contributor of this article, you may not use it on any platform.
|
https://localnews8.com/news/2022/05/05/convicted-murderer-in-11-year-olds-stabbing-sentenced-to-life-in-prison/
| 2022-05-05T18:15:06Z
|
A local golf tournament benefiting Project Graduation for Temple High School seniors will tee off at 1 p.m. on Friday at the Sammons Golf Course in Temple.
“We’re worried that our registration is low and I’m trying to do everything I can to get more people registered,” Frankie Keith-Garner, a member of the parent group that is organizing this year’s Project Graduation event, told the Telegram. “We have enough people to hold a tournament, but we haven’t had as many people sign up as we would have hoped. So we have about 20 or more spots still open.”
Three registration packages for the tournament at 2727 W. Adams Ave. in Temple are available for purchase online at bit.ly/3LQVqiM: single player, $75; two players, $150; and four players, $300.
All proceeds, Keith-Garner said, will go toward hosting Project Graduation on May 28 at the Ralph Wilson Youth Club — an event that was not held the last two years in response to COVID-19.
“The kids will play games, like casino games and basketball tournaments, all evening and for everything they participate in they get a voucher,” Keith-Garner said. “Then they get to bid on a bunch of different prizes that we are able to provide, things that the kids might need for college.”
This year, a scholarship from the University of Mary Hardin-Baylor, is among those prizes.
“These kids were impacted by COVID-19 the last couple of years in that they had to move in-and-out of the classroom,” Keith-Garner, who noted how past Project Graduation celebrations have featured 350 to 500 students, said. “It’s been a challenging time so we’re really excited to finally end their (high school careers) on a positive note.”
Jeniece Washburn, a Project Graduation co-chairman, noted how residents — who are unable to the golf tournament on Friday — can still contribute to the end-of-the-year celebration.
Donations can be made to “Temple High School Project Graduation" through Venmo to @templehspg and CashApp to $classof2022ths, or by mail to 415 N. 31st St. in Temple.
|
https://www.tdtnews.com/news/central_texas_news/article_505a8a0a-b9eb-11ec-9b7f-1f0ba0804287.html
| 2022-04-12T01:02:52Z
|
Australian central bank decides first rate hike in 11 years
By ROD McGUIRK
Associated Press
CANBERRA, Australia (AP) — Australia’s central bank has lifted its benchmark interest rate for the first time in more than 11 years. The cash rate rose from 0.1% to .35%in a move potentially damaging to a government that will seek reelection on May 21. A rise on Tuesday was widely expected after official data released last week showed that Australia’s inflation rose to 5.1% in the year through March. It is the highest annual rate since 2001. Inflation in the latest March quarter was sharply higher than the 3.5% three months earlier. The Reserve Bank of Australia adjusts interest rates to keep inflation within a 2-3% target band. The cash rate has been at a record low 0.1% since November 2020.
|
https://localnews8.com/news/ap-national-business/2022/05/02/australian-central-bank-decides-first-rate-hike-in-11-years/
| 2022-05-03T05:49:20Z
|
NEW YORK, June 24, 2022 /PRNewswire/ -- Jakubowitz Law announces that a securities fraud class action lawsuit has commenced on behalf of shareholders of Verrica Pharmaceuticals, Inc. (NASDAQ: VRCA).
To receive updates on the lawsuit, fill out the form:
https://claimyourloss.com/securities/verrica-pharmaceuticals-inc-loss-submission-form/?id=29057&from=4
The lawsuit seeks to recover losses for shareholders who purchased Verrica between May 28, 2021 and May 24, 2022.
Shareholders interested in acting as a lead plaintiff representing the class of wronged shareholders have until August 5, 2022 to petition the court. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.
According to a filed complaint, Verrica Pharmaceuticals, Inc. issued materially false and/or misleading statements and/or failed to disclose that: (1) there were manufacturing deficiencies at the facility where Verrica's contract manufacturer produced a bulk solution for the Company's lead product candidate, VP-102; (2) these deficiencies were not remediated when Verrica resubmitted its New Drug Application for VP-12 for molluscum; (3) the foregoing presented significant risks to Verrica obtaining regulatory approval of VP-102 for molluscum; and (4) as a result of the foregoing, defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.
Jakubowitz Law is vigorous in pursuit of justice for shareholders who have been the victim of securities fraud. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT:
JAKUBOWITZ LAW
1140 Avenue of the Americas
9th Floor
New York, New York 10036
T: (212) 867-4490
F: (212) 537-5887
View original content:
SOURCE Jakubowitz Law
|
https://www.kxii.com/prnewswire/2022/06/24/vrca-shareholder-alert-jakubowitz-law-reminds-verrica-shareholders-lead-plaintiff-deadline-august-5-2022/
| 2022-06-24T10:28:41Z
|
LEESBURG, Fla., July 20, 2022 /PRNewswire/ -- Newly recognized non-profit Choose Charities has launched Summer 2022 on a mission to end homelessness, hunger, and more in the United States.
Co-founder Bill Galli has combined his passions for creative branding and assisting the marginalized into a new creative agency engineered for making change. The US Census Bureau reported in 2021 that "In the United States alone, 37.2 million people are living in poverty." The more he discovered, the more he knew he needed to act. With the Global Wealth Report by Credit Suisse reporting over 21.9 million millionaires living in the U.S., Galli knew there had to be some way of connecting those with resources to those desperately in need.
With the launch of Choose Charities, Bill is turning his passions into a national giveback plan. Choose Charities is a creative branding agency that is on a mission "To create a worldwide philanthropy that addresses the economic, medical, psychological, and social issues of our society's vulnerable in order to provide a sustainable living blueprint of self-help and support."
The non-profit accomplishes this by partnering together brands with charitable causes and generating creative marketing strategies to amplify the voices of those in need. Choose Charities creates catchy marketing programming that aims to raise awareness and funds for the charitable organization.
Choose Charities as a newly launched organization is looking for companies who are ready to step up their philanthropic outreach. Together, Choose Charities believes that we can create a place where our V.E.T.S. and vulnerable citizens can finally call "home" and assimilate back into society, providing them the opportunity to live the rest of their lives with dignity and respect.
You can learn more about our mission by going to our website at www.choosecharities.org or watching the promotional video www.facebook.com/choosecharities/videos/590368829091394. Any brands interested in partnering with Choose Charities and a non-profit of their choosing can contact us online at https://www.choosecharities.org/contact or email the founder directly at hello@choosecharities.org. Individuals can also get involved through participating in our program marketplace, volunteering, sharing the mission, or donating directly at https://www.choosecharities.org/donate.
Contact: Bill Galli, hello@choosecharities.org, 844 740 5004
View original content:
SOURCE Choose Charities
|
https://www.mysuncoast.com/prnewswire/2022/07/20/new-501c3-organization-pair-up-charities-business-organizations-amplify-voices-those-need/
| 2022-07-20T12:21:53Z
|
Industry-leading parcel and shipping carrier, FirstMile, is purchased by founding CEO, Devin Johnson
LAS VEGAS, Aug. 1, 2022 /PRNewswire/ -- Devin Johnson, a leader in the eCommerce parcel and shipping industry, today announced the purchase of FirstMile. Johnson, the company's founder and CEO will continue to lead the company.
"With the purchase of FirstMile and its sister company, our clients will benefit by our reclaiming original ownership of FirstMile and continuing its growth and optimization as a domestic and international carrier" explained Devin Johnson, Chief Executive Officer and owner of FirstMile and ShipNetwork. "This acquisition is a reinvestment in our commitment to support small, medium and large eCommerce companies in today's challenging supply chain climate."
FirstMile provides a one-stop-shop for eCommerce shipping; clients have access to multiple delivery networks through one, simple interface and one-point of pick-up. Using its proprietary technology—Xparcel—FirstMile provides clients with a unique combination of best price and service for every shipped package.
The acquisition of FirstMile and ShipNetwork will help facilitate a strong partnership between two national logistics leaders that will prove invaluable for clients of both companies.
"For all of our clients, our goal remains the same: provide speedy deliveries at affordable rates to eCommerce customers," Johnson explained. "In our business, the ability to scale is extremely important, and as a result of this acquisition, the addition of this shipping volume will benefit all of our 3PL partners and eCommerce clients."
"FirstMile will gain added density and volume as a result of our expanded reach through ShipNetwork," said Johnson. "Our clients will benefit from our increased ability to reach deeper into regional and postal carrier networks. End of the day, that translates into both improved service and a reduction in costs to all our clients."
As witnessed during the recent pandemic, eCommerce businesses and the logistics firms supporting them, play critical roles in the nation's supply chain. FirstMile allows eCommerce merchants to remain focused on building a prosperous business, secure in the knowledge that clients may expect delivery of their products in a timely and cost-efficient manner.
"As national leaders in eCommerce logistics, FirstMile and ShipNetwork assume responsibility for warehousing, warehouse technology, fulfillment, and shipping expertise," Johnson said. "For our clients, both our 3PL partners and eCommerce merchants, that means their entire focus can be on ensuring their companies continue to grow and prosper."
For more information on FirstMile visit www.firstmile.com
FirstMile is an eCommerce parcel carrier providing solutions for eCommerce retailers. FirstMile's unique approach allows small, medium, and large eCommerce shippers to get the best combination of price and service across a wide network international, national, regional, local and micro delivery solutions. We do this with one API connection, one pick-up via our FirstMile-owned and operated vehicles, and one invoice. Our patented Xparcel algorithm solution drives the right label to you for each and every package, every day, across multiple networks.
Carolina Cano-Espinoza
Marketing Manager, ShipNetwork
(702) 664-1481
View original content to download multimedia:
SOURCE FirstMile
|
https://www.kxii.com/prnewswire/2022/08/01/firstmile-founder-ceo-regains-ownership-leading-parcel-carrier/
| 2022-08-01T23:36:38Z
|
BOLINGBROOK, Ill., Aug. 9, 2022 /PRNewswire/ -- ATI Physical Therapy ("ATI" or the "Company") (NYSE: ATIP), the largest single-branded outpatient physical therapy provider in the United States, today announced that Eimile Tansey will be joining the company later this month as Chief People Officer. Tansey will lead ATI's priority initiatives to drive excellence in employee recruiting, hiring, training and retention as critical elements of the Company's growth strategy.
"Eimile truly puts the 'people' part first as a Chief People Officer," said ATI Chief Executive Officer Sharon Vitti. "In committing to the importance of hiring and retaining our best people — from our clinical care providers to our corporate support staff and everyone in between — we knew we needed someone who understands the human element of delivering outstanding patient care. We couldn't be happier to have found just that person in Eimile. She is an innovative, transformative leader and we are excited to have her join our strong, high-performing team."
In a field in which more than 60% of clinicians are women, Tansey joins Vitti and Chief Legal Officer Diana Chafey as the third woman on the Company's executive leadership team. Among her early priorities, Tansey emphasized the importance of promoting a culture of inclusivity.
"In talking with Sharon and other ATI leaders, it was clear they understand that our people are the single biggest key to our success. They are ATI. It's who we are," Tansey said. "I am humbled to have been chosen to lead such a vital function at a mission-driven company that is all about serving people. I look forward to continuing to build on the history of excellence our team has established at ATI as a relentlessly patient-focused team."
Tansey has more than 20 years' experience in Human Resources and Operations across a variety of industries such as healthcare, manufacturing and more, including more than 15 years in leadership and executive roles. She comes to ATI after having most recently served as Chief People Officer at elder-care provider InnovAge. Prior to that, Tansey held various HR leadership positions at CVS Health for more than a decade, rising to Vice President of Human Resources. She holds a Master of Science, Human Resources Management/Personnel Administration from the University of Maryland Global Campus and a Bachelor of Arts in Political Science and Government from Ohio Wesleyan University.
At ATI Physical Therapy, we are passionate about potential. Every day, we restore it in our patients and activate it in our team members in our more than 900 locations in 25 states. With outcomes from more than 2.5 million unique patient cases, ATI is making strides in the industry by setting quality standards designed to deliver predictable outcomes for our patients with musculoskeletal (MSK) issues. ATI's offerings span across a broad spectrum for MSK-related issues. From preventative services in the workplace and athletic training support to outpatient clinical services and online physical therapy via our online platform, CONNECT™, a complete list of our service offerings can be found at ATIpt.com. ATI is based in Bolingbrook, Illinois.
Category: Leadership
Contact:
Rob Manker, Director of Customer Marketing & Public Relations
ATI Physical Therapy
Warren.Manker@atipt.com
630-296-2222 x7432
Media Relations:
Sean Leous
ICR Westwicke
Sean.Leous@Westwicke.com
646-866-4012
Investor Relations:
Joanne Fong, SVP, Treasurer and Head of Investor Relations
ATI Physical Therapy
Joanne.Fong@atipt.com
630-296-2222 x7131
View original content to download multimedia:
SOURCE ATI Physical Therapy
|
https://www.kxii.com/prnewswire/2022/08/09/ati-physical-therapy-announces-healthcare-veteran-eimile-tansey-chief-people-officer/
| 2022-08-09T12:56:58Z
|
HAMBURG, Germany, Aug. 31, 2022 /PRNewswire/ -- Dana Incorporated (NYSE: DAN) announced today the launch of the Brevini EvoMax™ series of helical and bevel-helical gearboxes for marine and offshore applications. The gearbox range introduces five completely new sizes and includes 14 redesigned gearboxes to provide higher torque, greater efficiency, and longer service.
Available for order today, the gearboxes will be on display as part of Dana's exhibit Sept. 6-9 at SMM, in hall A3, booth 304, at the Hamburg Messe exhibition hall in Germany.
The modular series is designed to provide greater product flexibility, higher efficiency, and increased sustainability while helping to minimize total operating costs.
"The demand for global shipping continues to rise, and our customers require robust solutions that can be adapted to their specific on-shore port or off-shore marine applications," said Jeroen Decleer, senior vice president of Dana Off-Highway Drive and Motion Technologies. "Dana continues to supply new equipment, upgrades, and modernizations for the marine industry through our broad range of solutions for this critically important sector."
Leveraging decades of product application knowledge and customer feedback, Dana's new series of gearboxes provides a highly engineered solution with a comprehensive suite of features, including:
- a new housing design to reduce weight, increase structural strength, and optimize internal oil flow for better thermal management;
- custom gearing for smooth operation, low noise levels, and high efficiency;
- updated housing materials and seals to enable low temperature operation;
- best-in-class torque density; and
- increased product range to provide a more targeted solution for customer applications.
In addition to helical and bevel-helical gearboxes, Dana offers Brevini®-brand axial piston motors, axial piston pumps, slewing drives, proportional directional valves, winches, winch drives, wheel drives, and other motion products for the marine and offshore industry. To learn more, visit www.dana.com/offhighway.
Dana is a leader in the design and manufacture of highly efficient propulsion and energy-management solutions that power vehicles and machines in all mobility markets across the globe. The company is shaping sustainable progress through its conventional and clean-energy solutions that support nearly every vehicle manufacturer with drive and motion systems; electrodynamic technologies, including software and controls; and thermal, sealing, and digital solutions.
Based in Maumee, Ohio, USA, the company reported sales of $8.9 billion in 2021 with 40,000 associates in 31 countries across six continents. Founded in 1904, Dana was named one of "America's Most Responsible Companies 2022" by Newsweek for its emphasis on sustainability and social responsibility. The company is driven by a high-performance culture that focuses on valuing others, inspiring innovation, growing responsibly, and winning together, earning it global recognition as a top employer. Learn more at dana.com.
View original content to download multimedia:
SOURCE Dana Incorporated
|
https://www.kxii.com/prnewswire/2022/08/31/dana-introduces-new-brevini-evomax-helical-bevel-helical-gearbox-range-marine-offshore-applications-smm-2022/
| 2022-08-31T12:11:17Z
|
New Investment from Prominent Industry Partners is Set to Facilitate Expanded Product Offerings
LOS ANGELES, Aug. 29, 2022 /PRNewswire/ -- RentSpree, the industry's premier end-to-end rental management software provider, today announced that it has closed $17.3 million in Series B financing. This brings the company's total amount raised to nearly $28 million. These investments will help the company expand product offerings for both renters and agents and secure additional strategic partnerships, furthering its mission to help the real estate industry embrace a growing nation of renters.
This latest round of funding is led by Green Visor Capital. The fintech venture capital firm is joined by new investors Rally Ventures, the California Association of REALTORS® (C.A.R.), Venture MLS, ECG-Research, KEC Ventures, and Gaingels, with participation from existing investors 645 Ventures and Vesta Ventures.
"We recognized a marked shift toward renting that has been years in the making," says Michael Walsh, General Partner, Green Visor Capital. "That transformation has only accelerated over the last 24 months. RentSpree is well-poised to continue leading the industry through these changing dynamics due to its partnerships, product innovation, and momentum."
With rising mortgage rates making it more expensive to buy a home, the demand for rentals has been skyrocketing. With this in mind, RentSpree will use the new funding to further empower renters, agents, and landlords with new tools, such as rent payment. Case in point, RentSpree has seen an average monthly increase of rent collected via this latest feature by more than 30% year to date. Given this trajectory, RentSpree is on track to process more than $160 million in rental payments over the next 12 months.
By providing decision-enablement resources, RentSpree will assist renters in better understanding their finances on their real estate journey. These tools are designed to help solve financial pain points, set renters up for success in the rental market, and allow them to reach their long-term goals. In concert, the company is equipping agents and brokers with the tools necessary to seamlessly diversify their client portfolio and income, as well as support their rental clients' transition to homeownership in due time.
"From RentSpree's start, we wanted to create an easier and more effective process to qualify renters," says Michael Lucarelli, CEO of RentSpree. "In time, we realized that we were only scratching the surface of unmet needs within the market, such as streamlining marketing, facilitating payments, and helping consumers build wealth. With the introduction of new tools and plans for strategic partnerships in today's hot rental market, it is our goal over the next 24 months to have 30%+ of all active U.S. agents leveraging RentSpree, and together, we will assist millions of rental clients annually."
The round of Series B funding comes on the heels of RentSpree ranking in the top 13% of Inc. 5000's fastest-growing companies of 2022. In addition, RentSpree recently reached one million users across the country as a result of partnerships with more than 250 of the nation's top multiple listing services (MLSs), associations, brokerages, and proptech platforms. This growth trajectory is on track to heighten with this latest investment.
"While our members predominantly service clients seeking to buy and sell real estate, we recognize that many people are renting much longer today compared with any other point in history," says C.A.R. President Otto Catrina. "We have been collaborating with RentSpree already for more than five years to ensure our members have access to technology to address rental needs, and we are excited to take this significant step in helping RentSpree transform the real estate ecosystem."
For more information on RentSpree, please visit rentspree.com.
Los Angeles-based RentSpree is a provider of award-winning rental software that helps seamlessly connect real estate agents, owners, and renters to simplify and automate the entire rental process, from listing to lease. The all-in-one platform is known across all 50 states for its easy and secure interface and suite of rental tools, including tenant screening, rent payments, marketing and renter management. To date, RentSpree has partnered with more than 250 of the most influential MLSs, real estate associations and brokerages to serve over one million users in the U.S. RentSpree is ranked 625th on Inc. 5000's fastest-growing private companies in 2022. Visit rentspree.com for more information.
Green Visor Capital invests in, and works with, passionate entrepreneurs that use innovative technology to solve substantive issues in financial services and do so in a socially responsible manner, which we believe will lead to the generation of large-scale shareholder value. Green Visor Capital launched in late 2013, and its general partners include Joe Saunders, the former chairman and CEO of Visa, Inc., the world's largest payments company. For more information, visit http://www.greenvisorcapital.com.
Leading the way…® in California real estate for more than 110 years, the CALIFORNIA ASSOCIATION OF REALTORS® (www.car.org) is one of the largest state trade organizations in the United States, with more than 217,000 members dedicated to the advancement of professionalism in real estate. C.A.R. is headquartered in Los Angeles.
View original content to download multimedia:
SOURCE RentSpree
|
https://www.wibw.com/prnewswire/2022/08/29/rentspree-raises-173-million-series-b-propelling-continued-growth-booming-rental-market/
| 2022-08-29T13:54:21Z
|
SAN FRANCISCO, June 20, 2022 /PRNewswire/ -- Tim Hunt is the latest addition to Newfront, a tech-enabled, full-service brokerage. As Associate Vice President on the Employee Benefits team, Tim joins Newfront from Marsh McLennan Agency, where he spent the last four years helping his clients find solutions to improve and manage their employee benefits programs.
"Tim brings additional background as a small business owner and therefore has a deep understanding of the challenges that arise in the benefits space around retaining and attracting great talent," said Newfront President Brian Hetherington. "His passion for discovering innovative solutions for businesses of all sizes and industries will help enhance our world-class employee benefits team even further."
Tim is based in the San Diego area and will serve clients across the country.
"Tim has found innovative ways to go to market and drive value for clients, especially during the pandemic," said Linde Hotchkiss, Newfront Regional Managing Director for the Southwest Market. "He is a great addition to the team and our resources will amplify his ability to create a better client experience."
Tim is known for his ability to deliver competitive and compelling programs for his clients.
"I'm thrilled to embark on my new journey with Newfront," Tim said. "The entire team at Newfront is focused on providing the best customer service experience for our clients by putting them front and center of all we do. Furthermore, Newfront has the culture and values that align with my personal vision."
Newfront's Employee Benefits team just announced an exclusive partnership with Alpine Rewards to provide strategic Total Rewards advice for the world's top employers.
"The data, technology, and resources offered to our clients is cutting edge and makes the whole process of benefit administration much easier for the client," Tim added.
About Newfront
Newfront is transforming the delivery of risk management, employee experience, insurance, and retirement solutions by building the modern insurance platform. Transparent data delivered real-time translates into a lower total cost of risk and greater insights. Newfront makes insurance work for you. Headquartered in San Francisco, Newfront has offices throughout the country and is home to more than 750 employees who serve clients across the United States and globally.
Contact Information
Jane Paolucci
Senior Vice President, Marketing
Newfront
jane.paolucci@newfront.com
415-798-2693
View original content to download multimedia:
SOURCE Newfront Insurance
|
https://www.kxii.com/prnewswire/2022/06/20/tim-hunt-joins-newfronts-growing-employee-benefits-team/
| 2022-06-20T21:07:21Z
|
Depot Day planned in Ardmore to celebrate new Depot Park
ARDMORE, Okla. (KXII) - After years of work Ardmore’s Depot Park is finally open and the Ardmore Main Street Authority is inviting the whole city out to celebrate.
A few years ago the area at the corner of Main Street and Caddo was nothing but gravel and building debris.
But the Main Street Authority had a vision of turning it into a staple of the cities downtown and the perfect welcome area for Amtrak passengers.
“It wasn’t very pretty, it wasn’t very appealing to be our downtown area,” said public relations director Trish Maher.
The process was long and difficult but after several years depot park was completed and filled with amenities to attract visitors.
“They’ve put in all of these beautiful grassy areas where you can come and play frisbee, you can come and hangout or read a book,” said Maher. “The benches, the tables, the wonderful annex that’s back here that has all the picknick tables in there.”
Beyond being aesthetically pleasing, the park pays homage to the city’s history.
Specifically the 1915 east end wagon yard explosion which decimated downtown and killed 43 people which is symbolized by the parks train engine.
“This was the engine that brought all of the doctors and nurses into town to help get help to all these injured people,” said Maher.
To celebrate the completion of the park the main street authority is inviting the community out on Saturday the 21st for the inaugural depot day.
“There will be all kinds of fun,” said Maher. “Food trucks, bounce houses, the usual suspects face painters, balloon artists, were going to have games. Corn hole, giant Jenga, all kinds of games.”
There will also be musical guests and a ribbon cutting ceremony featuring city officials and Chickasaw Governor Bill Anoatubby.
The event begins at 11 a.m. and the main street authority hopes that it will be the first of many.
“Our hope in the future is that we’ll expand every year,” said Maher. “Ultimately we’ll go from this park to central park so we have our anchor on both ends of main street and we can bring in all the businesses.”
Copyright 2022 KXII. All rights reserved.
|
https://www.kxii.com/2022/05/13/depot-day-planned-ardmore-celebrate-new-depot-park/
| 2022-05-13T04:04:48Z
|
THE HAGUE, Netherlands (AP) — Police investigating suspected doping by the Tour de France team Bahrain Victorious seized more than 450 capsules of unidentified substances at a house in Slovenia during raids across Europe, the European agency Eurojust said Friday.
Riders and staff had their homes raided and the team’s hotel in Denmark was searched this week ahead of the three-week race which started on Friday in Copenhagen.
In a statement, the European Union Agency for Criminal Justice Cooperation (Eurojust) said 14 properties in six countries were searched and three people were interrogated.
Eurojust said “412 capsules with undetermined brown content and 67 capsules with undetermined white content” were found at a property in Slovenia, where a mobile phone was also seized.
Substances were also seized in Belgium, Italy and Poland, plus computers, phones and other electronic devices. Police also searched properties in Spain and seized potential evidence.
The investigation was opened in May and led by prosecutors in Marseille, France, Eurojust said, adding the target was “suspected doping violations involving an international cycling team.”
The team sponsored by the government of Bahrain also was raided by French police during last year’s Tour.
___
More AP sports: https://apnews.com/apf-sports and https://twitter.com/AP_Sports
|
https://cw33.com/sports/ap-sports/european-police-raid-bahrain-cycling-team-seize-evidence/
| 2022-07-02T15:11:14Z
|
Collaboration expands product and service portfolio for both organizations to support Industry 4.0 initiatives
STOW, Ohio, June 22, 2022 /PRNewswire/ -- Razorleaf Corporation, a consulting and systems integrator specializing in product life cycle management (PLM), today announced a new strategic partnership with iBASEt, the company that simplifies how complex products are built and maintained, to drive digital transformation for manufacturers to more effectively bring new products to market.
The partnership brings together two established leaders in manufacturing transformation to offer strategic consulting, deployment, and technical services built around iBASEt's Solumina iSeries platform, an industry-leading software solution that simplifies how complex manufacturing, quality, and MRO processes are managed and improved to support Industry 4.0 strategies.
"Razorleaf's expertise in Product Lifecycle Management (PLM) and Integration represents an expansion of our customer value," said Daniel Flick, VP of Global Alliances, iBASEt. "PLM data is fundamental to complex manufacturing operations, which rely on accurate, real-time engineering and production specifications. Successful Industry 4.0 initiatives drive the highest value when enabling a consistent digital thread across disparate systems. Razorleaf shares our vision to support product and operations innovation and help manufacturers accomplish their digital transformation initiatives."
"Our iBASEt partnership expands our application and technical expertise beyond PLM and Integration to encompass MES, MRO and Supply Chain -- which is a natural progression of how manufacturers are evolving their product processes into manufacturing," said Razorleaf CEO Eric Doubell. "This partnership opens new opportunities for our global clients who are considering expanding smart manufacturing initiatives to embrace the shop floor, supply chain and MRO. We look forward to working closely with iBASEt and delivering success for their customers."
iBASEt is a software company that simplifies how complex products are built and maintained. Founded in Southern California in 1986, iBASEt solutions ensure digital continuity across manufacturing, quality, and maintenance, repair, and overhaul (MRO) operations on a global scale. The iSeries, powered by Solumina, is a cloud-native platform that establishes a digital ecosystem to drive innovation and improve operational performance. With offices in the U.S., UK, France, and India, iBASEt customers include Lockheed Martin, Northrop Grumman, Honeywell Aerospace, Rolls Royce, Pratt & Whitney, and Textron. Learn more at iBASEt.com.
Founded in 2000, Razorleaf is a consulting & systems integrator with specialized expertise in PLM. We are focused on helping manufacturing organizations connect products and processes across the digital enterprise to drive more value from the innovation process. Led by a highly skilled and seasoned team of experts across the United States and Europe, Razorleaf transforms businesses by offering comprehensive consulting and implementation services focused on managing the digital thread across the product life cycle and supply chain. For more information, visit http://www.razorleaf.com.
View original content to download multimedia:
SOURCE Razorleaf Corporation
|
https://www.mysuncoast.com/prnewswire/2022/06/22/razorleaf-partners-with-ibaset-drive-manufacturing-transformation/
| 2022-06-22T15:32:01Z
|
MILWAUKEE, July 25, 2022 /PRNewswire/ -- Ademi LLP is investigating IEA (NASDAQ: IEA) for possible breaches of fiduciary duty and other violations of law in its transaction with MasTec.
Click here to learn how to join the action: https://www.ademilaw.com/case/infrastructure-energy-alternatives-inc or call Guri Ademi toll-free at 866-264-3995. There is no cost or obligation to you.
Ademi LLP alleges IEA's financial outlook and prospects are excellent and yet IEA holders will receive only $14.00 per share, comprised of $10.50 per share in cash and 0.0483 of a MasTec share, with a value of $3.50 per share, based on MasTec's closing share price on July 22, 2022. The transaction agreement unreasonably limits competing bids for IEA by imposing a significant penalty if IEA accepts a superior bid. IEA insiders will receive substantial benefits as part of change of control arrangements.
We are investigating the conduct of IEA's board of directors, and whether they are (i) fulfilling their fiduciary duties to all shareholders, and (ii) obtaining a fair and reasonable price for IEA.
If you own IEA common stock and wish to obtain additional information, please contact Guri Ademi either at gademi@ademilaw.com or toll-free: 866-264-3995, or https://www.ademilaw.com/case/infrastructure-energy-alternatives-inc.
We specialize in shareholder litigation involving buyouts, mergers, and individual shareholder rights throughout the country. For more information, please feel free to call us. Attorney advertising. Prior results do not guarantee similar outcomes.
Contacts
Ademi LLP
Guri Ademi
Toll Free: (866) 264-3995
Fax: (414) 482-8001
View original content to download multimedia:
SOURCE Ademi LLP
|
https://www.kxii.com/prnewswire/2022/07/25/shareholder-alert-ademi-llp-investigates-whether-infrastructure-amp-energy-alternatives-inc-has-obtained-fair-price-its-transaction-with-mastec/
| 2022-07-25T16:08:04Z
|
JonBenet Ramsey’s father wants outside agency to test DNA
DENVER (AP) — The father of JonBenet Ramsey is supporting an online petition asking Colorado’s governor to intervene in the investigation into her death more than 25 years ago by putting an outside agency in charge of DNA testing in the case.
The 6-year-old was found dead in the basement of her family’s home in Boulder on Dec. 26, 1996, bludgeoned and strangled, several hours after her mother called 911 to say her daughter was missing and a ransom note had been left behind. Her death was ruled a homicide, but nobody was ever prosecuted.
John Ramsey said he wants DNA evidence that was never tested before to be transferred away from Boulder police to a different agency, KUSA-TV reported Sunday.
“Somehow we’ve got to force the police, or take it away from them, the ability to go ahead and test some of the crime scene evidence that was never tested for DNA,” he said. “Why that’s never been done and will never be done by the police baffles me.”
The petition notes that advancements in DNA and the use of genetic genealogy is leading to the solving of more cold case around the country. It criticizes the Boulder Police Department for not doing enough to use DNA to solve the case, noting that the department said at the time of the 25th anniversary of JonBenet’s death that it was “actively reviewing genetic DNA testing processes” to see if those could be applied to the case.
In a statement, a spokesperson for Polis said “The State will review the petition and look into how the state can assist in using new technology to further investigate this cold case and to identify JonBenet Ramsey’s killer.” The statement did not address the involvement of Boulder police.
Meanwhile, the Boulder Police Department said it has been working with state law enforcement agencies and the FBI, on the investigation and that DNA from the case is regularly checked for any new matches. As of December, the Colorado Bureau of Investigation has updated over 750 DNA samples from the investigation with the latest DNA technology, the department said in a statement.
“We have a shared goal to bring justice—and hopefully some peace—to JonBenet’s family and everyone who was impacted by her loss,” Police Chief Maris Herold said in the statement.
The police department was criticized for its initial handling of the investigation into the death of JonBenet, who had competed in beauty pageants.
The details of the crime and video footage of JonBenet from the pageants propelled the case into one of the highest-profile mysteries in the United States, unleashing a series of true-crime books and TV specials.
While the district attorney at the time of JonBenet’s death said her parents were under “an umbrella of suspicion” early on, tests in 2008 on newly discovered DNA on her clothing pointed to the involvement of an “unexplained third party” in her slaying, and not her parents, John and Patsy Ramsey, or their son, Burke. That led former district attorney Mary Lacy to clear the Ramseys of any involvement, two years after Patsy Ramsey died of cancer, calling the couple “victims of this crime.”
Copyright 2022 The Associated Press. All rights reserved.
|
https://www.mysuncoast.com/2022/05/02/jonbenet-ramseys-father-wants-outside-agency-test-dna/
| 2022-05-02T20:49:21Z
|
Laramie County deputy shot, suspect killed in Cheyenne
CHEYENNE, Wyo. (AP) — A Laramie County sheriff’s deputy is expected to recover from a gunshot wound he sustained in an exchange of fire with a person suspected of assaulting and robbing a student at Laramie County Community College. The sheriff’s office says the suspect was killed in the exchange, which occurred off-campus. Sheriff’s Capt. Don Hollingshead tells The Wyoming Tribune Eagle that the deputy, whose name was not released, was wounded after a brief vehicle chase in Cheyenne following the alleged assault and robbery on Saturday. The deputy was listed in stable condition at Cheyenne Regional Medical Center and is expected to recover. The name of the person killed and other information about the incident were being withheld Sunday.
|
https://localnews8.com/news/ap-wyoming/2022/04/03/laramie-county-deputy-shot-suspect-killed-in-cheyenne/
| 2022-04-03T22:15:45Z
|
Newest Product Streamlines Health Plan RFP Process and Increases Efficiencies
OVERLAND PARK, Kan., June 22, 2022 /PRNewswire/ -- Quest Analytics, the leader in provider network management solutions and services, today launched the company's newest software innovation, Quest Enterprise Services (QES) Access Reporting, at AHIP 2022 in Las Vegas. Designed to simplify the health plan response for proposal (RFP) process for employer groups, QES Access Reporting provides sales teams with a cloud-based, self-service environment that cuts report generation time by 50% and increases volume by 37% with no change to staffing. Not only does QES Access Reporting streamline the RFP reporting process, but it also quickly demonstrates how the network meets the requestor's business needs, increases response time and transparency of the network, and enhances cross-team collaboration to get information to decision-makers sooner.
"Responding quickly and efficiently to employer group RFPs with optimal and differentiated networks is vital to a health plan's growth and success," said Barbara Dumery, Chief Product Officer, Quest Analytics. "We created QES Access Reporting to empower health plan sales teams to create these network reports in a self-service environment with a quick turnaround time to increase the number of selling opportunities as well as improve win rates and drive success."
At AHIP 2022, Quest Analytics will demonstrate the benefits and functionality of QES Access Reporting at the Company's booth #306. In addition, Quest Analytics' Chairman Roger Holstein will speak about health equity and what health plans can do to ensure that access to care is, in fact, equal access. The session entitled, "Can we transform health plan networks into health equity networks," will take place on Wednesday, June 22, from 2:45 p.m. to 3:30 p.m. PT as part of the Data, Analytics, and Actionable Intelligence track. For more information, or to book a session with a Quest Analytics representative onsite at AHIP, click here.
Quest Analytics' software platform and services are trusted by more than 400 clients, including all eight of the nation's largest health plans, regulators, including the Centers for Medicare and Medicaid Services (CMS) and multiple state regulatory agencies, and many of the nation's leading health systems and provider groups to manage, measure and monitor health plan network performance. The company helps 90% of all healthcare networks deliver differentiated member experiences, thereby impacting 90% of Americans' ability to access quality healthcare. For more information, please visit www.questanalytics.com.
View original content to download multimedia:
SOURCE Quest Analytics
|
https://www.mysuncoast.com/prnewswire/2022/06/22/quest-analytics-launches-qes-access-reporting/
| 2022-06-22T12:27:52Z
|
HILLSDALE, Mich., Sept. 15, 2022 /PRNewswire/ -- CNB Community Bancorp, Inc. (OTCQX: CNBB) announced that the Board of Directors has declared a quarterly cash dividend on the Company's common stock in the amount of $0.28 per share, an increase of $0.01 from the dividend paid for the 2nd Quarter of 2022, payable on October 14, 2022 for shareholders of record on September 30, 2022.
About CNB Community Bancorp, Inc.
CNB Community Bancorp Inc. (OTCQX: CNBB) is a one-bank holding company. Its subsidiary bank, County National Bank ("CNB"), is a nationally chartered full-service community bank that also offers investment management and trust services, which has been serving South Central Michigan since 1934. In 2022, CNB was ranked 30th in American Banker Magazine's Top 200 publicly traded banks under $2 billion and CNB has grown to over $1 billion in assets. The corporate headquarters are in Hillsdale, Michigan. CNB provides a wide array of financial products and services through its 13 full-service offices and 19 ATMs.
View original content:
SOURCE CNB Community Bancorp, Inc.
|
https://www.kxii.com/prnewswire/2022/09/15/cnb-community-bancorp-inc-declares-quarterly-cash-dividend-028-per-share/
| 2022-09-15T20:56:46Z
|
New Styles Feature Eco-Conscious Materials & Classic Dead Head Details
GOLETA, Calif., June 9, 2022 /PRNewswire/ -- Sanuk, a division of Deckers Brands (NYSE: DECK), today announced the sixth iteration of its ongoing collaboration with iconic rock band the Grateful Dead, powered by Warner Music Artist Services. The capsule collection features a premium lineup of men's and women's summer styles made with natural, repurposed and recycled materials and honors the Grateful Dead's legacy with iconic band logos.
This fresh Sanuk x Grateful Dead collection introduces four new styles and colorways to the collaboration roster, featuring new earth tones, floral boho patterns and funky geometric pops of color. Special Dead details in the collaboration include debossed band emblems, band tags, premium printed footbeds and stamped hemp-lined uppers.
- The Sanuk Avery Lace x GRATEFUL DEAD is an ultra-comfy packable women's sneaker made with sustainable materials like hemp and cotton, recycled polyester and high rebound BLOOM™ x Soft Top Foam insoles made from repurposed algae.
- The Sanuk Lola x GRATEFUL DEAD women's sandal rises up to comfort paradise, featuring comfy hemp blend slide straps with breezy, printed hemp lining and high rebound BLOOM™ x Soft Top Foam footbeds, in addition to other eco-friendly materials like hemp, cotton, recycled polyester and responsible leather.
- The Sanuk Bixby x GRATEFUL DEAD men's sandal stars super soft suede-lined footbeds on high rebound BLOOM™ x Soft Top Foam midsoles with an adjustable hook and loop closure for the perfect fit and elevated, celestial-level comfort.
- The Sanuk Tideline Lace x GRATEFUL DEAD is a stylish, versatile men's sneaker decked out with groovy band details and custom Dead artwork. Crafted with sustainable and recycled materials like RPET, hemp, recycled polyester and BLOOM™ x Soft Top Foam footbeds made from repurposed algae, these kicks provide a comfy trip to your happy place.
"This expansion of our partnership with the band embodies a trendy, retro look and an especially comfy feel," said Seth Pulford, Director of Marketing at Sanuk. "In classic Grateful Dead fashion, this collection is timeless. Dead Heads of all ages can rock these comfy new styles in celebration of the band's transcendent legacy."
The sixth installment of the SANUK & GRATEFUL DEAD™ collection launches today exclusively on Sanuk.com. Retail prices range from $50-70.
For more information about the SANUK & GRATEFUL DEAD™ collection, visit www.sanuk.com/grateful-x-grateful-dead-collaboration or follow along on Instagram @sanuk #smilepassiton.
About Grateful Dead
Grateful Dead is a social and musical phenomenon that grew into a genuine American treasure. In 1965, an entire generation was linked together by common ideals, gathering by the hundreds and thousands. This movement created a seamless connection between the band and its fans. As the band toured, Dead Heads would follow. Not because it was a part of popular culture, but because it is a true counterculture that exists to this very day-one that earnestly believes in the value of its beliefs. By 1995, Grateful Dead had attracted the most concert goers in the history of the music business, and today remain one of the all-time leaders in concert ticket sales. Eventually, the caravan evolved into a community with various artists, craftsmen and entrepreneurs supplying a growing demand for merchandise that connected them to the music. Today, the connection is as strong as ever. The band was inducted into the Rock & Roll Hall Of Fame in 1994 and received a Grammy® Lifetime Achievement Award in 2007. Their final tally of 2,318 total concerts remains a world record. The Grateful Dead recently celebrated their 52nd top 40 album on the Billboard chart, a feat no other group has achieved.
About SANUK®
Welcome to the world of Sanuk. We're an unconventional footwear brand on a mission to be the outfitter for the journey to your happy place. In 1997, we were founded with one simple goal: to make people smile....and pass it on. In the world of Sanuk, smiles are always wider…every step of the way to your happy place. For more information, visit sanuk.com or follow @sanuk #smilepassiton
About Deckers Brands
Deckers Brands is a global leader in designing, marketing and distributing innovative footwear, apparel and accessories developed for both everyday casual lifestyle use and high performance activities. The Company's portfolio of brands includes UGG®, KOOLABURRA®, HOKA ONE ONE®, Teva®, and Sanuk®. Deckers Brands products are sold in more than 50 countries and territories through select department and specialty stores, Company-owned and operated retail stores, and select online stores, including Company-owned websites. Deckers Brands has a 40-year history of building niche footwear brands into lifestyle market leaders attracting millions of loyal consumers globally. For more information, please visit www.deckers.com.
Media Contact:
Emily Roethle, Crowe PR
eroethle@crowepr.com
(909) 957-7646
View original content to download multimedia:
SOURCE Sanuk
|
https://www.kxii.com/prnewswire/2022/06/09/latest-sanuk-amp-grateful-dead-collection-offers-summertime-slip-on-sandals/
| 2022-06-09T10:56:52Z
|
Charita Goshay: Canton's Charles Keith helps Texas mother fight execution
Sometimes, you don't get to choose what you want to do with your life.
Sometimes, it chooses you.
Last month, Melissa Lucio of Brownsville, Texas, came within a hair's breadth of becoming the first woman in Texas to be executed.
More:Listen to Melissa Lucio hear that her execution was halted
She had been convicted of killing her toddler daughter. Mounting evidence suggests that Lucio may indeed be innocent. It's caused 103 members from the Texas Legislature, and five jurors from her trial to call for stay of execution, which was granted late last month.
It is believed by her supporters that the little girl died as a result of an accidental fall down a set of steps the day before she died.
Among those offering support was Charles Keith of Canton who traveled to Brownsville to advise the family as a community liaison with the Death Penalty Action, a national anti-death penalty organization.
More:Canton man's new mission: Eliminating Ohio's death penalty
"The family had no idea what to do," Keith said. "We were preparing them how to engage with the media. We were able to get them going. They had great family support."
Educating the state
Keith said he and Death Penalty Action founder Abe Borowitz traversed the state on Lucio's behalf.
"People were very receptive everywhere we went," he said. "We were educating the state."
For nearly 30 years, Keith has been fighting on behalf of his younger brother Kevin, who had his execution for a triple murder in Bucyrus in 1994 commuted to life in prison.
No physical evidence has linked Kevin Keith to the crime. He continues to maintain his innocence. To help his brother, Charles Keith put his own life on hold and managed to uncover enough evidence to convince former Gov. Ted Strickland to issue the commutation in 2010.
Kevin Keith's case was specifically cited by President Bill Clinton when he visited Bucyrus to tout the crime bill in 1994.
A new investigative piece in The Atlantic on investigations conducted by former Ohio Bureau of Criminal forensic scientist G. Michelle Yezzo cites Kevin Keith's case.
Charles Keith's one-man crusade has resulted in documentaries about his brother's case, and has drawn the support and attention of former federal prosecutor Justin Herdman, former Ohio Attorney General Lee Fisher, former Ohio Secretary of State Jim Petro, and Kim Kardashian, who has take up the issue of prison reform while pursuing a law degree.
Last year, Charles Keith's devotion turned into a job.
Lucio, the mother of 14, remains in prison while her request for a new trial winds it way through the courts.
"It was definitely shown she didn't kill her baby; she fell down the steps," Charles Keith said. "If they had let her children testify, she wouldn't have been prosecuted. There was no physical evidence. She had a deformed foot. She had fallen down stairs while in foster care, hitting head on the floor. When they brought that baby home, they never told (Lucio) about the injuries. I actually discovered those documents. This was the first time we've gone in deep, not just rallying, but fighting."
There also are reports that police used an abusive interviewing tactic known as the "Reid Method" during Lucio's interrogation, coercing a confession.
'She's a beautiful person.'
Meanwhile, former Cameron County District Attorney Armando Villalobos, who tried Lucio's case, has been accused of ignoring or botching 100 allegations of child abuse.
Critics accuse him of using Lucio's case during an election year to present himself as tough on crime. He currently is serving 13 years in federal prison on bribery and extortion charges.
"He cost the state millions of dollars," Charles Keith said. "Why is Melissa still in prison when there was no crime committed? She never got a chance to grieve. She wrote me a letter and touched my heart. She's a beautiful person."
He's motivated by his deep belief that the death penalty violates Christian principles.
"I'm fighting in the name of Jesus, in the name of the executed ones," he said. "The execution of anyone is wrong whether they're guilty or innocent. Jesus told a murderer 'This day you shall be in paradise.' The rest of us are trying to figure out how to get into heaven, and a murderer is already sitting there."
After Texas, Charles Keith traveled to Arizona to fight another scheduled execution.
"Julius Jones, Melissa, Kevin Keith, they're all innocent; that's the thing." he said. "I think they've all been victims of the 1994 crime bill. Things have changed but my brother is still incarcerated."
Charita M. Goshay is a Canton Repository staff writer and member of the editorial board. Reach her at 330-580-8313 or charita.goshay@cantonrep.com. On Twitter: @cgoshayREP
|
https://www.cantonrep.com/story/opinion/2022/05/15/cantons-charles-keith-helped-texas-woman-fight-her-execution-charita-goshay/9731679002/
| 2022-05-15T14:38:43Z
|
The ecosystem includes solutions like BigCommerce, Netlify, and Cloudinary that work with Storyblok's headless CMS
LINZ, Austria, June 20, 2022 /PRNewswire/ -- Storyblok, an enterprise headless content management system (CMS) that enables developers and marketers to deliver powerful content experiences on any digital platform, today announced the launch of its Technology Ecosystem. This new program is a curated collection of MACH-ready technology solutions that can be integrated together, with Storyblok as the central content hub.
Storyblok's Technology Ecosystem contains an initial group of 15 partners, including BigCommerce, Netlify, and Cloudinary. Storyblok provides integrations for e-commerce, localization, deployment and hosting, personalization, marketing, analytics, and more to allow businesses to build successful digital experiences across channels on top of best-of-breed, composable technology.
"In the last few years, Storyblok's customers have already built more than 120,000 projects, not only on top of our headless CMS, but in a composable manner with multiple technologies connected," said Barry D'Arcy, VP of Partners at Storyblok. "We want to offer businesses a strong ecosystem of powerful API-led technologies to support the growth of their digital offerings. Partnering with other best-in-class solutions allows us to co-innovate within the ecosystem and deliver better digital outcomes."
"Jamstack is an approach to build for the web that has generated a large global community and movement over the past six years," said Sarfaraz Rydhan, Senior Director of Business Development at Netlify. "Netlify is focused on bringing the modern web community together and enabling the benefits of Jamstack with our platform alongside partners and customers. We are delighted to be part of Storyblok's Technology Ecosystem to help empower our customers to build better digital experiences with the Jamstack."
"Cloudinary firmly believes in establishing relationships with other software companies that share our belief in headless, API-first software and composable technology - which is why we're so excited to be a part of the Storyblok Technology Ecosystem," said Gary Ballabio, VP of Technology Partnerships at Cloudinary.
Read more about the Technology Ecosystem on Storyblok's blog, and visit the Technology Ecosystem page to see the full list of partners and learn how to become a partner.
- View Storyblok's press kit: https://www.storyblok.com/press
- See case studies: https://www.storyblok.com/case-studies
- Learn more about Storyblok: https://www.storyblok.com
Storyblok is a headless CMS that enables developers and marketers to deliver powerful content experiences on any digital platform. Developers create flexible components that are independently managed by content teams through a collaborative visual editor and customizable workflow. Published content is delivered through an API, so changes are made once and will appear everywhere: websites, mobile, IoT, the metaverse, and beyond. This approach reduces maintenance and makes content management more efficient. Leading brands such as Adidas, Renault, and Marc O'Polo use Storyblok to manage and share their content with the world. Storyblok was named the #1 CMS for 2022 by G2.
For more information, visit https://www.storyblok.com and follow Storyblok on LinkedIn and Twitter.
Press Contact
Brandon Watts
brandon.watts@storyblok.com
View original content:
SOURCE Storyblok
|
https://www.kxii.com/prnewswire/2022/06/20/storyblok-launches-technology-ecosystem-help-businesses-build-scalable-digital-experiences/
| 2022-06-20T07:23:58Z
|
HAYWARD, Calif., Sept. 6, 2022 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), ("AcelRx"), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for use in medically supervised settings, today announced that Chief Executive Officer, Vince Angotti will present in-person and be available for one-on-one meetings throughout the H.C. Wainwright Annual Investment Conference, to be held in person and virtually September 12-14, 2022 in New York, NY.
H.C. Wainwright Annual Investment Conference
Format: Live presentation and 1x1 Meetings
Date: Monday, September 12th, 2022
Time: 12:00 PM EDT
Webcast Link: [CLICK HERE]
The recorded presentation will also be available for 90 days on AcelRx's website within the Investors/News/Events section.
This release is intended for investors only. For more information, including important safety information and black box warning for DSUVIA, please visit www.DSUVIA.com.
AcelRx Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for use in medically supervised settings. AcelRx's proprietary, non-invasive sublingual formulation technology delivers sufentanil with consistent pharmacokinetic profiles. The Company has one approved product in the U.S., DSUVIA® (sufentanil sublingual tablet, 30 mcg), approved as DZUVEO® in Europe, indicated for the management of acute pain severe enough to require an opioid analgesic for adult patients in certified medically supervised healthcare settings, and several product candidates. The Company's product candidates include: two developmental pre-filled, ready-to-use syringes of ephedrine and phenylephrine licensed for the U.S. from Aguettant; Niyad™, a developmental device for use as a regional anticoagulant for the extracorporeal circuit; LTX-608, for the potential treatment of COVID-19, disseminated intravascular coagulation, acute respiratory distress syndrome and acute pancreatitis; and Zalviso® (sufentanil sublingual tablet system, SST system, 15 mcg), an investigational product in the U.S. being developed as an innovatively designed patient-controlled analgesia (PCA) system for reduction of moderate-to-severe acute pain in medically supervised settings.
This release is intended for investors only. For additional information about AcelRx, please visit www.acelrx.com.
View original content to download multimedia:
SOURCE AcelRx Pharmaceuticals, Inc.
|
https://www.kxii.com/prnewswire/2022/09/06/acelrx-pharmaceuticals-participate-hc-wainwright-annual-investment-conference/
| 2022-09-06T22:04:34Z
|
CHICAGO, Aug. 8, 2022 /PRNewswire/ -- 3Cloud's rapid growth and continued innovation in managed services was recognized by two prestigious organizations, Channel E2E and Channel Futures, naming 3Cloud as top managed services provider globally. 3Cloud's Managed Services practice experienced over 100% year-over-year growth from 2020 to 2021.
"3Cloud is honored to be recognized for the growth our Managed Services team has made in the breadth of services offered along with our vertical offerings," said Mark Nelson, Vice President Managed Services. "3Cloud recognizes that to provide the Ultimate Azure Experience, our customers require innovative and secure Managed Services allowing them to focus on their critical business priorities while we handle their infrastructure, application, and data analytics support. We are proud to have our Managed Services team recognized for their passion and expertise provided to our customers."
The annual Top 100 Vertical Market MSPs list and research, according to ChannelE2E (hashtag: #MSP100) identify and honor the top 100 managed services providers (MSPs) in healthcare, legal, government, financial services, manufacturing and additional vertical markets. 3Cloud was ranked among the top vertical market MSPs in the Financial Services vertical.
This year's research revealed several key MSP business, security and market trends. Key takeaways include:
- Surging MSP Revenues: Honorees generated a combined $3.05 billion in vertical market annual recurring revenue (ARR) in 2021, up 42% from $2.14 billion million in 2020. The surge involved extremely strong MSP merger and acquisition (M&A) activity; accelerated demand for cloud & cybersecurity services; and successful MSP pivots amid the continued COVID-19 pandemic.
- Key Verticals: The most successful vertical market MSPs are zeroing in on healthcare and manufacturing, with continued strong interest in financial services, legal and government opportunities.
- Managed Security Services: All of the honorees offer some form of managed security services – particularly backup and disaster recovery (96%), endpoint detection & response (EDR, 88%) and managed detection and response (MDR), 82%). Moreover, the MSPs increasingly focus on emerging areas such as Cloud Security Posture Management (CSPM, 49%) and eXtended Detection and Response (XDR, 38%).
- End-Customer Reach: The Top 100 Vertical Market MSPs now manage more than 6.1 million users across their customer sites as of 2021, up from 3.1 million in 2020.
- Top 10 Strategic Technology Partners: MSPs consider their top vertical market technology partners to be Microsoft (46%), ConnectWise (18%), Datto (18%), Cisco Systems (15%), Dell Technologies (14%), Ingram Micro (13%), Amazon Web Services (10%), SentinelOne (10%), Fortinet (9%) & Tech Data (7%).
"ChannelE2E and CyberRisk Alliance congratulate 3Cloud on this honor," said Amy Katz, executive VP and general manager of ChannelE2E, a CyberRisk Alliance resource. "Businesses worldwide increasingly outsource their most critical security, business automation and IT management requirements to the world's Top 100 Vertical Market MSPs."
3Cloud was also selected as one of the technology industry's top-performing providers of managed services by the editors of Channel Futures. For the past 16 years, managed service providers (MSPs) from around the globe have submitted applications to be included in this prestigious and definitive listing. The Channel Futures survey examines organizational performance based on annual sales, recurring revenue, profit margins, revenue mix, growth opportunities, innovation, technology solutions supported, and company and customer demographics.
MSPs that qualify for the list must pass a rigorous review conducted by the research team and editors of Channel Futures. It ranks applicants using a unique methodology that weighs financial performance according to long-term health and viability, commitment to recurring revenue and operational efficiency.
"We extend our heartfelt congratulations to the 2022 winners, and gratitude to the thousands of MSPs that have contributed to the continuing growth and success of the managed services sector," said Kelly Danziger, general manager of Informa Tech Channels. "These providers are most certainly driving a new wave of innovation in the industry and are demonstrating a commitment to moving the MSP and entire channel forward."
3Cloud's vision is to create the Ultimate Azure Experience for our customers, employees and stakeholders. 3Cloud recently hit a milestone by hiring its 600th full-time Azure expert. With a team of industry leaders, 3Cloud accelerates digital transformation across data and analytics, application innovation and cloud platform.
Since its beginning in 2016, 3Cloud has experienced unprecedented growth organically and through acquisitions and continues to outpace the Azure market growth of 46% year-over-year. Backed by Gryphon Investors since 2020, 3Cloud is the largest Azure exclusive Microsoft partner. 3Cloud was recently recognized as a top Microsoft Partner and received six 2022 Microsoft Partner of the Year Awards, including Migration to Azure and Solution Assessments.
As a top Microsoft services partner focused 100% on the Azure platform, 3Cloud helps clients build, migrate, modernize and manage their applications, infrastructure, data and analytics in the cloud. Founded by Mike Rocco and Jim Dietrich who served over 15 years together at Microsoft, 3Cloud combines a team of highly experienced cloud architects and technologists with a strong network of Microsoft sales and engineering relationships to deliver the ultimate Azure experience for clients. 3Cloud is headquartered in Chicago and serves clients throughout the U.S. To learn more, visit www.3cloudsolutions.com.
ChannelE2E (www.ChannelE2E.com), a CyberRisk Alliance resource, is the leading digital destination for MSPs, IT service providers, channel partners and strategic investors seeking to maximize their business valuations, mitigate business risk and maximize security -- from Entrepreneur to Exit.
CyberRisk Alliance (CRA) is a business intelligence company serving the high growth, rapidly evolving cybersecurity community with a diversified portfolio of services that inform, educate, build community, and inspire an efficient marketplace. Our trusted information leverages a unique network of journalists, analysts and influencers, policymakers, and practitioners. CRA's brands include SC Media, Security Weekly, InfoSec World, Cybersecurity Collaboration Forum, our research unit CRA Business Intelligence, the peer-to-peer CISO membership network, Cybersecurity Collaborative, and now Identiverse, ChannelE2E and MSSP Alert.
Channel Futures is a media and events platform serving companies in the information and communication technologies (ICT) channel industry with insights, industry analysis, peer engagement, business information and in-person events. We provide information, perspective, and connection for the entire channel ecosystem. This community includes technology and communications consultants, integrators, sellers, MSPs, agents, vendors and providers.
Our properties include the Channel Futures MSP 501, a list of the most influential and fastest-growing providers of managed services in the technology industry; Channel Partners events, which delivers unparalleled in-person events including Channel Partners Conference & Expo, the MSP 501 Summit and Channel Partners Europe; and Allies of the Channel Council (ACC) and DEI Community Group, our initiatives to educate, support and promote diversity, equity and inclusion (DE&I) in the ICT channel industry. Channel Futures is where the world meets the channel; we are leading Channel Partners forward. More information is available at channelfutures.com.
Channel Futures is part of Informa Tech, a market-leading B2B information provider with depth and specialization in ICT sector. Every year, we welcome 14,000+ subscribers to our research, more than 4 million unique monthly visitors to our digital communities, 18,200+ students to our training programs and 225,000 delegates to our events.
View original content to download multimedia:
SOURCE 3Cloud
|
https://www.mysuncoast.com/prnewswire/2022/08/08/3cloud-recognized-by-channele2e-channel-futures-top-managed-services-provider/
| 2022-08-08T17:48:58Z
|
KABUL, Afghanistan (AP) — A powerful earthquake struck a rural, mountainous region of eastern Afghanistan early Wednesday, killing 1,000 people and injuring 1,500 more in one of the deadliest temblors in decades, the state-run news agency reported. Officials warned that the already grim toll may still rise.
Information remained scarce on the magnitude 6.1 temblor near the Pakistani border, but quakes of that strength can cause severe damage in an area where homes and other buildings are poorly constructed and landslides are common. Experts put the depth at just 6 miles — another factor that could lead to severe destruction.
The disaster posed a major test for the Taliban-led government, which seized power last year as the U.S. planned to pull out from the country and end its longest war, two decades after toppling the same insurgents in the wake of the 9/11 attacks.
Rescuers rushed to the area by helicopter Wednesday, but the response is likely to be complicated since many international aid agencies left Afghanistan after the Taliban takeover. Reaching rural areas even in the best circumstances remains difficult in Afghanistan, a landlocked nation just smaller than Texas with rutted mountain roadways that may now have sustained significant damage.
Neighboring Pakistan’s Meteorological Department said the quake's epicenter was in Afghanistan's Paktika province, some 31 miles southwest of the city of Khost. Buildings were also damaged in Khost province, and tremors were felt 230 miles away in the Pakistani capital of Islamabad.
Footage from Paktika showed men carrying people in blankets to waiting helicopters. Others were treated on the ground. One resident could be seen receiving IV fluids while sitting in a plastic chair outside the rubble of his home and still more were sprawled on gurneys. Some images showed residents picking through clay bricks and other rubble from destroyed stone houses, some of whose roofs or walls had caved in.
The death toll given by the Bakhtar News Agency was equal to that of a quake in 2002 in northern Afghanistan. Those are the deadliest since 1998, when a 6.1 magnitude temblor and subsequent tremors in Afghanistan’s remote northeast killed at least 4,500 people.
In most places in the world, an earthquake of that magnitude wouldn’t inflict such extensive devastation, said Robert Sanders, a seismologist with the U.S. Geological Survey. But a quake’s death toll more often comes down to geography, building quality and population density.
“Because of the mountainous area, there are rockslides and landslides that we won’t know about until later reporting. Older buildings are likely to crumble and fail,” he said. “Due to how condensed the area is in that part of the world, we’ve seen in the past similar earthquakes deal significant damage.”
The Taliban are still trying to reconstitute government ministries abandoned by staff loyal to its previous Western-backed government, and it was not clear how officials arrived at the casualty tolls reported by Bakhtar.
In Kabul, Prime Minister Mohammad Hassan Akhund convened an emergency meeting at the presidential palace to coordinate the relief effort, and Bilal Karimi, a deputy spokesman for the Taliban government, wrote on Twitter to urge aid agencies to send teams to the area.
The “response is on its way,” the U.N. resident coordinator in Afghanistan, Ramiz Alakbarov, wrote on Twitter.
That may prove difficult given the situation Afghanistan finds itself in today. After the Taliban swept across the country in 2021, the U.S. military and its allies fell back to Kabul’s Hamid Karzai International Airport and later withdrew completely. Many international humanitarian organizations followed suit because of concerns about security and the Taliban's poor human rights record.
In the time since, the Taliban has worked with Qatar, Turkey and the United Arab Emirates on restarting airport operations in Kabul and across the country — but nearly all international carriers still avoid the country, and reluctance on the part of aid organizations to put any money in the Taliban's coffers could make it difficult to fly in supplies and equipment.
The Afghan Red Crescent Society, however, sent some 4,000 blankets, 800 tents and 800 kitchen kits to the affected area, according to Bakhtar’s director-general, Abdul Wahid Rayan.
The Italian medical aid group Emergency, which still operates in Afghanistan, said it sent seven ambulances and staff to the areas closest to the quake zone.
“The fear is that the victims will increase further, also because many people could be trapped under collapsed buildings,” said Stefano Sozza, country director for Emergency in Afghanistan. “This latest tragedy cannot but worsen further the condition of fragility and economic and social difficulties which Afghanistan has experienced for months.”
Pakistan’s Prime Minister Shahbaz Sharif said his nation would provide help. At the Vatican, Pope Francis offered prayers for all those killed and injured and for the “suffering of the dear Afghan population.”
Some remote areas of Pakistan saw reports of damage to homes near the Afghan border, but it wasn’t immediately clear if that was due to rain or the earthquake, said Taimoor Khan, a disaster management spokesperson in the area.
The European seismological agency, EMSC, said the earthquake’s tremors were felt over 310 miles by 119 million people across Afghanistan, Pakistan and India.
Mountainous Afghanistan and the larger region of South Asia along the Hindu Kush mountains has long been vulnerable to devastating earthquakes.
___
Associated Press writers Rahim Faiez and Munir Ahmed in Islamabad and Jon Gambrell and Isabel DeBre in Dubai, United Arab Emirates, contributed to this report.
|
https://www.tdtnews.com/news/article_0409c7f8-f224-11ec-8897-436c99607aea.html
| 2022-06-22T13:30:29Z
|
First of its kind security label will enable retailers to effectively protect metallic merchandise
THOROFARE, N.J., May 2, 2022 /PRNewswire/ -- Solving one of the perennial problems associated with protecting merchandise using RF-based Electronic Article Surveillance (EAS) systems, Checkpoint Systems has today announced it has developed a unique security label specifically for metallic items.
Delivering a shrink reduction of up to 50% during trails with leading US and European retailers, the Checkpoint RF Metal™ Label will give retailers even more options when it comes to protecting metallic items.
Protecting at-risk items
Historically, hardware items like paint tins, drill bits and wrenches, as well as food and beauty products packaged in metallic materials, like foil and cans, have been difficult to protect without using defensive tactics, such as display cabinets. This is because the metallic material on such products absorbs the RF energy, making it harder to detect items passing out of the store.
With over 50 years' experience developing innovative solutions that meet the demands of retailers around the world, Checkpoint has revealed another industry first, becoming the only security label supplier with a dedicated solution to address this age-old concern.
Outstanding trial results
During a series of trials at retailers around the world, the Metal Label delivered incredible results – reducing shrinkage across all product types, including canned tuna, baby formula, deodorants, face creams and foil-lined coffee products. Over a six-week period, one line saw shrinkage reduce by as much as 85% by simply applying the new label, while shrink was at least halved on most other products.
The Metal Label can be quickly applied in-store or at source and can be used on most metallic object to create a strong visual deterrent. It will give retailers peace of mind that their at-risk items can now be displayed in prime positions whilst still being protected. And, importantly, it will not impact the customer experience, with the small label having minimal effect on the visual appearance of products.
Ivan Gosling, Global Product Manager at Checkpoint Systems, commented:
"This label is a game-changer for retailers. Since RF technology was introduced, there has always been a problem protecting metallic merchandise. Some retailers have learned to live with it, others have resorted to defensive measures, such as display cabinets, which naturally affect customer engagement and subsequently sales. The Metal Label is enabling most types of metallic items to now be protected in open display environments, and shrinkage can be cut significantly."
Checkpoint's RF Metal Label is available immediately.
About Checkpoint Systems, Inc. (www.checkpointsystems.com)
About CCL Industries
CCL Industries Inc., a world leader in specialty label and packaging solutions for global corporations, small businesses and consumers, employs approximately 19,000 people and operates 150 facilities in 25 countries on six continents with corporate offices in Toronto, Canada, and Framingham, Massachusetts. For more information, visit www.cclind.com.
View original content to download multimedia:
SOURCE Checkpoint Systems, Inc.
|
https://www.mysuncoast.com/prnewswire/2022/05/02/checkpoint-reveals-new-rf-label-that-slashes-shrink-metallic-items-by-up-50/
| 2022-05-03T00:45:19Z
|
Preliminary 3.3 magnitude quake jolts South Carolina
COLUMBIA, S.C. (AP) - A relatively rare East Coast earthquake centered just northeast of South Carolina’s capital city jolted large numbers of state residents awake early Monday, rocking the Southern state at a preliminary 3.3 magnitude, authorities said.
There were no immediate reports of any damages or injuries.
The pre-dawn temblor lasted only seconds but hundreds of people took to social media to describe being shaken from sleep when the quake hit shortly after 1:30 a.m. A seismic analyst monitoring the quake for the USGS Geological Survey’s National Earthquake Information Center in Colorado, called it the latest in a series of shakes in recent months but stronger than usual.
“There’s definitely been a ‘swarm’ here over the past several months. It’s not like a swarm like after a large seismic event but we have had a number of them in recent months,” geophysicist Amy Vaughan with the 24-hour monitoring service told The Associated Press by phone.
Vaughan said the 3.3 magnitude is an early assessment and could change, adding the quake had an epicenter of about 1.5 miles (3.1 kilometers) below the earth’s surface near the community of Elgin. That location is about 25 miles (40 kilometers) northeast of downtown Columbia, the capital city.
Those awakened reported feeling the earth shaking for several seconds and some even described what sounded like a heavy truck moving nearby. Vaughan said only an hour afterward she had reports pouring in to the quake monitoring center.
“I have not heard of any damage reports so far but have had over a thousand ... reports,” she said. “If people were sleeping they obviously would have been woken up and things might have been rattling off shelves or countertops but not the kind of shaking or intensity to cause damage of any significance.”
Still, she called it “alarming for sure” and said some lesser aftershocks were possible in coming days or weeks. She noted there were quakes of a preliminary 2.0 or higher in April and March and others going back little more than four months in the region — and a 3.3 quake last December.
She said the quake was a rather shallow one, fairly close to the surface, which made it felt, adding the area has been experiencing other shocks recently.
Two dozen minor quakes have rattled near Columbia since the end of last year, more than the 20 typically averaged by the state in an entire year, according to the South Carolina Emergency Management Division. Elgin is along a large fault system that extends from Georgia through the Carolinas and into Virginia.
Last year, the area near Jenkinsville — about 40 miles (60 kilometers) west of this group of tremors — registered six small earthquakes in over a week, with three quakes registered on a single day alone.
According to emergency management officials, about 70% of South Carolina earthquakes are located in the Middleton Place-Summerville Seismic Zone, about 12.4 miles (20 kilometers) northwest of Charleston.
In 1886, that historic coastal city was home to the largest recorded earthquake in the history of the southeastern United States, according to seismic officials. The quake, thought to have had a magnitude of at least 7, left dozens of people dead and destroyed hundreds of buildings.
That event was preceded by a series of smaller tremors over several days, although it was not known that the foreshocks were necessarily leading up to something more catastrophic until after the major quake.
___
Meg Kinnard can be reached at http://twitter.com/MegKinnardAP.
Copyright 2022 The Associated Press. All rights reserved.
|
https://www.wibw.com/2022/05/09/preliminary-33-magnitude-quake-jolts-south-carolina/
| 2022-05-09T07:57:28Z
|
- HanAll Biopharma and Daewoong Pharmaceutical invest in the broad potential of Turn Biotechnologies
- Turn has developed a novel cell rejuvenating platform with significant potential for application in an array of age-related diseases
SEOUL, South Korea, April 12, 2022 /PRNewswire/ -- HanAll Biopharma (KRX: 009420.KS) and Daewoong Pharmaceutical (KRX: 069620.KS) today announced expansion of their open collaboration strategy by investing in Turn Biotechnologies, a Silicon Valley based company focused on developing novel mRNA medicines. The companies are supporting Turn Bio's continued development of a high-potential platform and are009420 considering future long-term collaborations.
Turn Bio is a pre-clinical-stage biopharmaceutical company focused on cellular repair via epigenetic reprogramming of cells. The technological foundation for Turn Bio's proprietary Epigenetic Reprogramming of Age (ERA™) methodology was developed by Turn Bio's co-founders in the Sebastiano Lab, Institute for Stem Cell Biology and Regenerative Medicine, Stanford School of Medicine. The technology has since been patented and Turn Bio is currently using it to complete pre-clinical research on therapies targeting indications in dermatology and immunology, as well as developing therapies for ophthalmology, osteoarthritis and the muscular system.
"Many age-related diseases have long been significant areas of patients' unmet need," said Dr. Almira Chabi, chief medical officer and chief development officer at HanAll Pharmaceutical International. "Turn Bio's innovative platform may bring a pivotal transformation to a wide array of therapeutic areas. HanAll is committing support and investment to help realize the full potential of this pioneering technology as Turn Bio advances to a new phase of growth."
"The support of Daewoong Pharmaceutical and HanAll Biopharma validates our approach to cellular rejuvenation and enables Turn to expand its efforts in multiple therapeutic indications," said Anja Krammer, the company's CEO. "We are thrilled that a company as well known for its innovation, has taken interest in our promise to transform the way medicine treats diseases of aging and we look forward to further collaborations to help change quality of life and healthcare economics globally."
The proceeds from this round of financing will support Turn Bio's advancement towards a phase 1 trial of its mRNA therapy candidate TRN-001, which targets indications in dermatology.
About HanAll Biopharma Co., Ltd.
HanAll Biopharma (KRX: 009420.KS) is a global biopharmaceutical company founded in 1973, with a mission of making meaningful contributions to patients' lives by introducing innovative, impactful therapies to address severe unmet medical needs. HanAll has been operating a portfolio of pharmaceutical products in areas ranging from endocrine, circulatory, and urologic diseases for more than 48 years.
HanAll has also expanded its focus to ophthalmology, immunology, oncology and neurology to discover and develop innovative medicines for patients with diseases for which there are no effective treatments. A leading pipeline asset, HL161 (INN: batoclimab), an anti-FcRn antibody drug, is in Phase 3 and Phase 2 trials across the world for the treatment of rare autoimmune disorders including myasthenia gravis, thyroid eye disease, warm autoimmune hymolytic anemia, neuromyelitis optica, and immune thrombocytopenia. Another main asset, HL036 (INN: tanfanercept), an anti-TNF alpha protein drug, is in Phase 3 clinical trials in the US and China for the treatment of dry eye disease.
For further information visit our website, and connect with us on linkedin. For any media inquiries, please contact HanAll PR/IR (pr@hanall.com, ir@hanall.com).
About Daewoong Pharmaceutical. Co., Ltd.
(https://www.daewoong.co.kr/en)
Established in 1945, Daewoong Pharmaceutical Co., Ltd. is a leading South Korean pharmaceutical company that develops, manufactures, and commercializes pharmaceuticals for both domestic and international markets. With a strong and innovative in-house R&D and advanced manufacturing facilities, Daewoong provides a total healthcare solution to customers across the globe. Continuing on their course of building a strong global healthcare company, Daewoong has broadened international operations by establishing branch offices and research centers throughout Asia and the United States. Daewoong has also expanded strategic partnerships in more than 100 countries worldwide.
About Turn Biotechnologies
Turn Bio is a pre-clinical-stage company focused on repairing tissue at the cellular level. The company's proprietary mRNA platform technology, ERA™, restores optimal gene expression by combatting the effects of aging in the epigenome. This restores the cells' ability to prevent or treat disease, and heal or regenerate tissue and will help to fight incurable chronic diseases.
Turn Bio's technology provides a platform from which to attack a variety of now incurable chronic diseases. The company is currently completing pre-clinical research on tailored therapies targeting indications in dermatology and immunology, as well as developing therapies for ophthalmology, osteo-arthritis and the muscular system. For more information, see turn.bio or contact Jim Martinez, rightstorygroup / jim@rightstorygroup.com or (312) 543-9026
Disclaimer statement
The contents of this announcement include statements that are, or may be deemed to be, "forward-looking statements." These forward-looking statements can be identified by the use of forward-looking terminology, including the terms "believes," "estimates," "anticipates," "expects," "intends," "may," "will," or "should" and include statements HANALL (the company, we) makes concerning its 2022 business and financial outlook and related plans; the therapeutic potential of its product candidates; the intended results of its strategy and the company, and its collaboration partners', advancement of, and anticipated clinical development, data readouts and regulatory milestones and plans, including the timing of planned clinical trials and expected data readouts; the design of future clinical trials and the timing and outcome of regulatory filings and regulatory approvals. By their nature, forward-looking statements involve risks and uncertainties, and readers are cautioned that any such forward-looking statements are not guarantees of future performance. The company's actual results may differ materially from those predicted by the forward-looking statements as a result of various important factors our expectations regarding its the inherent uncertainties associated with competitive developments, preclinical and clinical trial and product development activities and regulatory approval requirements; our reliance on collaborations with third parties; estimating the commercial potential of our product candidates; our ability to obtain and maintain protection of intellectual property for its technologies and drugs; our limited operating history; and our ability to obtain additional funding for operations and to complete the development and commercialization of its product candidates. A further list and description of these risks, uncertainties and other risks can be found in Korea Stock Exchange (KRX) filings and reports, including in our most recent annual report as well as subsequent filings and reports filed by the company with the KRX. Given these uncertainties, the reader is advised not to place any undue reliance on such forward-looking statements. These forward-looking statements speak only as of the date of publication of this document. We undertake no obligation to publicly update or revise the information in this press release, including any forward-looking statements, except as may be required by Korean law and regulations.
View original content:
SOURCE HanAll Biopharma
|
https://www.kxii.com/prnewswire/2022/04/13/hanall-biopharma-daewoong-pharmaceutical-invest-turn-biotechnologies-expand-growth-initiative/
| 2022-04-13T00:15:30Z
|
Gainbridge extends deal as presenting sponsor of Indy 500
By JENNA FRYER
AP Auto Racing Writer
INDIANAPOLIS (AP) — The Indianapolis 500 will be presented by Gainbridge for the next several years under a contract extension announced Wednesday with the online investment platform. Gainbridge in 2019 became presenting sponsor of the iconic race. Gainbridge is also the primary sponsor for Andretti Autosport driver Colton Herta. It also holds the naming rights to Gainbridge Fieldhouse, home of the NBA’s Indiana Pacers. Gainbridge is also founding partner of the Miami Grand Prix Formula One race. Terms of the Indy 500 deal were not disclosed.
|
https://localnews8.com/news/ap-national-business/2022/05/25/gainbridge-extends-deal-as-presenting-sponsor-of-indy-500-2/
| 2022-05-25T19:59:13Z
|
- SaaS Strength: Annual Recurring Revenue of $368 million, up 41%
- Profit of $0.71 per diluted share, non-GAAP diluted EPS of $0.44, Adjusted EBITDA of $50 million
- Future contracted revenue surpasses $3 billion
SCOTTSDALE, Ariz., Aug. 9, 2022 /PRNewswire/ --
Dear Shareholders,
Our second quarter financial results reflect continued momentum throughout the business, including notable across-the-board strength in new product adoption.
Revenue growth of 31% year over year was driven by strong demand for Axon Cloud SaaS solutions, Axon Body 3 and Axon Fleet 3 systems, and our TASER 7 platform. Revenue from new SaaS products — such as productivity solutions, real-time operations, Axon Air, ALPR and VR(1) — nearly tripled year over year, highlighting our ability to drive customer adoption of our new software solutions.
We also executed against several key priorities in the quarter that position us well for future growth — including deepening our relationships with key partners and strategically investing to build out the Axon Ecosystem.
In June, we renewed our strategic technology partnership with Microsoft Azure — signing a six-year agreement that provides long-term pricing certainty and cost visibility for our Axon Cloud business. The renewal will support our software gross margin target of 80%+, and enables us to offer pricing predictability to our own customers. We discuss other ecosystem developments in more detail, below.
Customers are increasingly demonstrating their confidence that we are the right technology partner for them, for the next decade. We make it easy for our customers to bet on us, because we deliver. In the second quarter, 108 customers signed contracts for longer than five years. The quality of the deal flow is also strong. About a third of our top 100 deals were for a decade or more. This drives our confidence in our ability to continue scaling a rapidly growing, highly recurring SaaS business, with virtually zero churn.
(1) ALPR is the industry acronym for automatic license plate recognition. Enabled by artificial intelligence, Axon's ALPR solution comes standard with the Axon Fleet 3 in-car camera system. Plate read data that is collected during patrol is then retained and can be queried through Axon Evidence for later investigations.
VR is Axon's virtual reality training solution, which is included stand-alone or included in our highest value bundled offerings.
Select Highlights:
Management updates
Josh Isner, COO
In June, we appointed Josh Isner to the role of Chief Operating Officer, a newly created position to expand the office of the CEO. Josh is an executive familiar to investors who have tuned into Axon's earnings calls, which we've hosted over Zoom since early 2020. He's had an outsized impact on Axon, including during his most recent tenure as chief revenue officer. As CRO, Josh was responsible for Axon's global growth, customer service, professional services, and sales operations. He has been instrumental in building Axon's revenue stream to support our 2022 guidance above $1 billion, and was a key member of the executive team responsible for driving historical annual revenue growth rates exceeding 25%. He now oversees Axon's operational functions including business operations and execution, policies and employees.
Isaiah Fields, CLO
In July, we appointed Isaiah Fields to the role of Chief Legal Officer, where he will spearhead Axon initiatives across legal operations, government affairs, risk management and compliance. In Isaiah's previous role as general counsel, he drove success across all elements of our global organization. We are confident that Isaiah's leadership, devotion to his team and passion for our mission will help Axon successfully navigate this phase of rapid growth as we scale in complexity and expand globally.
CFO search
Our search process for a permanent CFO is progressing well and includes a strong pipeline of quality candidates. We hope to welcome shortly an outstanding executive who brings an appetite for strong financial rigor, along with the operational expertise to continue to drive scale and long-term growth at Axon.
Customers & Product
New VR simulator promotes de-escalation for public safety: The Phoenix Police Department and New Castle County Police in Delaware are the first agencies to deploy Axon's latest improvement in its VR offerings. The new simulator allows officers to train from anywhere. Trainees learn to operate TASER 7 devices and training firearms in VR. Scenarios include indoor range and an outdoor, nighttime setting. The fast-paced exercises help trainees learn safety features, recognize proper spread and probe placement on moving subjects, manage clothing disconnects, and practice for higher effectiveness when deploying TASER cartridges. More than 1,000 U.S. agencies now use Axon VR training.
TASER 7 Device adoption accelerates in Canada: Police services in Ontario, including Toronto, found that simply presenting a TASER device de-escalates a situation between 70% to 90% of the time, without having to deploy a cartridge. Recent TASER 7 device adoption in Canada has included the Calgary Police Service, York Regional Police, Peel Regional Police, Toronto Police Service and the Edmonton Police Service.
U.S. federal funding momentum: Axon's Federal business outlook continues to strengthen with recent developments signaling broad support for body camera adoption. In May, the White House issued an executive order that mandated body cameras for federal law enforcement. In addition, the White House's proposed FY2023 budget includes body camera funding for the Justice Department. We are also seeing support in Congress for body camera programs among the following federal law enforcement customers: Justice Department agencies, including the FBI, the U.S. Marshals, the U.S. Drug Enforcement Administration, the Bureau of Alcohol, Tobacco, Firearms and Explosives; Department of Homeland Security agencies, including U.S. Customs & Border Patrol, and U.S. Immigration & Customs Enforcement; and Department of Interior agencies. The House is also proposing funding for state and local agency matching grants to drive body camera adoption.
Strategic initiatives:
In May, we hosted our seventh annual Axon Accelerate — our user conference that has become the largest technology conference in public safety. On display was the strength of the Axon Ecosystem, featuring a growing network of partnerships and integrated products. Our go-to-market strategy for the Axon Ecosystem has graduated from an idea to now delivering tangible customer value.
In addition to extending our technology partnership with Microsoft, highlighted at the beginning of this letter, we also executed several new key strategic initiatives during the second quarter:
- Foundry 45: In April, we announced the acquisition of Foundry 45, a VR studio focused on delivering immersive training modules to large organizations. The acquisition bolsters Axon's VR team in transforming public safety by making training more accessible, relevant and affordable — with the goal of better preparing officers for real-life situations.
- Fūsus: In May, we announced a strategic partnership with Fūsus along with a $21 million non-controlling minority investment. Fusus is the U.S. market leader in real-time crime center solutions for public safety. The partnership makes it easier and more cost-effective for communities to aggregate live feeds from public and private cameras in addition to live video feeds from Axon Body 3, Axon Fleet 3 and Axon Air connected drones, creating a unified operational picture for first responders.
- Skydio: In May, we also announced live-streaming from Skydio drones into our Axon Respond platform. The integration with Respond will enable command staff and 911 dispatchers to combine the live-streaming capabilities of Axon body-worn and in-car cameras with the Skydio drone's aerial perspective to provide a more comprehensive operational picture.
- Dedrone: In June, we closed a $25 million non-controlling minority follow-on investment in Dedrone, a market leader in counter unmanned aircraft systems. Axon led the company's oversubscribed $30 million Series C-1 financing round, which follows our initial $25 million investment in Dedrone in December 2021. Dedrone is accelerating on a path towards making the world safer from unauthorized and malicious drones. After conducting extensive due diligence to evaluate opportunities to participate in the rapidly growing air security market, we were impressed by Dedrone's technology, team and commercial traction.
- DroneSense: In June, we also closed a $15 million non-controlling minority investment in DroneSense in support of our previously announced partnership to implement its piloting, program management and operations solution via Axon's unmanned aircraft program, Axon Air. DroneSense has also integrated its software platform with Axon's digital evidence management platform, Axon Evidence, and real-time operations hub, Axon Respond, to provide agencies with a comprehensive solution to start and operate a drone program. This integration streamlines first responder and drone pilot communications — allowing live streaming from the UAS into Axon's real-time operations platform and digital footage to be stored in Axon's evidence management platform.
In addition to these recent new initiatives, we are also seeing positive momentum across our broader ecosystem. In late 2021, we acquired Occam Video Solutions, a leader in digital video investigations software. The business has been integrated with Axon, and, in addition to powering our Third-Party Video Playback solution, Occam's flagship investigative software, iNPUT-ACE, has been relaunched as Axon Investigate, and is seeing growing interest from our customers.
Our partnerships with Flock Safety and RapidSOS are also expanding in value for the Axon Ecosystem. We are seeing strong adoption of Flock Safety's ALPR cameras nationwide. Plate reads captured by Flock Safety's cameras can be shared to cases with a single-click and managed within Axon Evidence workflows. RapidSOS's technology powers Axon's recently launched consumer focused smart phone app for personal safety, Axon Protect (available in the Apple App Store and on Google Play), which enables users to connect with a live Axon agent. We also recently launched an Axon Respond integration with RapidSOS, which enables 911 operators that use the company's Jurisdiction View software platform to see live locations of first responders equipped with Axon Body 3 cameras and also live-stream videos from those cameras.
Summary of Q2 2022 results
- Quarterly revenue of $286 million grew 31% year over year, exceeding our expectations, and led by software and sensors segment growth of 41%.
- Total company gross margin of 60.9% improved 20 basis points sequentially.
- Operating profit was $21 million. Operating expenses for the quarter of $153 million included $20 million in stock based compensation expenses.
- $5 million tied to hiring that supports our long-term growth profile
- $3 million tied to higher bonuses paid to employees at the senior director level and below,
- $2 million tied to annual company bonus accruals resulting from our improved outlook, and
- $1 million tied to our annual user conference.
- We expect expense growth, excluding stock-based compensation, to moderate in the back half of the year.
- Our quarterly net income of $51 million, or $0.71 per diluted share, included $21 million in stock based compensation expenses, a $12 million non-cash, unrealized, mark-to-market loss related to our strategic investment in Cellebrite, and $60 million in net unrealized gains related to strategic investments.
- Non-GAAP net income was $32 million, or $0.44 per share.
- Adjusted EBITDA was $50 million.
- Operating cash flow of $19 million supported free cash flow generation of $7 million and adjusted free cash flow generation of $10 million. We define free cash flow as operating cash flow less capital expenditures and purchases of intangible assets. Adjusted free cash flow excludes campus investments.
- As of June 30, 2022 Axon had $356 million in cash, equivalents and investments.
- Axon has zero debt.
(2) These innovative stock-based compensation plans were approved by shareholders in 2018 and 2019 and align the interests of management and employees with shareholders.
Financial commentary by segment:
- TASER segment revenue growth was driven by demand for our TASER 7 platform, with units up 85% year over year.
- Q2 2022 TASER segment gross margin slightly declined sequentially. We expect further TASER 7 automation to come online in the back half of this year and contribute to segment gross margin improvement in 2023. We also expect to generate leverage on our fixed cost base as we grow into our expanding manufacturing footprint.
- Axon Cloud revenue grew 35%year over year to $82 million, reflecting strong user growth for our Axon Evidence (Evidence.com) platform, and software features including transcription and body-camera enabled real-time operations capabilities across location-based services, live streaming and incident event alerts.
- Axon Cloud gross margin of 70.4% included expected costs to scale our cloud business. This includes the low-to-no margin professional services costs of teams who help our customers deploy Axon's solutions. The software-only revenue in this segment, which is annually recurring and includes cloud storage and compute costs, has consistently carried a gross margin above 80%.
- Sensors & Other revenue grew 49% year over year to $68 million, reflecting growth in Axon Fleet 3 shipments followed by body camera unit growth.
- Sensors & Other gross margin was 42.9%, reflecting a favorable product mix. As a reminder, we manage toward a 25% gross margin for camera and sensors hardware, and the gross margin will fluctuate quarter to quarter depending on the customer mix.
- Annual Recurring Revenue (ARR) grew 41% year over year to $368 million.
- Net revenue retention was 119% in the quarter, reflecting our ability to deliver additional value to our customers over time and de minimis attrition. We drive adoption of our cloud software solutions through integrated bundling. Our law enforcement agency customers often sign up for five to ten-year subscriptions. This SaaS metric purposely excludes the hardware portion of customer subscriptions. We further define this metric under "Statistical Definitions."
- Total company future contracted revenue grew to $3.33 billion, reflecting strong bookings in the quarter. This metric is also known as "remaining performance obligations." Most of our bookings are for multi-year contracts. See definition of this metric under "Statistical Definitions."
- The percentage of TASER devices sold on a subscription was 76% in the quarter, reflecting a stronger mix of our TASER 7 devices, which are mostly sold on a subscription. As a reminder, Axon has been successfully transitioning its TASER hardware business into a subscription service in more mature markets and expanding into new markets where some initial sales are not on a subscription, with the intention of building subscription businesses in those markets over time.
Outlook
The following forward-looking statements reflect Axon's full year 2022 expectations as of August 9, 2022, and are subject to risks and uncertainties.
- Axon's upwardly revised full year 2022 revenue expectation has improved to a range of $1.07 billion to $1.12 billion, reflecting approximately 27% annual growth at the midpoint. Previously, Axon had guided to a range of $1.05 billion to $1.1 billion, reflecting 25% growth at the midpoint.
- We now expect to deliver 2022 Adjusted EBITDA at the higher end of the previously communicated range of $190 million to $200 million.
- We expect stock-based compensation expense to be more than $104 million for the full year. Because our stock-based compensation expense may vary based on changes in the probability of attaining certain operational or market capitalization metrics or attainment of such metrics and with changes in the expected or actual timing of such attainment, it is inherently difficult to forecast future stock-based compensation expense.
- We are maintaining our expected adjusted free cash flow range of $125 million to $145 million in 2022, compared with $85 million in 2021. This range reflects our expectations for operating cash flow, minus our expected purchases of property and equipment (CapEx) of $80 million to $90 million, excluding any investments made in our campus facility, which we expect to be less than $25 million.
- We are revising our expected 2022 capital expenditures to a range of $80 million to $90 million, compared with our previous expectation of $135 million to $160 million.
We are energized by the momentum in our business, superior execution by our teams and the underlying strength of our model, all of which sets us up to continue accelerating growth and profitability.
Thank you for investing in our mission to protect life.
-The Axon team
Quarterly conference call and webcast
We will host our Q2 2022 earnings conference call webinar on Tuesday, August 9, at 2 p.m. PT / 5 p.m. ET.
The webcast will be available via a link on Axon's investor relations website at https://investor.axon.com (https://investor.axon.com/), or can be accessed directly via https://axon.zoom.us/j/98326867283.
Statistical Definitions
Bookings: We consider bookings to be a statistical measure defined as the sales price of orders (not invoiced sales), including contractual optional periods we expect to be exercised, net of cancellations, inclusive of renewals, placed in the relevant fiscal period, regardless of when the products or services ultimately will be provided, so long as they are expected to occur within five years. Most bookings will be invoiced in subsequent periods. Due to municipal government funding rules, in some cases certain of the future period amounts included in bookings are subject to budget appropriation or other contract cancellation clauses. Although we have entered into contracts for the delivery of products and services in the future and anticipate the contracts will be fulfilled, if agencies do not exercise contractual options, do not appropriate funds in future year budgets, or enact a cancellation clause, revenue associated with these bookings may not ultimately be recognized, resulting in a future reduction to bookings. Bookings, as presented here, represent total company bookings inclusive of all product. Certain customers sign contracts for time periods longer than five-years, which generates a larger-sized booking — but the expected exercise amounts after the five-year period is not included in bookings, as described here, in order to facilitate comparisons between periods.
Net revenue retention: Dollar-based net revenue retention is an important metric to measure our ability to retain and expand our relationships with existing customers. We calculate it as the software and camera warranty subscription and support revenue from a base set of agency customers from which we generated Axon Cloud subscription revenue in the last month of a quarter divided by the software and camera warranty subscription and support revenue from the year-ago month of that same customer base. This calculation includes high-margin warranty but purposely excludes the lower-margin hardware subscription contingent of the customer contracts, as it is meant to be a SaaS metric that we use to monitor the health of the recurring revenue business we are building. This calculation also excludes the implied monthly revenue contribution of customers that were added since the year-ago quarter, and therefore excludes the benefit of new customer acquisition. The metric includes customers, if any, that terminated during the annual period, and therefore, this metric is inclusive of customer churn. This metric is downwardly adjusted to account for the effect of phased deployments -- meaning that for the year-ago period, we consider the total contractually obligated implied monthly revenue amount, rather than monthly revenue amounts that might have been in actuality smaller on a GAAP basis due to the customer not having yet fully deployed their Axon solution. For more information relative to our revenue recognition policies, please reference our SEC filings.
Total company future contracted revenue: Total company future contracted revenue includes both recognized contract liabilities as well as amounts that will be invoiced and recognized in future periods. The remaining performance obligations are limited only to arrangements that meet the definition of a contract under Topic 606 as of June 30, 2022. We expect to recognize between 15% - 20% of this balance over the next twelve months, and generally expect the remainder to be recognized over the following ten years, subject to risks related to delayed deployments, budget appropriation or other contract cancellation clauses.
Non-GAAP Measures
To supplement the Company's financial results presented in accordance with GAAP, we present the non-GAAP financial measures of EBITDA, Adjusted EBITDA, Non-GAAP Net Income, Non-GAAP Diluted Earnings Per Share, Free Cash Flow and Adjusted Free Cash Flow. The Company's management uses these non-GAAP financial measures in evaluating the Company's performance in comparison to prior periods. We believe that both management and investors benefit from referring to these non-GAAP financial measures in assessing its performance, and when planning and forecasting our future periods. A reconciliation of GAAP to the non-GAAP financial measures is presented herein.
- EBITDA (Most comparable GAAP Measure: Net income) - Earnings before interest expense, investment interest income, income taxes, depreciation and amortization.
- Adjusted EBITDA (Most comparable GAAP Measure: Net income) - Earnings before interest expense, investment interest income, income taxes, depreciation, amortization, non-cash stock-based compensation expense, realized and unrealized gains/losses on strategic investments and marketable securities and pre-tax certain other items (identified and listed below in the reconciliation).
- Non-GAAP Net Income (Most comparable GAAP Measure: Net income) - Net income excluding the costs of non-cash stock-based compensation and excluding any net gain/loss/write-down/disposal/abandonment of property, equipment and intangible assets; realized and unrealized gains/losses on strategic investments and marketable securities; loss on impairment; costs related to strategic investments and business acquisitions; costs related to the FTC litigation and pre-tax certain other items (listed below). The Company tax-effects non-GAAP adjustments using the blended statutory federal and state tax rates for each period presented.
- Non-GAAP Diluted Earnings Per Share (Most comparable GAAP Measure: Earnings Per share) - Measure of Company's Non-GAAP Net Income divided by the weighted average number of diluted common shares outstanding during the period presented.
- Free Cash Flow (Most comparable GAAP Measure: Cash flow from operating activities) - cash flows provided by operating activities minus purchases of property and equipment and intangible assets.
- Adjusted Free Cash Flow (Most comparable GAAP Measure: Cash flow from operating activities) - cash flows provided by operating activities minus purchases of property and equipment and intangible assets, excluding the net impact of investments in our new Scottsdale, Ariz. campus.
Caution on Use of Non-GAAP Measures
Although these non-GAAP financial measures are not consistent with GAAP, management believes investors will benefit by referring to these non-GAAP financial measures when assessing the Company's operating results, as well as when forecasting and analyzing future periods. However, management recognizes that:
- these non-GAAP financial measures are limited in their usefulness and should be considered only as a supplement to the Company's GAAP financial measures;
- these non-GAAP financial measures should not be considered in isolation from, or as a substitute for, the Company's GAAP financial measures;
- these non-GAAP financial measures should not be considered to be superior to the Company's GAAP financial measures; and
- these non-GAAP financial measures were not prepared in accordance with GAAP or under a comprehensive set of rules or principles.
Further, these non-GAAP financial measures may be unique to the Company, as they may be different from similarly titled non-GAAP financial measures used by other companies. As such, this presentation of non-GAAP financial measures may not enhance the comparability of the Company's results to the results of other companies.
About Axon
Axon is the global leader in connected public safety technologies. We are a mission-driven company whose overarching goal is to protect life. Our vision is a world where bullets are obsolete, where social conflict is dramatically reduced, where everyone has access to a fair and effective justice system and where racial equity, diversity and inclusion is centered in all of our work. Axon is also a leading provider of body cameras for US public safety, providing more transparency and accountability to communities than ever before.
You may learn about our Environmental, Social, and Governance (ESG) and Corporate Social Responsibility (CSR) efforts by reading our ESG report at investor.axon.com.
We work hard for those who put themselves in harm's way for all of us. More than 270,000 lives and countless dollars have been saved with the Axon Network of devices, apps and people. Learn more at www.axon.com or by calling (800) 978-2737. Axon is a global company with headquarters in Scottsdale, Arizona, and a global software engineering hub in Seattle, Washington, as well as additional offices in the US, Australia, Canada, Finland, Vietnam, the UK and the Netherlands.
Apple and App Store are trademarks of Apple, Inc., Cellebrite is a trademark of Celebrite Mobile Synchronization Ltd.; Dedrone is a trademarks of Dedrone Holdings, Inc.; DroneSense is a trademark of DroneSense, Inc., Facebook is a trademark of Facebook, Inc.; Flock Safety is a trademark of Flock Group, Inc., dba Flock Safety; Google Play is a trademark of Google, Inc.; Microsoft and Azure are trademarks of Microsoft Corporation; RapidSOS is a trademark of Rapid SOS, Inc.; Skydio is a trademark of Skydio, Inc.; Twitter is a trademark of Twitter, Inc.; and Zoom is a trademark of Zoom Video Communications, Inc.
Axon, the Delta Logo, Axon Accelerate, Axon Air, Axon Body, Axon Evidence, Axon Fleet, Axon Network, Axon Respond, TASER, TASER 7 and Protect Life are trademarks of Axon Enterprise, Inc., some of which are registered in the US and other countries. For more information, visit www.axon.com/legal. All rights reserved.
Follow Axon here:
- Axon on Twitter: https://twitter.com/axon_us
- Axon on Facebook: https://www.facebook.com/Axon.ProtectLife/
Forward-looking statements
Forward-looking statements in this letter include, without limitation, statements regarding: proposed products and services and related development efforts and activities; expectations about the market for our current and future products and services; strategies and trends relating to subscription plan programs and revenues; strategies and trends, including the benefits of, research and development investments; the timing and realization of future contracted revenue; the fulfillment of bookings; expectations about customer behavior; statements concerning projections, predictions, expectations, estimates or forecasts as to our business, financial and operational results and future economic performance, including our outlook for 2022 full year revenue, stock-based compensation expense, adjusted EBITDA, adjusted free cash flow, and capital expenditures; statements of management's strategies, goals and objectives and other similar expressions; as well as the ultimate resolution of financial statement items requiring critical accounting estimates, including those set forth in our Form 10‑K for the year ended December 31, 2021. Such statements give our current expectations or forecasts of future events; they do not relate strictly to historical or current facts. Words such as "may," "will," "should," "could," "would," "predict," "potential," "continue," "expect," "anticipate," "future," "intend," "plan," "believe," "estimate," and similar expressions, as well as statements in future tense, identify forward-looking statements. However, not all forward-looking statements contain these identifying words.
We cannot guarantee that any forward-looking statement will be realized, although we believe we have been prudent in our plans and assumptions. Achievement of future results is subject to risks, uncertainties and potentially inaccurate assumptions. The following important factors could cause actual results to differ materially from those in the forward-looking statements: the potential global impacts of the COVID-19 pandemic; our exposure to cancellations of government contracts due to appropriation clauses, exercise of a cancellation clause, or non-exercise of contractually optional periods; our ability to design, introduce and sell new products or features; our ability to defend against litigation and protect our intellectual property, and the resulting costs of this activity; our ability to manage our supply chain and avoid production delays, shortages, and impacts to expected gross margins; the impact of stock compensation expense, impairment expense, and income tax expense on our financial results; customer purchase behavior, including adoption of our software as a service delivery model; negative media publicity regarding our products; the impact of product mix on projected gross margins; defects in our products; changes in the costs of product components and labor; loss of customer data, a breach of security, or an extended outage, including by our third party cloud-based storage providers; exposure to international operational risks; delayed cash collections and possible credit losses due to our subscription model; changes in government regulations in the U.S. and in foreign markets, especially related to the classification of our products by the United States Bureau of Alcohol, Tobacco, Firearms and Explosives; our ability to integrate acquired businesses; our ability to attract and retain key personnel; and counter-party risks relating to cash balances held in excess of FDIC insurance limits. Many events beyond our control may determine whether results we anticipate will be achieved. Should known or unknown risks or uncertainties materialize, or should underlying assumptions prove inaccurate, actual results could differ materially from past results and those anticipated, estimated or projected. You should bear this in mind as you consider forward-looking statements. The Annual Report on Form 10‑K that we filed with the Securities and Exchange Commission ("SEC") on February 25, 2022 lists various important factors that could cause actual results to differ materially from expected and historical results. These factors are intended as cautionary statements for investors within the meaning of Section 21E of the Exchange Act and Section 27A of the Securities Act. Readers can find them under the heading "Risk Factors" in the Report on Form 10‑K, and investors should refer to them. You should understand that it is not possible to predict or identify all such factors. Consequently, you should not consider any such list to be a complete set of all potential risks or uncertainties.
Except as required by law, we undertake no obligation to publicly update forward-looking statements, whether as a result of new information, future events or otherwise. You are advised, however, to consult any further disclosures we make on related subjects in our Form 10-Q, 8-K and 10-K reports to the SEC. Our filings with the SEC may be accessed at the SEC's web site at www.sec.gov.
Update on Legal Matters:
Axon v. FTC
Axon continues to vigorously prosecute its federal court constitutional case against the Federal Trade Commission (FTC) while the FTC's separate antitrust administrative action against the company regarding its 2018 acquisition of Vievu LLC remains stayed.
On January 24, 2022, the U.S. Supreme Court accepted review of an important jurisdictional issue raised by Axon's constitutional challenges to the FTC's internal administrative structure and procedures. The high Court's action is a critical first step for all businesses seeking to vindicate their constitutional rights and hold government regulators accountable. Oral argument is now set at the Supreme Court for November 7. A decision is unlikely before March 2023. Links to all court filings and opinions can be found on Axon's FTC Investor Briefing page at https://www.axon.com/ftc.
Parallel to these matters Axon is evaluating strategic alternatives to litigation, which Axon might pursue if determined to be in the best interests of shareholders and customers. This could include a divestiture of the Vievu entity and/or related assets. While Axon continues to believe the acquisition was lawful and a benefit to Vievu's customers, the cost, risk and distraction of protracted litigation merit consideration of settlement if achievable on terms agreeable to the FTC and Axon.
For investor relations information please contact Investor Relations via email at IR@axon.com.
CONTACT:
Investor Relations
Axon Enterprise, Inc.
IR@axon.com
View original content to download multimedia:
SOURCE Axon
|
https://www.wibw.com/prnewswire/2022/08/09/axon-reports-record-revenue-up-31-286-million-raises-full-year-outlook/
| 2022-08-09T20:26:47Z
|
Dear Heloise: Several times a year, I have seen write-ups about folks who did not read their owner’s manual for their automatic garage door opener and they placed an LED lightbulb in the opener. If you read the instructions in your manual, it usually tells you not to use LED lightbulbs because they interfere with the electronics of the door openers. Please, no LED lightbulbs in garage openers. You must use an incandescent or CFL bulb.
— Jack C., Westerville, Ohio
|
https://www.tdtnews.com/life/advice_columns/article_48372064-cc91-11ec-8eb9-9f34ed102d75.html
| 2022-05-06T10:01:36Z
|
Actor Jake Gyllenhaal is helping bring back a cult classic.
Gyllenhaal is set to star in a remake of "Road House" for Amazon Prime.
According to a synopsis, the movie will be "a reimagined take" on the 1989 film that starred Patrick Swayze. "The Bourne Identity" director Doug Liman will direct.
The new film follows a former UFC fighter (Gyllenhaal) who "takes a job as a bouncer at a rough-and-tumble roadhouse in the Florida Keys, but soon discovers that not everything is what it seems in this tropical paradise," according to a press release.
"Road House is a homerun for us. Not only is it a nod to fans of the original, but it is also a big, fun, broad audience movie," said Jennifer Salke, head of Amazon Studios. "We are thrilled to collaborate with Joel (Silver), Doug, and this great cast led by Jake Gyllenhaal, and for them to come together to reimagine the classic MGM film as an action-packed adventure for our global audience."
Liman said, "I'm thrilled to put my own spin on the beloved Road House legacy. And I can't wait to show audiences what Jake and I are going to do with this iconic role."
The movie also stars Billy Magnussen, Daniela Melchior, Gbemisola Ikumelo, Lukas Gage and others.
It is set to go into production in the Dominican Republic this month. It will stream on Prime Video upon release.
Keep it Clean. Please avoid obscene, vulgar, lewd,
racist or sexually-oriented language. PLEASE TURN OFF YOUR CAPS LOCK. Don't Threaten. Threats of harming another
person will not be tolerated. Be Truthful. Don't knowingly lie about anyone
or anything. Be Nice. No racism, sexism or any sort of -ism
that is degrading to another person. Be Proactive. Use the 'Report' link on
each comment to let us know of abusive posts. Share with Us. We'd love to hear eyewitness
accounts, the history behind an article.
|
https://www.albanyherald.com/entertainment/jake-gyllenhaal-to-star-in-road-house-remake-for-amazon-prime/article_d1acc2e9-28b8-51e2-b062-e7c69aae4399.html
| 2022-08-02T17:25:55Z
|
LOS ANGELES, May 18, 2022 /PRNewswire/ -- On May 18, Knight Law Group kicks off its Return-to-Office transition with a celebration honoring its hard-working staff.
The firm announced its adoption of a hybrid work model, with team members working in the office Tuesday through Thursday and working remotely Mondays and Fridays. As another feature of the new policy, the firm now allows employees to work fully remotely for two additional weeks per year. The Return-to-Office announcement comes with a bonus and salary increase for each employee of up to 20% of their current pay, including employees that may have just started in the past few weeks.
In recognition of staff reconnecting in-person with colleagues, festivities will be the order of the day. The Wednesday celebration will feature welcome-back gifts for each employee, delicious food and drink, a cocktail reception, a DJ and dance party, along with a drawing that will award two grand prizes worth thousands of dollars. Knight's Return to Office is accompanied by expanded benefits and perks for its loyal staff. Employees will receive apparel and gas gift cards to offset new wardrobe and commuting costs.
"Before Covid, the notion of employees working from home was not considered to be a feasible model. But after we all made emergency adjustments two years ago, it turned out the traditional fears were unjustified. This hybrid program gives employees the in-office benefits of collaboration, culture and assistance while trusting our team with the flexibility we once thought was impracticable," said Roger Kirnos, Managing Partner of Knight Law Group.
"We're looking forward to more insightful or witty conversations by a co-worker's desk and fewer interactions that begin with 'you need to unmute yourself,'" said Leon Boyer, Chief Operating Officer. "But our embrace of a hybrid model means that the positives that we gained from working remotely will remain in place going forward."
The firm today also announced across-the-board compensation increases.
"As of today, every single Knight employee has received both a bonus based on years of service and a significant salary increase, in compensation for a job well done and for the additional travel expenses that will come with in-person travel to the office," added Boyer.
In preparation for the re-opening of the office, the workspace has been upgraded to include improved ventilation, touchless faucets for restrooms, new MERV 14 air filters, and a UVC Emitter system. This UVC light provides continuous germicidal cleaning of air coils and other components, improving overall indoor air quality.
Employee feedback was key to the crafting of the hybrid policy, which was influenced by opinions shared by staff during the extended work-from-home period.
In accordance with Knight Law Group's stature as one of the largest and most successful consumer-protection law firms in the country, its employee benefits surpass those of other consumer-protection firms, in recognition of the spirit and effort put in by its team members.
Existing benefits of medical, dental, and vision coverage, parking/bus pass reimbursement, and the Employee Assistance Program remain in place. During the pandemic, Knight Law Group began providing employees with pet insurance, and this popular benefit will continue as well.
"For those who have enjoyed conducting their work duties from home, we are happy to announce that there will be a great deal of flexibility within our Return to Office transition," said Angelo D'Agostino, Chief Human Resources Officer.
"We have worked diligently to create a welcoming, safe environment to reconvene in, and I am know my colleagues will find a lot to enjoy about this experience, even after the RTO celebration is finished," he concluded.
About Knight Law Group: Knight Law Group is the preeminent California consumer rights law firm, specializing in the practice of Automotive Lemon Law. Knight Law Group has successfully handled cases against most major auto manufacturers and has received record settlements for its clients.
View original content to download multimedia:
SOURCE Knight Law Group, LLP
|
https://www.kxii.com/prnewswire/2022/05/18/knight-law-group-celebrates-its-return-office/
| 2022-05-18T12:13:20Z
|
NEW YORK, Aug. 19, 2022 /PRNewswire/ -- Jakubowitz Law announces that a securities fraud class action lawsuit has commenced on behalf of shareholders of Wells Fargo & Company (NYSE: WFC).
To receive updates on the lawsuit, fill out the form:
https://claimyourloss.com/securities/wfc-lawsuit-loss-submission-form/?id=30969&from=4
This lawsuit is on behalf of persons and entities that purchased or otherwise acquired Wells Fargo common stock between February 24, 2021 and June 9, 2022.
Shareholders interested in acting as a lead plaintiff representing the class of wronged shareholders have until August 29, 2022 to petition the court. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.
According to a filed complaint, Wells Fargo & Company issued materially false and/or misleading statements and/or failed to disclose that: (i) Wells Fargo had misrepresented its commitment to diversity in the Company's workplace; (ii) Wells Fargo conducted fake job interviews in order to meet its Diverse Search Requirement; (iii) the foregoing conduct subjected Wells Fargo to an increased risk of regulatory and/or governmental scrutiny and enforcement action, including criminal charges; (iv) all of the foregoing, once revealed, was likely to negatively impact Wells Fargo's reputation; and (v) as a result, the Company's public statements were materially false and misleading at all relevant times.
Jakubowitz Law is vigorous in pursuit of justice for shareholders who have been the victim of securities fraud. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT:
JAKUBOWITZ LAW
1140 Avenue of the Americas
9th Floor
New York, New York 10036
T: (212) 867-4490
F: (212) 537-5887
View original content:
SOURCE Jakubowitz Law
|
https://www.mysuncoast.com/prnewswire/2022/08/19/wfc-shareholder-alert-jakubowitz-law-reminds-wells-fargo-shareholders-lead-plaintiff-deadline-august-29-2022/
| 2022-08-19T11:34:36Z
|
SEBRING, Fla., June 15, 2022 /PRNewswire/ -- With 14 facilities spanning nationwide, Banyan Treatment Centers is proud to announce our newest inpatient location in Sebring, FL. By treating over 40,000 patients and counting, Banyan has helped the lives of many across the nation combat addiction, mental illness, and eating disorders.
Its latest facility, Banyan Sebring, offers inpatient treatment for substance use, mental health, and co-occurring disorders. Located on Lake Sebring, this detox and residential facility has 40 beds, a swimming pool, a volleyball court, and many more incredible amenities.
Our Substance Use Program includes medically assisted detox for patients who are physically and chemically dependent on substances as well as residential care for patients with substance use, mental health, or co-occurring disorders. The Mental Health Program at Banyan Sebring treats disorders such as but not limited to mood, thought, and anxiety disorders, schizophrenic disorders, bipolar disorders, and post-traumatic stress disorder.
As an inpatient facility, Banyan Sebring offers safe and secure housing where patients while receiving 24/7 care from medical and clinical staff. During programming, patients receive daily group therapy and weekly individualized therapy. Banyan Sebring also offers a family program, alumni program, faith program, and case management services.
For those seeking a full continuum of care, Banyan has additional locations in Florida offering outpatient services for substance use and mental health disorder.
As one of the leading drug and alcohol addiction treatment programs, Banyan's mission is to help those who suffer from addiction and mental illness achieve true happiness and long-lasting recovery. Banyan has set an exceptional standard within the addiction and mental health industry with robust clinical services along with a holistic and innovative approach to treatment.
Banyan will be hosting an Open House event on July 12th, from 11 am – 4 pm for those in the community interested in meeting the team and learning more. To RSVP, please visit www.banyansebring.eventbrite.com.
To learn more about the program offered at Banyan Sebring, visit our website at BanyanSebring.com. Banyan continues to strive to improve the lives of individuals with substance use and mental health disorders. See the organization's media section or Banyan blog here. If you or someone you know is struggling with a mental health disorder, substance use disorder, or eating disorder, please call us today at (877) 836-7614.
FOR FURTHER INFORMATION:
Alyssa Shapper
National Director of Digital Marketing
Banyan Treatment Centers
Website: https://www.banyantreatmentcenter.com/
Email: ashapper@banyancenters.com
Telephone: (888) 230-3122
View original content to download multimedia:
SOURCE Banyan Treatment Centers
|
https://www.wibw.com/prnewswire/2022/06/15/banyan-treatment-centers-opens-15th-location-sebring-florida-offering-substance-use-disorder-mental-health-treatment-with-detox-residential-levels-care/
| 2022-06-15T16:47:03Z
|
WURI Accolades Minerva's Innovative Learning Methodologies & Industrial Applications
SAN FRANCISCO, June 10, 2022 /PRNewswire/ -- Minerva University, an independent, non-profit, U.S. accredited institution of higher education with a transformational approach to experiential learning in immersive global settings, is ranked the #1 Most Innovative University in the World by World's Universities with Real Impact (WURI) in its 2022 report. Minerva first joined the WURI rankings in 2020 and has continuously earned top rankings for its groundbreaking, high-quality education, moving from #5 in 2020 to now, #1 in 2022.
In addition to receiving the overall most innovative ranking—the utmost ranking allotted in WURI's 2022 report—Minerva also ranked #1 in the "Industrial Application" category which acknowledges the University's active learning pedagogy and technically innovative learning platform.
"We're honored to receive this recognition, as it touts everything Minerva stands for, and has strived for, during its years of continuous innovation," said Mike Magee, President of Minerva University. "This accomplishment speaks volumes for Minerva's now proven scalability, amid a global pandemic. As the world is changing, Minerva is a step ahead of the curve, building the most global, immersive, ethical and purposeful university in the world, during the most complex and challenging years we have seen. Our most important years of innovation and growth remain ahead of us, as we further implement our mission to nurture critical wisdom for the sake of the world— an ongoing endeavor we owe to our world's future leaders."
A not-for-profit program, WURI is the first global innovative university ranking created to stimulate and evaluate universities' flexible and innovative efforts to foster a workforce that meets the demand of industry and society. WURI is organized by the Institute for Policy and Strategy on National Competitiveness (IPSNC) and is supported by four other organizations including the United Nations Institute for Training and Research (UNITAR). While traditional higher education ranking systems focus on the total number of faculty, campus life or majors offered, the WURI ranking evaluates the university's real contributions to society, highlighting creative and innovative approaches of universities' research and educational programs based on the following six categories: Industrial Applications; Value-Creating; Social Responsibility, Ethics, and Integrity; Student Mobility and Openness; Crisis Management; and Progress during the Fourth Industrial Revolution.
Minerva University offers a reinvented university experience for the brightest, most motivated students from around the world. Minerva's undergraduate offering combines a pathbreaking cross-contextual interdisciplinary curriculum, the highest academic standards, an accomplished faculty versed in the science of learning, a global, immersive residential experience that traverses seven countries, and a cutting-edge digital learning environment that produces deep and long-lasting learning. Minerva University is accredited by the Western Association of Schools and Colleges/Senior College and University Commission (WSCUC). The groundbreaking creation of Minerva is detailed in the book Building the Intentional University: Minerva and the Future of Higher Education (MIT Press.)
Jessica Segers
jsegers@lakpr.com
View original content to download multimedia:
SOURCE Minerva University
|
https://www.mysuncoast.com/prnewswire/2022/06/10/minerva-university-named-most-innovative-university-world/
| 2022-06-10T19:12:08Z
|
(NewsNation) — Support to bring Brittney Griner home continues to grow despite the WNBA star pleading guilty to drug charges on Thursday.
During an exclusive interview on NewsNation’s “Banfield,” Billy Hayes, who spent five years in a Turkish prison for drug smuggling, shared advice for Griner. He said the mentality she uses to succeed as an athlete will be invaluable as she navigates this situation.
“If you can keep a control on yourself, it puts perspective on things,” Hayes said. But he knows that’s much easier said than done.
In 1970, Hayes was arrested at an airport in Turkey while carrying four pounds of hashish. He was given a life sentence.
Five years after his arrest, with no movement on the diplomatic side, Hayes escaped back to the United States as a fugitive. He later wrote an autobiography, “Midnight Express,” which adapted into an Academy Award-winning film of the same name in 1978.
His story, he told NewsNation, has similarities to that of Griner’s. She was arrested in February at Moscow’s Sheremetyevo Airport after vape cartridges with hashish oil were allegedly found in her luggage.
“Unfortunately, I can relate. The beginning of this process is something that she inadvertently got into,” Hayes said. “I know she had some hashish oil in her bag. It’s for her own personal use, and she had a prescription for this. Unfortunately, that doesn’t really matter in a lot of foreign countries because laws are different. You need to discover the differences quickly, or you end up in a very bad place.”
Hayes said he thinks that Russia would like to bring Griner home because the world is watching.
“We should be emphasizing that we are watching. Hopefully, now that her her sentence is going to be finished, all the legal ramifications that take forever in any country, but especially a foreign countries,” Hayes said.
Hayes said he hopes Brittney will focus on the victories, no matter how big or small.
“It looks awful from the inside, but to know there are people on the outside who care and are working for you, that will help a lot.”
|
https://cw33.com/news/nexstar-media-wire/billy-hayes-whose-story-inspired-midnight-express-has-advice-for-brittney-griner/
| 2022-07-09T16:29:49Z
|
Agreement expands Agency Revolution's website capabilities and cements their position as the premier end-to-end marketing solution for insurance agencies and agents
SAN DIEGO, Aug. 17, 2022 /PRNewswire/ -- Agency Revolution, the leading provider of digital marketing solutions for the insurance industry, today announced its acquisition of Forge3, the highest-rated, fastest-growing insurance agency website platform.
"Forge3 has a tremendous reputation in the industry with a 9.9 out of 10 post-launch client rating and five stars on Google," said Scott White, CEO of Agency Revolution. "They've pioneered the use of interactive website designs to provide insurance agencies with the tools to get found, close business, and deliver a seamless client experience. Forge3's products and team will remain intact as we combine what they are loved for, high converting insurance websites, with the power of Agency Revolution's robust marketing automation and workflow capabilities. The result of this partnership is a one-stop solution that meets all the marketing needs for insurance agents."
With this agreement, Agency Revolution will combine its best-in-class marketing automation platform, Fuse™, with Forge3's innovative ActiveAgency website platform creating an unparalleled marketing system for the insurance industry. Agency Revolution, known as the pioneer in marketing automation for insurance agents in both personal and commercial lines of business, enables personalized, multi-touch, cross-channel communications at pivotal points in the customer journey.
"We're incredibly proud of the website platform we've built and the reputation we've established over many years working with well over 1,200 independent insurance agencies," said Jeff Teschke, founder and CEO of Forge3. "Looking forward, we're excited to combine our proven, best-in-class website platform with Agency Revolution's leading marketing, content, and communication solution. It's a powerful combination unlike anything else in the industry."
For more information on this news and to register for a webinar with the Agency Revolution leadership team discussing how this exciting news affects existing Forge3 and Agency Revolution clients, click here.
Agency Revolution, an FMG company, has served the insurance industry for more than 25 years with a marketing platform to help independent insurance agents and brokers automate their communications, build deeper, more meaningful client relationships, and grow their agencies and brokerages. From professionally designed websites backed by an award-winning content library to a collection of marketing, communication, and relationship-building tools, Agency Revolution empowers the modern insurance agency with the services and solutions to advance how they do business and grow. Learn more.
Founded in 2004, Forge3's ActiveAgency website platform is now used by well over 1,200 independent insurance agencies across the country. Forge3 has pioneered the industry's most innovative and powerful sales tools, including Clickable Coverage, Hello Producer, Power Panels, and more, while also earning an incredible reputation within the industry. They are known for their human-powered, people-first approach combined with innovative technology and solutions. ActiveAgency is the highest-rated, fastest-growing insurance agency website platform in the industry, focused on enabling agencies to look amazing, get found, sell more, and service better.
Agency Revolution Press Contacts
Katherine Verducci
1903 PR
kverducci@1903pr.com
View original content:
SOURCE Agency Revolution
|
https://www.wibw.com/prnewswire/2022/08/17/agency-revolution-acquires-forge3-become-undisputed-leader-marketing-solutions-insurance-industry/
| 2022-08-17T16:43:36Z
|
MIAMI, Aug. 9, 2022 /PRNewswire/ -- Miami Heat forward/center Bam Adebayo, 25, visited Nicklaus Children's Hospital for a special reunion with a cancer warrior. Michael, age 21 from Miami, has a very rare and aggressive form of leukemia that affects his liver and spleen and has been in treatment for a couple of years at Nicklaus Children's Hospital.
Several months ago, Michael received a special FaceTime from Bam that started their friendship. This time, they met in person when the Miami Heat superstar paid a surprise visit to Michael and other children receiving care at Nicklaus Children's.
Separately, Miami Heat head coach, Erik Spoelstra, and his wife Nikki Sapp Spoelstra, also turned to Nicklaus Children's when their 4-year-old son Santiago was diagnosed with Burkitt lymphoma. Last month, the Spoelstra's announced that Santiago was in remission, now cancer free.
During his visit, Bam also delivered food to the nursing staff in the Emergency Department with Pedro Pollo from Pollo Tropical, and spent some time with patients in the hematology / oncology unit. Bam took photos, handed out coloring / activity books with his friend and Miami artist Vic Garcia, and enjoyed a meet and greet with more patients and their families.
Before leaving, Michael surprised Bam with an autographed basketball signed by many of the other cancer warriors he met during his day at the hospital.
MEDIA CONTACT:
Fuad Kiuhan
786-449-4797
fuad.kiuhan@nicklaushealth.org
Founded in 1950 by Variety Clubs International, Nicklaus Children's Hospital is South Florida's only licensed specialty hospital exclusively for children, with nearly 800 attending physicians and more than 500 pediatric subspecialists. The 309-bed hospital, known as Miami Children's Hospital from 1983 through 2014, is renowned for excellence in all aspects of pediatric medicine with many specialty programs routinely ranked among the best in the nation by U.S. News & World Report since 2008. The hospital is also home to the largest pediatric teaching program in the southeastern United States and since 2003 has been designated an American Nurses Credentialing Center (ANCC) Magnet facility, the nursing profession's most prestigious institutional honor. For more information, please visit www.nicklauschildrens.org.
View original content to download multimedia:
SOURCE Nicklaus Children’s Health System
|
https://www.wibw.com/prnewswire/2022/08/09/miami-heat-center-bam-adebayo-receives-autographed-basketball-nicklaus-childrens-cancer-patients/
| 2022-08-09T15:55:48Z
|
ALBANY -- A local manufacturer with a long history in Albany is looking at nearly doubling its workforce.
Thrush Aircraft announced Thursday that it is looking to hire more than 125 employees over the next year to join the 170 currently working at the plant.
The company, which has been in business since the 1970s, plans to hire more workers after that time and also is looking to get approval for two new aircraft models.
"The new product takes a new combination of our best airframe and our new engines to create a combination that is the best of both worlds," Thrush CEO Mark McDonald said during a Thursday morning news conference.
Thrush builds precision aerial application aircraft used in agricultural and firefighting roles at its Albany facility.
The temperatures says summer's here, although it's still a few days away on the calendar, and there's plenty to do in the Albany area this weekend. Click for more.
Keep it Clean. Please avoid obscene, vulgar, lewd,
racist or sexually-oriented language. PLEASE TURN OFF YOUR CAPS LOCK. Don't Threaten. Threats of harming another
person will not be tolerated. Be Truthful. Don't knowingly lie about anyone
or anything. Be Nice. No racism, sexism or any sort of -ism
that is degrading to another person. Be Proactive. Use the 'Report' link on
each comment to let us know of abusive posts. Share with Us. We'd love to hear eyewitness
accounts, the history behind an article.
|
https://www.albanyherald.com/news/thrush-aircraft-to-add-125-jobs-at-albany-facility/article_82ae5108-e821-11ec-b8de-b3af422dd2fc.html
| 2022-06-09T19:46:50Z
|
Power pole replacement to close lane of SW Topeka Blvd.
Published: Aug. 5, 2022 at 3:40 PM CDT|Updated: 11 minutes ago
TOPEKA, Kan. (WIBW) - A power pole replacement will close a northbound lane of SW Topeka Blvd. for three days.
Starting at 9 a.m. on Tuesday, Aug. 9, the City of Topeka says Torgeson Trenching will close the right northbound lane of SW Topeka Blvd. just north of 45th St. for a power pole replacement.
The City said the closure is expected to last about three days.
Copyright 2022 WIBW. All rights reserved.
|
https://www.wibw.com/2022/08/05/power-pole-replacement-close-lane-sw-topeka-blvd/
| 2022-08-05T20:53:18Z
|
ZUG, Switzerland, May 9, 2022 /PRNewswire/ -- Art should be accessible to everyone. Art can awaken in people the desire to discover hidden talents and become creators themselves. And the metaverse has the power to make it all possible, finally.
As a company that specializes in operating virtual environments, we are excited to confirm the ongoing development of a digital art gallery.
The goal of this project is to offer authors — both professionals and amateurs – new tools that endow their creations with immersive properties.
Unlike other digital galleries available on the market today, mostly limited to the transfer of physical objects into virtual environments, Sensorium's gallery moves towards understanding the nature of a person's creativity.
Sensorium Galaxy aims to contribute to the evolution of the entertainment industry. For example, our first virtual world PRISM, expected for release after the completion of the closed beta, is dedicated to electronic music. This digital space is constantly mutating based on the nature of music tracks.
The Sensorium Digital Art Gallery is integrated into our second virtual world — Motion, dedicated to the practices of self-development and self-discovery. The concept of our gallery is not built around the development of digital copies of existing artworks. As of today, there are world leaders in that specific field, and, if necessary, we could collaborate with one of them.
Our area of professional interest is englobed by the answers to the following questions: What new opportunities for Humanity could new technologies that allow us to integrate physical values into digital environments bring to the world? What is the meaning of this? What is fundamentally new and valuable that can be achieved by such integrations? Can the ideas of authors from different eras, with the help of digital technologies, become the catalyst for the development of new artistic processes?
Our main task is to promote the integration of physical and digital art into the virtual environments of the Sensorium Galaxy metaverse, turning existing art pieces into building materials for the creation of new art or unleashing the creative potential of all users.
Our concept for Sensorium's gallery relies on synthesizing several types of art. Visitors of the gallery not only dive deep into artworks but can also run independent experiments with them to create objects of their own, involving fragments of the creative heritage of famous authors.
As with every experiential project, we are currently going through a path of reflection and approaching the generation of new value.
The first exhibition will feature two internationally acclaimed contemporary artists.
Art gallery technologies will complement the exhibitions with immersiveness, bringing users closer to the discovery of the authors' intentions.
We will gradually reveal the details of our collaborations as we approach the expected opening date of the art gallery, scheduled for Q4 2022.
During the development of this project, we plan to involve our partners in a diverse range of initiatives related to the virtual environments of Sensorium Galaxy.
While our first exhibition will first focus on modern art, Sensorium's gallery is being designed for ultimate flexibility. The space will adapt to host any art and create compelling experiences around it.
Photo - https://mma.prnewswire.com/media/1813054/Sensorium_Art_Gallery.jpg
View original content to download multimedia:
SOURCE Sensorium Corporation
|
https://www.wibw.com/prnewswire/2022/05/09/sensorium-is-developing-an-immersive-art-gallery-elevate-digital-exhibitions-metaverse/
| 2022-05-09T10:03:48Z
|
GENEVA, June 21, 2022 /PRNewswire/ -- The United Nations global fund for education in emergencies and protracted crises, Education Cannot Wait (ECW), released a shocking new report today that indicates the number of crisis-impacted school-aged children requiring educational support has grown from an estimated 75 million in 2016 to 222 million today.
Of the 222 million crisis-affected children and adolescents in need of urgent support, the study indicates that as many as 78.2 million are out of school, and close to 120 million are in school, but not achieving minimum proficiency in math or reading. In fact, just one in ten crisis-impacted children attending primary or secondary education are actually achieving these proficiency standards.
"We need governments, businesses, foundations and individuals to support the vital work of Education Cannot Wait. Help us place education within reach of every child, everywhere. Help us keep 222 million dreams alive," said UN Secretary-General António Guterres.
The analysis indicates that 84% of the out-of-school crisis-impacted children are living in areas with protracted crises. The vast majority of these are in countries specifically targeted through ECW's ground-breaking multi-year investments, including Afghanistan, Democratic Republic of the Congo, Ethiopia, Mali, Nigeria, Pakistan, Somalia, South Sudan, Sudan and Yemen.
To respond to this pressing global education crisis, ECW and strategic partners launched the #222MillionDreams resource mobilization campaign in Geneva today. The campaign calls on donors, the private sector, philanthropic foundations and high-net-worth individuals to urgently mobilize more resources to scale up ECW's investments, which are already delivering quality education to over 5 million children across more than 40 crisis-affected countries.
"The financial resources to ensure that every child and young person can receive a quality education exist in the world. Governments, private sector and foundations can and must unlock these resources," said The Rt. Hon. Gordon Brown, UN Special Envoy for Global Education and Chair of ECW's High-Level Steering Group.
The campaign leads up to the Education Cannot Wait High-Level Financing Conference taking place 16-17 February 2023 in Geneva.
"This is a global call to action. While the world struggles with the devastating impacts of armed conflicts, COVID-19 and climate change, 222 million children live through these horrific experiences. It is our duty to empower them through education and help make their dreams come true," said ECW Director Yasmine Sherif.
View original content to download multimedia:
SOURCE Education Cannot Wait
|
https://www.wibw.com/prnewswire/2022/06/21/education-cannot-wait-222-million-crisis-impacted-children-urgent-need-educational-support/
| 2022-06-21T09:01:16Z
|
Which keyboard for an iPad is best?
The default onscreen keyboard of Apple’s operating system works great for typing short words or phrases. But unfortunately, it isn’t conducive to drafting epic novels or essays. The best solution, which will also keep your display fingerprint-free, is to get a keyboard for your iPad.
The small wireless device is a great alternative to the onscreen keyboard, letting you be more productive with a familiar gadget. An excellent choice is the Apple Magic Keyboard for iPad Pro — you can tilt it whichever way you want, and it keeps your iPad protected from dust and bumps.
What to know before you buy a keyboard for an iPad
Wireless keyboards require a battery
While it is always a good idea to have a power bank with you when you work remotely, you might need it to charge your keyboard. Wireless iPad keyboards come with a built-in battery, and just like any tech gadget, need to be recharged. You might get away with connecting the keyboard to the iPad with a cable, but it’s not something you want to risk.
You don’t have to buy the official Apple keyboard
The beauty of Bluetooth technology is that you can use any gadget with a Bluetooth-capable device. This includes a keyboard for your iPad, so you don’t need to buy the official Apple product. There are plenty of choices from third-party manufacturers, and while the Apple Magic Keyboard is the best, it’s also more expensive than others.
It will take some time to get used to
You’re probably familiar with working on a keyboard, but one designed for an iPad is slightly different. It’s much thinner and lighter than a regular, full-size keyboard, so it might feel a bit awkward at first. The travel distance of the keys and their tactile responsiveness is also less, which can be a stark difference from what you are used to.
What to look for in a quality keyboard for an iPad
Combine the keyboard with an iPad case
The best thing to do when looking for an iPad keyboard is to combine it with a case or cover. This gives you the freedom of working on a laptop-like keyboard while also protecting your iPad when you aren’t using it. As a bonus, the case also functions as a stand so you can angle the tablet for the best viewing position.
Well-built and durable
Unless you are looking for a one-off solution, the keyboard’s durability ensures that you can use it for many years. A good-quality keyboard is made from solid plastic, metal or a combination of materials. In the case of a keyboard combination, it should also have a microfiber lining on any parts that will come in contact with the iPad’s body or screen.
Battery longevity
The keyboard draws power from a built-in battery, which needs to be charged sporadically. Typically, you can connect the keyboard to the iPad or power bank for charging, but that isn’t possible with all models. Some use non-rechargeable coin batteries, which still give you a few months of operating time. Naturally, a wired keyboard doesn’t have a battery.
How much you can expect to spend on a keyboard for an iPad
The average price of a keyboard for your iPad depends on the functions. A basic keyboard that provides no protection or additional functions costs $15-$20. But a keyboard-case combo can retail for $100-$300.
Keyboard for an iPad FAQ
Are there wired keyboards for an iPad?
A. Yes, since any keyboard can technically work with an iPad. Bluetooth is the easiest way to connect a wireless keyboard. To use a regular keyboard, you need a Camera Connection Kit that changes the Lightning port into a USB port.
Are keyboards interchangeable between iPads?
A. Typically, any device that uses Bluetooth can connect to an iPad, no matter the model or release year. Where the device model matters are when you’re looking for a case combo, as those are specific to the device.
What’s the best keyboard for an iPad to buy?
Top keyboard for an iPad
Apple Magic Keyboard For iPad Pro
What you need to know: Few iPad keyboards can beat the design and function of Apple’s original creation. As a case-keyboard combo, you magnetically attach the iPad to the backplate and the thin keyboard flips closed to become the lid.
What you’ll love: The sturdy cantilever hinge on the inside of the keyboard case lets you effortlessly change the screen’s angle. It also has a trackpad that functions in the same way it does on a laptop.
What you should consider: The keyboard case is compatible with the Apple Pencil, but there isn’t a dedicated slot to keep the Pencil in place.
Where to buy: Sold by Amazon
Top keyboard for an iPad for the money
Omoton Wireless Rechargeable Keyboard For iPad
What you need to know: This is an easy and affordable solution if you need a compact wireless keyboard for working remotely.
What you’ll love: The backlit keys of this wireless keyboard can change among seven colors while the body is white. It has a built-in rechargeable battery that can give you around 40 hours of operation. The keyboard, while still compact, has additional multimedia keys to control your music or streaming content.
What you should consider: Weighing only 8.8 ounces, it might not be robust enough for some users.
Where to buy: Sold by Amazon
Worth checking out
Logitech Slim Folio iPad Keyboard Case
What you need to know: This keyboard comes as part of a case combination, letting you work efficiently while also protecting your device.
What you’ll love: The hard shell of the case clips onto the iPad, and the horizontal fold down the middle serves as the hinge for angling it perfectly. It has an elastic loop to keep your Apple Pencil in place, and the keyboard uses a non-rechargeable coin battery. The keyboard connects to the iPad through Bluetooth.
What you should consider: Although the battery can last for several years, it can leave you in a pickle when it dies suddenly.
Where to buy: Sold by Amazon
Want to shop the best products at the best prices? Check out Daily Deals from BestReviews.
Sign up here to receive the BestReviews weekly newsletter for useful advice on new products and noteworthy deals.
Charlie Fripp writes for BestReviews. BestReviews has helped millions of consumers simplify their purchasing decisions, saving them time and money.
Copyright 2022 BestReviews, a Nexstar company. All rights reserved.
|
https://cw33.com/reviews/br/electronics-br/tablets-accessories-br/best-keyboard-for-ipad/
| 2022-05-27T01:49:56Z
|
Bonneville County Sheriff’s Office investigates suspicious death
BONNEVILLE COUNTY, Idaho (KIFI) - Bonneville County Sheriff’s deputies are investigating a suspicious death at the Lane Clark Hill Rest Area on Hwy 26 (Approx. Mile Post 356) East of Ririe.
At 6:30 a.m. Friday morning, dispatch received a report of what appeared to be a deceased subject near a parked vehicle in the parking lot.
A large portion of the Rest Area is closed at this time whiled detectives collect evidence and process the scene.
The Bonneville County Coroners Office is also assisting at the scene.
The sheriff’s office is asking for anyone with information or anyone who may have been in the area between 4:30 p.m Thursday and 6:30 a.m. Friday morning to contact our dispatch at 208-529-1200, report anonymously through Crime Stoppers at www.ifcrime.org or on the P3tips app on your mobile device, or contact the Idaho Fusion Center Tipline at 1-833-445-2092.
The investigation is ongoing and further information will be updated at a later time.
|
https://localnews8.com/news/crime-tracker/2022/05/13/bonneville-county-sheriffs-office-investigates-suspicious-death/
| 2022-05-13T17:40:53Z
|
The Texas A&M AgriLife Extension Service will hold a Mediterranean Diet Cooking Class on Thursday in Waco.
The class is presented by the AgriLife Extension office in McLennan County in cooperation with McLennan Community College Continuing Education. It will be held at 4224 Cobbs Drive.
The cost is $39, and the course will be 5:30-7:30 p.m. Participants must preregister at https://tx.ag/MedDiet or by calling 254-299-8888.
“The Mediterranean diet has been researched extensively for decades now and the more we learn, the more this approach has solidified itself as one of the best lifestyle approaches to improve diet-related chronic disease risk,” said Colleen Foleen, AgriLife Extension family and community health agent for McLennan County.
What is often called the Mediterranean diet in the U.S. refers to a way of eating and preparing foods based on the eating traditions from Italy, Greece and other countries that border the Mediterranean Sea.
“The Mediterranean-style eating pattern should be referred to as a lifestyle approach rather than a diet,” she said. “It is not prescriptive, and it integrates more than just nutrition. It focuses on sustainability, social environment and physical activity.”
Cooking class overview
Foleen said over the course of the evening participants will:
- Learn about healthy eating patterns.
- Plan menus and shopping lists to make healthy choices easier.
- Learn to modify some recipes to a Mediterranean style.
- See a cooking demonstration.
- Taste some wonderful and healthy foods.
- Leave with a better understanding of the concept of the Mediterranean diet and the health benefits of this eating pattern and lifestyle.
Diet benefits
The Mediterranean-style eating pattern is high in fruits, vegetables, beans, legumes, healthy fats and whole grains. Foleen said this indicates that it is also high in antioxidants, polyphenols, mono/polyunsaturated fatty acids, fiber, vitamins and minerals.
The foundation of the diet is whole grains, vegetables, legumes, fruits, nuts, seeds, herbs and spices. Foods such as fish, dairy, poultry and seafood are all eaten in moderation, which allows olive oil to be one of the main sources of added fat in this type of diet, she said.
“All of these can contribute to lowering cholesterol levels, preventing cell damage, providing anti-inflammatory effects, improving glycemic control and more,” Foleen said. “Researchers have determined that these nutritional mechanisms could be contributing to the success of this eating pattern.”
|
https://www.tdtnews.com/news/central_texas_news/article_b253bfa2-2682-11ed-80e6-5b57bf8f9e26.html
| 2022-08-28T07:29:27Z
|
MEMPHIS, Tenn., April 8, 2022 /PRNewswire/ -- First Horizon Corporation (NYSE: FHN) announced today that, in light of the proposed transaction with TD Bank Group, it now plans to release first quarter financial results on April 19, 2022 after the close of the market. The earnings materials will be available on the FHN website at ir.firsthorizon.com under Events and Presentations. FHN also noted that management no longer plans to conduct conference calls in reference to the earnings materials.
About First Horizon
First Horizon Corp. (NYSE: FHN), with $89.1 billion in assets as of December 31, 2021, is a leading regional financial services company, dedicated to helping our clients, communities and associates unlock their full potential with capital and counsel. Headquartered in Memphis, TN, the banking subsidiary First Horizon Bank operates in 12 states across the southern U.S. The Company and its subsidiaries offer commercial, private banking, consumer, small business, wealth and trust management, retail brokerage, capital markets, fixed income, mortgage, and title insurance services. First Horizon has been recognized as one of the nation's best employers by Fortune and Forbes magazines and a Top 10 Most Reputable U.S. Bank. More information is available at www.FirstHorizon.com.
View original content to download multimedia:
SOURCE First Horizon Corporation
|
https://www.wibw.com/prnewswire/2022/04/08/first-horizon-corporation-announces-revised-release-date-april-19-2022-first-quarter-results/
| 2022-04-09T01:20:03Z
|
– Discovered in-house by the internal R&D Team at Antengene, ATG-018 is an orally-bioavailable, small molecule ataxia telangiectasia and Rad3-associated (ATR) kinase inhibitor that targets the DNA damage response (DDR) pathway.
– This Phase I study will evaluate the safety, pharmacology and preliminary efficacy of ATG-018 in patients with advanced solid tumors and hematologic malignancies.
– ATG-018 has the potential as the first orally-available, small molecule ATR kinase inhibitor entering clinical development in Australia.
SHANGHAI and HONG KONG, June 6, 2022 /PRNewswire/ -- Antengene Corporation Limited ("Antengene" SEHK: 6996.HK), a leading commercial-stage global biopharmaceutical company dedicated to discovering, developing and commercializing first-in-class and/or best-in-class therapeutics in hematology and oncology, today announced that Antengene has received approval by the Bellberry Human Research Ethics Committee (HREC) in Australia to initiate the Phase I Trial of ATG-018 in patients with advanced solid tumors and hematologic malignancies (ATRIUM Trial).
ATG-018 is an orally-available, potent, selective small molecule ATR inhibitor. ATG-018 inhibits the ATR kinase, thus limiting cancer cells' ability to repair damaged DNA, in a mechanism also known as synthetic lethality or the DDR.
The primary objective of the study is to evaluate the safety and tolerability of ATG-018 as a monotherapy, to determine the appropriate dose for Phase II studies and assess preliminary efficacy, if available; the secondary objective is to characterize the pharmacology of ATG-018. The study will be conducted in two parts (dose-escalation and dose-expansion). Icon Brisbane in Australia is the lead site for the study, which will be conducted at five sites across Australia.
"DNA is constantly exposed to damage by sources such as ultraviolet light, toxins, certain chemicals, and natural biochemical processes inside our cells. The DNA damage response (DDR) is able to identify DNA damage and to induce various biological processes that correct these changes." Said Dr Jim Coward, Chair of Icon's Medical Oncology Research Committee and Associate Professor at University of Queensland School of Medicine. "The therapeutic landscape of antitumor agents targeting DDR pathways has rapidly expanded to include inhibitors of other key mediators of DNA repair and replication, such as ATR, ATM and DNA-PK[1]. Positive findings from the trials evaluating ATR inhibitors such as ATG-018 may help provide oncologists with a new tool for improving patient outcomes in challenging cases and give them new hope when other therapies have failed."
Dr. Bo Shan, Antengene's Chief Scientific Officer commented, "ATG-018 has a solid preclinical data package including efficacy as a monotherapy in solid tumor models, oral bio-availability and potential predictive biomarkers for response. It is also one of Antengene's first in-house programs to reach the clinic. The differentiated profile of ATG-018 may enable it to be used as monotherapy and open the door for novel collaborations and combination regimens that could benefit cancer patients around the world. We are very pleased to receive HREC approval for the Phase I ATRIUM trial for ATG-018 and we look forward to collaborating with Dr. Coward and the team at Icon Brisbane on this exciting trial."
About the ATRIUM Trial
The ATRIUM trial is a Phase I multi-center, open-label, dose finding study of ATG-018 monotherapy in patients with advanced solid tumors or hematologic malignancies. The primary objective of the study is to evaluate the safety and tolerability of ATG-018 and to determine the maximum tolerated dose (MTD) and/or recommended Phase 2 dose (RP2D) and/or biologically effective dose of ATG-018 monotherapy and preliminary efficacy, if available. The secondary objective is to characterize the pharmacology of ATG-018. As a Phase I study, there will be intensive safety monitoring throughout the trial.
About ATG-018
Discovered by the internal R&D Team at Antengene, ATG-018 is an oral, potent, selective small molecule inhibitor targeting ataxia telangiectasia and Rad3-associated (ATR) kinase. ATR kinase belongs to the phosphoinositide 3 kinase-related family. Inhibiting ATR kinase leads to increased accumulation of single-strand DNA breaks, particularly meaningful for tumor cells which rely on DNA damage repair (DDR). Preclinical studies have demonstrated that ATR inhibitor monotherapy or combination with other drugs (including DDR agents) could be promising therapeutic strategies for solid tumors (including gastric, esophageal, squamous cell carcinoma) and hematologic malignancies (chronic lymphocytic leukemia [CLL], diffuse large B-cell lymphoma [DLBCL] and multiple myeloma [MM]).
According to a preclinical poster presented at 2022 American Association for Cancer Research (AACR 2022) Annual Meeting, ATG-018 has demonstrated potent in vitro and in vivo monotherapy efficacy in solid tumor/hematologic cancer models with certain homologous recombination deficiencies. These data were supported by a series of genetic alterations that correlated with ATG-018 sensitivity and could be potential predictive biomarkers. Taken together, these data suggest that ATG-018 could be a promising therapeutic agent for patients with such homologous recombination deficiencies/genetic alterations.
About Antengene
Antengene Corporation Limited ("Antengene", SEHK: 6996.HK) is a leading commercial-stage R&D-driven global biopharmaceutical company focused on the discovery, development, manufacturing and commercialization of innovative first-in-class/best-in-class therapeutics for the treatment of hematologic malignancies and solid tumors, in realizing its vision of "Treating Patients Beyond Borders".
Since 2017, Antengene has a built broad and expanding pipeline of 15 clinical and preclinical assets, of which 10 are global rights assets, and 5 came with rights for Asia Pacific markets including the Greater China region. To date, Antengene has obtained 24 investigational new drug (IND) approvals in the U.S. and Asia, and submitted 6 new drug applications (NDAs) in multiple Asia Pacific markets, with the NDA for XPOVIO® (selinexor) already approved in mainland China, South Korea, Singapore and Australia.
Forward-looking statements
The forward-looking statements made in this article relate only to the events or information as of the date on which the statements are made in this article. Except as required by law, we undertake no obligation to update or revise publicly any forward-looking statements, whether as a result of new information, future events or otherwise, after the date on which the statements are made or to reflect the occurrence of unanticipated events. You should read this article completely and with the understanding that our actual future results or performance may be materially different from what we expect. In this article, statements of, or references to, our intentions or those of any of our Directors or our Company are made as of the date of this article. Any of these intentions may alter in light of future development. For a further discussion of these and other factors that could cause future results to differ materially from any forward-looking statement, see the section titled "Risk Factors" in our periodic reports filed with the Hong Kong Stock Exchange and the other risks and uncertainties described in the Company's Annual Report for year-end December 31, 2021, and subsequent filings with the Hong Kong Stock Exchange.
For more information, please contact:
Investor Contacts:
Donald Lung
E-mail: Donald.Lung@antengene.com
Mobile: +86 18420672158
PR Contacts:
Peter Qian
E-mail: Peter.Qian@antengene.com
Mobile: +86 13062747000
View original content to download multimedia:
SOURCE Antengene Corporation Limited
|
https://www.kxii.com/prnewswire/2022/06/07/antengene-announces-hrec-approval-australia-phase-i-trial-small-molecule-atr-inhibitor-atg-018/
| 2022-06-07T04:04:35Z
|
DALLAS, Aug. 3, 2022 /PRNewswire/ -- NexPoint Diversified Real Estate Trust ("NXDT" or the "Company") (NYSE: NXDT) will host an update call on August 10, 2022 to discuss the Company's operations as a REIT. To register to attend the call, click on "events and presentations" under "resources" on the Company's website at nxdt.nexpoint.com. A replay will be available on NXDT's website after the call.
Please note this call was originally scheduled for August 3, 2022, but has been rescheduled for August 10, 2022.
About NexPoint Diversified Real Estate Trust
NexPoint Diversified Real Estate Trust is an externally advised, publicly traded, diversified real estate investment trust (REIT) focused on the acquisition, development, and management, of opportunistic and value-add investments throughout the United States across multiple sectors where NexPoint and its affiliates have operational expertise. NXDT is externally advised by NexPoint Real Estate Advisors X, L.P. For more information, please visit nxdt.nexpoint.com.
Contact:
Jackie Graham
Director, Investor Relations
JGraham@nexpoint.com
Media Inquiries
Lucy Bannon
LBannon@nexpoint.com
View original content to download multimedia:
SOURCE NexPoint Diversified Real Estate Trust
|
https://www.mysuncoast.com/prnewswire/2022/08/04/nexpoint-diversified-real-estate-trust-announces-update-call/
| 2022-08-04T02:46:27Z
|
Hate crime charges filed against 2 in Black man’s beating
INVERNESS, Fla. (AP) — Two white Florida men have been charged with a federal hate crime for allegedly beating a Black man in a store parking lot while yelling racial slurs.
Roy Lashley, 55, and Robert Lashley, 52, were indicted by a grand jury, the U.S. Justice Department said in a news release Friday.
The pair had already been charged with assault and battery under state law for the November attack of the Black man in the parking lot of a Family Dollar store in Citrus County, which is north of the Tampa area.
Federal court records did not list an attorney for either man. It was not clear how or if they are related.
According to arrest records, the victim — identified only by the initials D.B. — said he was walking away from the store when someone began yelling racial slurs. Investigators say Robert Lashley ran toward D.B. and began hitting him in the face.
Roy Lashley then allegedly struck D.B. several times with an ax handle as the Black man lay on the ground. Roy Lashley also got into a confrontation with arresting deputies, which led to charges of resisting law enforcement, according to the arrest records.
Federal hate crime charges carry a maximum 10-year prison sentence and a fine of up to $250,000.
Copyright 2022 WWSB. All rights reserved.
|
https://www.mysuncoast.com/2022/06/18/hate-crime-charges-filed-against-2-black-mans-beating/
| 2022-06-18T17:52:18Z
|
Disney Veteran Brings More Than 20 Years of Global Experience in Licensing, Merchandising and Product Development
CHATSWORTH, Calif., May 17, 2022 /PRNewswire/ -- MGA Entertainment (MGA), the fastest growing and largest privately held toy company in the U.S., today announced the appointment of Mindy Puente-Escalera as its Senior Vice President of Global Licensing. She will lead the management of all licensing activities and develop a strategic approach for growth, giving consumers around the world more ways to enjoy MGA's highly-popular and award-winning brands, such as L.O.L. Surprise!™, Little Tikes®, Rainbow High™, and Bratz®, among many others.
"With more than 20 years of experience in global licensing, merchandising, buying and product development, Mindy brings a new point-of-view to our growing licensing business," said MGA Entertainment Founder and Chief Executive Officer, Isaac Larian. "I believe we have just scratched the surface with licensing of our large and growing family of well-known brands and have the opportunity to expand into new and innovative products working with new licensing partners worldwide."
Puente-Escalera comes to MGA from Living Spaces, where she held the role of Vice President, Buying, Licensing, Product Development & Visual. Prior, she spent nearly 12 years with The Walt Disney Company, first as Director, Softlines for Disney Consumer Products, then as Director, eCommerce Merchandising & Licensing for Disney Stores.
"I am excited to join the MGA Entertainment family and to have the opportunity to work with truly world-class brands that put smiles on the faces of children," said Mindy Puente-Escalera, Senior Vice President, Global Licensing, MGA Entertainment. "I look forward to working closely with Isaac and the MGA leadership team to grow the licensing business and expand the reach of MGA to more consumers globally.
About MGA Entertainment
MGA Entertainment is the fastest growing and largest privately held toy company in the U.S., headquartered in Chatsworth, Calif. The company creates innovative, proprietary, and licensed consumer products and entertainment, including toys, games, dolls, apparel, consumer electronics, home décor, stationery, and sporting goods. The MGA family includes award-winning brands such as L.O.L. Surprise!™, Little Tikes®, Rainbow High™, Bratz®, Shadow High™, Na! Na! Na! Surprise™, Mermaze Mermaidz™ Color Change, Baby Born® Surprise and Zapf Creations®. For more information, please visit us at www.mgae.com or check out our LinkedIn page.
View original content to download multimedia:
SOURCE MGA Entertainment
|
https://www.kxii.com/prnewswire/2022/05/17/mga-entertainment-appoints-mindy-puente-escalera-its-senior-vice-president-global-licensing/
| 2022-05-17T13:23:14Z
|
Teen shot 7 times and kicked by friend is fighting for his life, family says
CLEVELAND (WOIO/Gray News) – A teen in Ohio is fighting for his life after being gunned down while riding his bike, WOIO reports.
Curtis Jackson’s father said the 13-year-old has had five surgeries so far and has a long road to recovery.
“For this to happen to him in this kind of fashion -- it’s cold-blooded to be shot seven times then kicked,” his father said.
Curtis had just graduated middle school as valedictorian and was set to start high school next week.
Instead, he’s lying in a hospital bed.
“I whisper in his ear every night,” his dad said. “I whisper in his ear like it’s just me and you. I can’t let you out of my sight no more, it’s just me and you. Things happen. Life comes at you fast, but this one right here really hit home.”
Curtis’ father, also named Curtis Jackson, said his son was knocked off his bike and shot by a 15-year-old he considered a friend.
His son was shot four times in the chest, twice in the arm and a bullet grazed his head.
According to witnesses, the shooter allegedly kicked the 13-year-old in the head after shooting him and then ran away.
“It’s getting bad around here,” said Jackson. “It’s just the gun violence man and they’re getting younger and younger. My son is 13 years old; his birthday is Saturday.”
While it’s unclear when the teen will be released from the hospital, his father is hopeful Wednesday was his last surgery.
According to reports, the 15-year-old turned himself in to police.
Copyright 2022 WOIO via Gray Media Group, Inc. All rights reserved.
|
https://www.mysuncoast.com/2022/08/26/teen-shot-7-times-kicked-by-friend-is-fighting-his-life-family-says/
| 2022-08-26T16:40:26Z
|
ALM-488 is a peptide-dye conjugate designed to fluorescently highlight nerves in real time during surgery
LA JOLLA, Calif., Aug. 23, 2022 /PRNewswire/ -- Alume Biosciences, Inc, a leader in the field of nerve-targeted diagnostics and therapeutics, today announced that the first patient has been dosed in a Phase 3 pivotal study of ALM-488 (NCT05377554). ALM-488 is a peptide-dye conjugate designed to highlight nerves with fluorescence in real time during surgery.
"The successful initiation of this Phase 3 pivotal study is another major milestone for Alume. It marks the final phase of clinical trial testing for ALM-488 for patients undergoing Head and Neck Surgery" said Brett Berman, MD, chief medical officer at Alume Biosciences. "This study underscores our commitment to improve intraoperative visualization of nerves, enabling Precision Surgery™".
Alume successfully completed Phase 1/2 studies of ALM-488 in patients undergoing Head and Neck Surgery in 2021. The Phase 3 studies are being conducted at multiple academic medical centers throughout the US, and they are projected to be completed in 2023. "We look forward to exploring the power of ALM-488 as an intraoperative tool to identify nerves and potentially improve outcomes for our patients," said Karthik Rajasekaran MD, principal investigator at University of Pennsylvania.
About ALM-488
ALM-488 is a proprietary fluorescent peptide-dye conjugate in the visible spectrum and can be visualized with fluorescently enabled instrumentation including filter modified loupe systems, portable handheld systems, microscopes and laparoscopes. ALM-488 binds to the extracellular matrix of nerves, allowing real-time nerve illumination during surgery. ALM-488 is expected to have broad surgical application due to unique characteristics of binding that are independent of myelin. This allows ALM-488 to highlight multiple types of nerves including motor, sensory, and autonomic. Degenerated nerves, critically important during reconstructive procedures, are also highlighted with ALM-488. Surgeries where nerves are potentially at risk include procedures in the skull base, head and neck, spine, and nerve sparing prostatectomy. In vivo studies also indicate that ALM-488 has adequate pharmacokinetic characteristics to support clinical utility for the labelling of ureters in urology, gynecology and lower abdominal surgical indications.
About Alume Biosciences
Alume Biosciences is a late-stage clinical biotechnology company developing nerve specific targeting molecules. In addition to ALM-488, Alume is developing other nerve specific agents for diagnostic and therapeutic indications. The company was founded in 2017 and is headquartered in the Johnson & Johnson Innovation incubator JLABS @ San Diego. Learn more about Alume Biosciences at https://alumebiosciences.com
Media contact: Yana.Campen@alumebiosciences.com
View original content to download multimedia:
SOURCE Alume Biosciences
|
https://www.kxii.com/prnewswire/2022/08/23/alume-biosciences-announces-first-patient-dosed-with-alm-488-phase-3-pivotal-study-patients-undergoing-head-neck-surgery/
| 2022-08-23T10:38:02Z
|
NEW YORK, Sept. 2, 2022 /PRNewswire/ -- Jakubowitz Law announces that a securities fraud class action lawsuit has commenced on behalf of shareholders of Unity Software Inc. (NYSE: U).
To receive updates on the lawsuit, fill out the form:
https://claimyourloss.com/securities/unity-software-inc-loss-submission-form/?id=31290&from=4
The lawsuit seeks to recover losses for shareholders who purchased Unity between March 5, 2021 and May 10, 2022.
Shareholders interested in acting as a lead plaintiff representing the class of wronged shareholders have until September 6, 2022 to petition the court. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.
According to a filed complaint, Unity Software Inc. issued materially false and/or misleading statements and/or failed to disclose that: (i) deficiencies in Unity's product platform reduced the accuracy of the Company's machine learning technology; (ii) the foregoing was likely to have a material negative impact on the Company's revenues; (iii) accordingly, Unity had overstated the Company's commercial and/or financial prospects for 2022; (iv) as a result, the Company was likely to have to reduce its fiscal 2022 guidance; and (v) as a result, the Company's public statements were materially false and misleading at all relevant times.
Jakubowitz Law is vigorous in pursuit of justice for shareholders who have been the victim of securities fraud. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT:
JAKUBOWITZ LAW
1140 Avenue of the Americas
9th Floor
New York, New York 10036
T: (212) 867-4490
F: (212) 537-5887
View original content:
SOURCE Jakubowitz Law
|
https://www.wibw.com/prnewswire/2022/09/02/u-shareholder-alert-jakubowitz-law-reminds-unity-shareholders-lead-plaintiff-deadline-september-6-2022/
| 2022-09-02T11:07:23Z
|
NEW YORK, June 8, 2022 /PRNewswire/ -- Moore Kuehn, PLLC, a securities and shareholder law firm located on Wall Street, is investigating potential claims against:
- TELADOC HEALTH, INC. (NYSE: TDOC)
***Please contact only if you acquired shares before October 28, 2021
Teladoc provides virtual healthcare services in the U.S. and internationally through Business-to-Business ("B2B") and Direct-to-Consumer ("D2C") distribution channels. The Company offers its customers various virtual products and services addressing, among other medical issues, mental health through its BetterHelp D2C product, and chronic conditions.
Moore Kuehn is investigating whether Teladoc or its officers and directors failed to disclose that: (i) increased competition, among other factors, was negatively impacting Teladoc's BetterHelp and chronic care businesses; (ii) the growth of those businesses was less sustainable than Defendants had led investors to believe; (iii) as a result, Teladoc's revenue and adjusted EBITDA projections for FY 2022 were unrealistic; and (iv) as a result of all the foregoing, Teladoc would be forced to recognize a significant non-cash goodwill impairment charge.
If you still own Teladoc Health, Inc or TDOC since October 28, 2021, have information, would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Fletcher Moore, Esq. by email at fmoore@moorekuehn.com or telephone at (212) 709-8245.
There is no cost to you. Moore Kuehn is a New York-based law firm with attorneys representing investors and consumers.
Please visit http://www.moorekuehn.com/practice/new-york-shareholder-derivative-litigation/
Attorney advertising. Prior results do not guarantee similar outcomes.
Moore Kuehn, PLLC
Fletcher Moore, Esq.
30 Wall Street, 8th Floor
New York, New York 10005
fmoore@moorekuehn.com
(212) 709-8245
View original content to download multimedia:
SOURCE Moore Kuehn, PLLC
|
https://www.wibw.com/prnewswire/2022/06/08/moore-kuehn-encourages-investors-teladoc-health-inc-nyse-tdoc-contact-law-firm/
| 2022-06-08T23:50:24Z
|
Easter is a perfect opportunity to spend time as a family away from screens and tech, but once your kids are bored and hyped up on sugar, it doesn’t feel so idyllic. Playing games is a great way to keep kids engaged and occupied.
Once you’ve got your head around why Easter doesn’t fall on the same day each year, it’s time to plan some entertainment. These Easter family games will keep kids entertained, just choose options suitable for your kids’ ages and interests.
What games do you play on Easter?
Besides the traditional egg hunt, there aren’t really any specific games that are widely played on Easter. The good thing about this is it leaves you more freedom to find or come up with Easter-themed games that the kids in your life will enjoy. Any of the following can be great fun on Easter day.
Easter treasure hunt
Rather than hiding Easter eggs in multiple spots all over your home or yard, hide one big cache of eggs with a clue-based treasure hunt to find it. Start by giving your kids the first clue. Solving this will lead them to the location of the next written clue, which you can tuck inside a plastic Easter egg. Keep doing with more clues until the final clue leads them to the eggs.
The great thing about this kind of treasure hunt is that you can have as many clues as you like and you can tailor them to your kids’ ages and ability levels. If you think your children might lose interest without incentive, you can put a few pieces of candy in with every other clue.
Egg and spoon race
An egg and spoon race involves balancing an egg on a spoon over a set distance, with the first person to cross the finish line winning the game. Kids and adults alike can join in, resulting in some healthy intergenerational rivalry.
While you can use real hard-boiled eggs for this game, you can also buy egg and spoon race sets containing wooden or plastic eggs with spoons of a suitable size. These eliminate the prep time, potential mess and waste of food.
Carrots in a basket game
All you need for this game is an Easter basket for each team or child and a pile of carrots, for the Easter Bunny, of course. If you’re playing with just a handful of kids, they can each have a basket, but for large family gatherings with lots of kids, divide them into 2-4 teams.
The simple aim is to throw the carrots into the basket without crossing a set mark. It might not be an elaborate game, but this makes it great for young children. When older kids want to get involved, set their mark farther from the basket so they don’t have an advantage.
Challenge-based egg hunt
Spice up your usual egg hunt by filling half the eggs with your usual candy or toys and the other half with written challenges. These challenges can be anything you like but keep them fun and relatively brief. You can even make them Easter-themed, such as “hop like a bunny” or “make the sound of a chick.”
Scoop the jelly beans
For this game, you’ll need one bowl of jelly beans, one empty bowl and a spoon for each player. Give each player 30-60 seconds to move as many jelly beans as they can into the empty bowl using the spoon held in their mouth. Tip the jelly beans the player managed to move into a measuring cup and make a note of the measurement before moving on to the next player. At the end of each round, you can declare a winner.
Water balloon toss game
This is like an egg toss game but you won’t waste food and there’s less mess — assuming you play outside. Pair up the players and give them a filled water balloon each. The players must toss it between them, attempting not to drop it. If they drop the water balloon and it bursts, they’re out of the game. If it drops and doesn’t burst, they can pick it up and keep playing.
The last pair left in the game with an intact water balloon wins. You can make it more challenging for older kids by spacing them farther apart than younger kids, so it’s fairer for all players.
What you need for Easter games
Brach’s Classic Jelly Beans — 54 oz (Pack of 2)
These two bags of jelly beans contain roughly 6.75 pounds of beans total, which should be more than enough for any jelly bean-related games.
Sold by Amazon
With 36 plastic Easter eggs in a set, this should give you an ample amount for egg hunts, treasure hunts and so on. They come in six colors: orange, green, yellow, blue, pink and purple.
Sold by Amazon
Joyin Easter Egg and Spoon Relay Game
Containing 12 eggs and 12 spoons, this set is perfect for getting the whole family involved in an egg and spoon race.
Sold by Amazon
Sign up here to receive the BestReviews weekly newsletter for useful advice on new products and noteworthy deals.
Lauren Corona writes for BestReviews. BestReviews has helped millions of consumers simplify their purchasing decisions, saving them time and money.
Copyright 2022 BestReviews, a Nexstar company. All rights reserved.
|
https://cw33.com/reviews/br/apparel-br/holiday-br/these-easter-family-games-are-sure-to-keep-your-kids-entertained/
| 2022-04-07T23:57:27Z
|
Demo More than 100+ Thrilling 'Electric Vehicles' at Electrify Expo
LONG BEACH, Calif., June 1, 2022 /PRNewswire/ -- As supply chain woes and the war in Ukraine continue to affect worldwide markets, fuel prices have reached all-time highs across the U.S., with some per-gallon gas prices in California exceeding minimum wage in some states. Consumers are tired of shelling out $100 or more to fill the tank and are searching for various modes of transportation less reliant on gasoline.
Electrify Expo, North America's largest electric-vehicle festival, kicks off the first of five electric vehicle events of 2022 beginning in Long Beach, CA, to showcase the best in EV technology. From e-bikes, e-motorcycles, e-skateboards, and e-scooters to the latest in Electric Cars, consumers will be able to ride, drive and demo the newest tech in electric mobility. As the first stop on the festival tour, Long Beach provides a first look at exciting new electric tech from the world's leading brands. Attendees can visit exhibitor displays, demo 100s of new products, and drive EVs inside the Bridgestone EV Demo District. The family-friendly festival also includes the Hover-1 Kids Zone with activities for the whole family.
WHAT: Electrify Expo: Largest electric vehicle festival in North America
WHEN: Saturday & Sunday, June 4 & 5, 2022
TIME: 10 am - 5 pm Each Day
WHERE: Long Beach Convention Center
300 E Ocean Blvd
Long Beach, CA 90802
TICKETS: $20 Per Ticket, Kids under 5 are Free
https://www.electrifyexpo.com/long-beach
To register for a press pass to attend Electrify Expo, you are invited to apply here https://www.electrifyexpo.com/exhibits-press#Press
Electrify Expo is North America's largest outdoor electric vehicle festival showcasing the latest electric vehicles and products, including EVs, e-motorcycles, e-bikes, e-scooters, e-skateboards, e-boats, e-surfboards, and more from top brands around the world. The festival addresses one of the most challenging barriers to mass adoption of electric vehicles with meaningful hands-on experiences, demonstrations, and test rides. Electrify Expo meets the soaring demand for companies to share new technologies, new modes of mobility and put products in the hands of consumers in a meaningful way. Electrify Expo will feature more than 1M+ square feet of exhibit space in Los Angeles County, Seattle, New York, Miami, and Austin.
Contact:
Mission Control Communications
electrifyexpo@missionc2.com
View original content to download multimedia:
SOURCE Electrify Expo
|
https://www.wibw.com/prnewswire/2022/06/01/high-gas-prices-jolt-consumers-attend-electrify-expo-june-4-amp-5/
| 2022-06-01T12:49:01Z
|
Highlights include the Disney Dream's first call to Europe and a return to Alaska
CELEBRATION, Fla., April 27, 2022 /PRNewswire/ -- Disney Cruise Line will offer families a variety of enchanting vacations in summer 2023, including cruises to new and favorite ports of call around the world. From the majestic glaciers of Alaska to the sun-kissed Greek isles, pink sand beaches of Bermuda and picturesque fjords of Norway, these summer destinations will sparkle with adventure and excitement. Plus, for the first time ever, families will have the opportunity to sail around the Mediterranean and British Isles on the Disney Dream during its first season in Europe.
"We are thrilled to have five ships at sea in summer 2023 with a wide array of destinations for families to enjoy," said Sharon Siskie, senior vice president & general manager of Disney Cruise Line. "These Disney Cruise Line sailings will take families on summer adventures in ways that only Disney can do, delighting guests of all ages with dazzling entertainment, world-class dining, unique character encounters, the ease and indulgence of carefree days at sea and the uncompromising guest service that defines a Disney vacation."
Bookings open to the public May 9, 2022. For more details, visit the Summer 2023 itineraries page of disneycruise.com.
Disney Dream Marks Inaugural Season in Europe
For its first-ever summer season in Europe, the Disney Dream will call on a wide variety of destinations among the most treasured in the world. With sailings anywhere from four to 11 nights, the Disney Dream will sail from Barcelona and Rome to picturesque ports of call throughout the Mediterranean, including a first-ever seven-night sailing to the Greek Isles with stops in the ever-popular ports of Santorini and Mykonos.
Late summer/early fall departures of the Disney Dream from Southampton will feature cruises to a wealth of destinations including Spain, France, the British Isles, Norway and Iceland. New ports of call include the postcard-worthy La Rochelle, France and two new ports in Norway – Skjolden, home to a wealth of natural attractions, and Sandnes, a small city just outside the metropolis of Stavanger known for its outdoor activities.
Summer 2023 sailings to Alaska aboard Disney Wonder
The breathtaking natural beauty of Alaska will combine with the magic of Disney on five-, seven- and nine-night sailings on the Disney Wonder from Vancouver, Canada. Beginning in May, cruisers will be invited to discover exciting ports like Ketchikan and Skagway, with their prehistoric glaciers, gold mining relics and spectacular land- and sea-life. Three Alaskan itineraries call at Icy Strait Point, home to a coastal rainforest, wilderness tours and – for thrill-seekers – ziplining above the treetops.
Tropical Escapes to the Bahamas and Caribbean from Florida
Sun-splashed tropical isles throughout the Bahamas and Caribbean will await guests on three Disney Cruise Line ships from Florida in summer 2023.
For its first full summer of sailing, the Disney Wish will homeport in Port Canaveral near Orlando for a series of three- and four-night Bahamas cruises to Nassau and Disney's private island oasis, Castaway Cay. The Disney Wish will feature exciting new additions including Disney's first "Frozen"-themed theatrical dining experience and AquaMouse, a wild water adventure and first-ever Disney attraction at sea.
Port Canaveral will also be the departure point for the Disney Fantasy for sailings ranging in length from five to 10 nights. In addition to seven-night cruises to popular ports in the eastern and western Caribbean, guests will also be able to experience a five-night Bahamian sailing with back-to-back calls at Castaway Cay, a 10-night southern Caribbean itinerary to the islands of Aruba and Bonaire and an eight-night cruise featuring two days on the beautiful pink sand beaches of Bermuda.
The Disney Magic will make its summer home in Miami for an assortment of exciting destinations. Starting May 27, the Disney Magic will sail four-night Bahamas cruises and five-night western Caribbean voyages, followed by two seven-night sailings in July to the eastern and western Caribbean. Select summer voyages aboard the Disney Magic will include double days – for double the fun – at Castaway Cay.
To learn more about Disney Cruise Line or to book a vacation, visit disneycruise.com, call Disney Cruise Line at 888-325-2500 or contact a travel agent.
View original content to download multimedia:
SOURCE Disney Cruise Line
|
https://www.kxii.com/prnewswire/2022/04/27/disney-cruise-line-celebrates-summer-2023-with-family-adventures-alaska-europe-bahamas-caribbean/
| 2022-04-27T19:25:01Z
|
Since Beyoncé is editing lyrics, Monica Lewinsky has a request.
Lewinsky, the former White House intern who became embroiled in a sex scandal with then President Bill Clinton in the 1990s, tweeted the news of Beyoncé removing an abelist slur from the song "Heated" on her new album "Renaissance" with a suggestion.
"Partition" is a track from the singer's 2013 self-titled fifth studio album. In the song, Beyoncé sings that a man "Monica Lewinsky'd all on my gown."
The affair between Clinton and then-22-year-old Lewinsky ultimately led to Clinton's impeachment in 1998 and much discussion about consent and abuse of power.
In 2021, Lewinsky told CNN's Jake Tapper that "what's really important to remember in today's world is that we never should have even gotten to a place where consent was a question."
"So it was wholly inappropriate as the most powerful man, my boss, 49 years old," she said. "I was 22, literally just out of college. And I think that the power differentials there are something that I couldn't ever fathom consequences at 22 that I understand obviously so differently at 48."
This week, Beyoncé agreed to scrub from her track "Heated" a reference which is considered demeaning to people with spastic cerebral palsy after there was a public outcry.
CNN has reached out to reps for the singer for comment about Lewinsky's request.
Keep it Clean. Please avoid obscene, vulgar, lewd,
racist or sexually-oriented language. PLEASE TURN OFF YOUR CAPS LOCK. Don't Threaten. Threats of harming another
person will not be tolerated. Be Truthful. Don't knowingly lie about anyone
or anything. Be Nice. No racism, sexism or any sort of -ism
that is degrading to another person. Be Proactive. Use the 'Report' link on
each comment to let us know of abusive posts. Share with Us. We'd love to hear eyewitness
accounts, the history behind an article.
|
https://www.albanyherald.com/entertainment/monica-lewinsky-wants-beyonc-to-remove-lyric-about-her-from-partition/article_e5526bb5-6320-56f3-9b12-313dbd5b4f09.html
| 2022-08-03T16:53:25Z
|
Vice President Kamala Harris appeared in a pre-taped interview on NBC’s “Meet the Press” last weekend. As is often the case with her interviews, Harris said a few awkward, ill-informed or downright odd things. For example, she claimed that the U.S.-Mexico border is “secure.” When asked if she was confident of that, Harris answered, “We have a secure border in that that is a priority for any nation, including ours and our administration.” It’s hard to figure out what that meant.
The most newsworthy thing Harris said concerned the state of the Senate filibuster. Democrats have been in control of the Senate since the 2020 election, but with a 50-50 tie, they do not control a majority of seats. Their margin of control is the vice president’s tiebreaking vote. But even to get to that point on a partisan measure, Democrats have to unite all 50 of their senators. That has been difficult when two centrist Democrats, Joe Manchin of West Virginia and Kyrsten Sinema of Arizona, sometimes declined to go along with their colleagues.
So a goal of Democrats in this November’s election — a dream scenario, actually — would be to win 52 seats. That way, even if Manchin and Sinema defected, there would still be 50 Democratic votes for a partisan measure, and Harris could cast the tiebreaking, winning vote.
Harris made the case on NBC, using abortion as the reason Democrats need a 52-seat majority.
“We are looking at a midterm election in which so much is on the line,” she said. “Take, for example, the issue of choice. The United States Supreme Court, in the Dobbs decision, just took a constitutional right that had been recognized from the women of America, from the people of America. Well, how does that relate to the midterms? Our president has said he will not let the filibuster get in the way. If the Senate, through a majority vote, votes to pass the Women’s Health Protection Act, he will sign it into law. You know what that means in the midterms? We need to hold on to the Senate and get two more. And then we can put into law the protections of Roe v. Wade.”
In Harris’ scenario, Democrats first need to get 50 votes for codifying Roe without having to worry about Manchin or Sinema. Then, if they get the 50 votes on the bill, they need 50 votes to eliminate the filibuster, which, were it still in effect, would require 60 votes for passage. According to the plan, Democrats would eliminate the filibuster on a 50-plus-Harris vote, and then codify Roe on a 50-plus-Harris vote. And just like that, the filibuster would be gone, and abortion would be legalized across America.
Killing the legislative filibuster would be, of course, a dramatic move in the Senate. It would change the way the institution works. It would set off a war between the parties and make the Senate even more partisan than it is today. It would lead to the passage of ill-considered legislation. But it is what many Democrats want to do. And now the vice president has laid out the administration’s rationale for doing it: to cement the now-repealed Roe decision into law.
But it’s more complicated than that.
“If Democrats get 52 Senate seats or more, [is] the legislative filibuster gone?” NBC’s Chuck Todd asked Harris. “Or just on this issue?” That is, do Democrats want to somehow eliminate the filibuster only for the purpose of codifying Roe, but keep it for other issues? As it turns out, Harris wants to eliminate the filibuster in order to codify Roe, but she also wants to eliminate the filibuster to pass two other high-priority Democratic bills grouped together under the heading of “voting rights”: the Freedom to Vote Act and the John Lewis Voting Rights Advancement Act.
So when Todd asked, “just on this issue,” meaning abortion, Harris answered: “On this issue and on a very important issue in addition to that important issue, which is voting rights.” She then explained that President Joe Biden “has been very clear. He will sign into law, and not let the filibuster get in the way, the John Lewis Voting Rights Advancement Act and the Freedom to Vote Act. ... So everything is on the line in these elections in just less than two months.”
That’s the plan: Democrats want to eliminate the filibuster for the purpose of passing three pieces of legislation: the Women’s Health Protection Act, the Freedom to Vote Act and the John Lewis Voting Rights Advancement Act. Then Todd asked Harris: “Are you comfortable that this could end the legislative filibuster for good, probably, even if you only try to do it for two issues?” Harris quickly answered, “No, I’m not. No, I’m not. No.” When Todd asked whether Harris believes the filibuster “will be held in place on other issues,” Harris answered, “That is very likely, yes.”
Yes, it’s possible Democrats could pull off a slick maneuver to pass only what they want right now. But do they not believe Republicans will do the same thing the next time they control the Senate? Control of the Senate has changed hands five times since 2000. Don’t Democrats know that will happen again? If it does, they will be in the minority. It might happen in a few weeks. In two years there could be a Republican Senate and White House.
The Senate is a place where what goes around comes around. If Democrats eliminate the legislative filibuster, even if they claim it is a limited elimination applying only to abortion and voting rights, Republicans will eliminate the filibuster to pass bills they’ve always wanted but that have zero Democratic support. Bills like a national right-to-work law, funding a border wall, making tax cuts permanent and much more. Had they respected the filibuster, Democrats could stop all that. If the filibuster is gone, they will have no power to do so.
Five years ago, on April 7, 2017, a group of 27 Senate Democrats, then in the minority, signed a letter defending the filibuster and urging that it not be eliminated. Then-Sen. Kamala Harris was one of those Democrats. Now, she is on the other side. If she gets her way, Democrats might notch a short-term victory but bring long-term disaster to the Senate.
Success! An email has been sent to with a link to confirm list signup.
Error! There was an error processing your request.
Byron York is chief political correspondent for The Washington Examiner.
Keep it Clean. Please avoid obscene, vulgar, lewd,
racist or sexually-oriented language. PLEASE TURN OFF YOUR CAPS LOCK. Don't Threaten. Threats of harming another
person will not be tolerated. Be Truthful. Don't knowingly lie about anyone
or anything. Be Nice. No racism, sexism or any sort of -ism
that is degrading to another person. Be Proactive. Use the 'Report' link on
each comment to let us know of abusive posts. Share with Us. We'd love to hear eyewitness
accounts, the history behind an article.
|
https://www.albanyherald.com/opinion/byron-york-short-term-victory-vs-long-term-disaster/article_62bdf0be-3778-11ed-8947-c7fda4593b07.html
| 2022-09-18T23:39:28Z
|
Applications for the sixth edition of SLINGSHOT open today
SINGAPORE, April 26, 2022 /PRNewswire/ -- SLINGSHOT powered by Startup SG returns for its sixth year[1]. A new immersion programme for the top 50 global startups to explore growth opportunities in Singapore, as well as an exclusive collaboration with Amazon Web Services (AWS) which offers access to cloud expertise, mentorship and its global community of potential customers, has been introduced for the competition. Organised by Enterprise Singapore (Enterprise SG), the SLINGSHOT grand finals will be held during the Singapore Week of Innovation & Technology[2] (SWITCH), from 25 to 28 October 2022.
Connecting top global startups to collaboration opportunities through Singapore
Inaugural programmes for top 50 finalists
This year, the top 50 global startups, to be announced in September, will each win a sponsored trip to Singapore to participate in an immersion programme one week before the grand finals. This will enable participants to experience the startup and innovation ecosystem in Singapore, and better understand how it can help accelerate their growth via Enterprise SG and scale their business to the region and beyond. In partnership with Action Community for Entrepreneurship (ACE), the national trade association for startups in Singapore, SLINGSHOT will curate a programme comprising matching and networking sessions with investors, accelerators, venture builders, corporates and innovators, providing access to fundraising, local and overseas business and collaboration opportunities. The startups will also go on site visits and lab crawls to research, innovation and corporate facilities.
SLINGSHOT is also collaborating with AWS for the first time, on its AWS Startup Ramp programme to support the top 50 finalists. AWS Startup Ramp is a programme for early-stage startups building solutions in health, digital government, smart cities, agriculture, and space technology, and dedicated to supporting entrepreneurs as they build, launch, and grow. AWS Startup Ramp will connect SLINGSHOT's top startup finalists to AWS's global community of partners and other startup members to deepen collaboration, and provide training and AWS credits to address challenges and accelerate public sector innovation.
Deep tech startups are welcome to participate in this year's Challenge Domains[3] of i) Manufacturing, Trade & Connectivity, ii) Health & Biomedical, iii) Environment, Energy & Green Technologies, iv) Transformative Digital Technologies, and v) Consumer Media, Goods & Services (refer to Annex for more details). The call for entries officially opens today and will close on 24 July 2022. Interested parties can find out more details and submit their applications at https://go.gov.sg/slingshot2022pr.
More than US$800,000 in total grant prizes are up for grabs this year:
- Grand winner grant prize of over US$130,000
- First runner-up grant prize of over US$100,000
- Second runner-up grant prize of over US$66,000
- Over US$33,000 grant prize each for top ten domain winners
In partnership with JTC, Singapore's lead agency championing sustainable industrial development, the top three SLINGSHOT winners will win up to 18 months' rent-free space at the JTC LaunchPad @ one-north or LaunchPad @ Jurong Innovation District. These LaunchPads are homes to vibrant communities of incubators, accelerators and venture capitalists.
Ms Cindy Ngiam, Director for SWITCH, Enterprise SG said, "Since 2017, SLINGSHOT has seen more than 15,000 applications from markets including leading startup hubs such as Canada, China, Germany, Israel, the United Kingdom, and the United States. Our top 40 SLINGSHOT winners have also gone on to raise almost US$400 million in investments, post-SLINGSHOT. Through SLINGSHOT, startups have been connected to over 400 judges and mentors globally from the innovation space. Our partnerships with established industry leaders like AWS will also provide prime opportunities for startups to gain more support and opportunities to scale into the region from Singapore."
On the collaboration with Enterprise Singapore, Mr Samuel Harris, Public Sector Startup Lead, Asia Pacific and Japan at AWS, said, "We are excited to be collaborating with SLINGSHOT to support Singapore's vibrant startup community. Startups play an important role in helping governments and organisations to deliver quality citizen services and better customer experiences, innovating faster at scale. AWS is delighted to support Enterprise SG's mission to drive local startup innovation. We are committed to bringing startups and the wider industry together to experiment with new ideas built on the cloud that help solve some of the world's biggest challenges."
Co-innovation opportunities for top 250 startups
SLINGSHOT 2021's top 100 startups were connected with more than 15 corporates to explore co-innovation opportunities. These corporates included AstraZeneca, Givauden, Hyundai, P&G, Philips, Rolls-Royce, Tata and Unilever.
This year, the top 250 startups will also stand the chance to be connected to top corporates for co-innovation opportunities through the SLINGSHOT Corporate Mixer. Participating global corporates will share their problem statements during the Corporate Mixer sessions, and explore new business and collaboration opportunities with these finalists.
About Enterprise Singapore
Enterprise Singapore (Enterprise SG) is the government agency championing enterprise development. We work with committed companies to build capabilities, innovate and internationalise.
We also support the growth of Singapore as a hub for global trading and startups, and build trust in Singapore's products and services through quality and standards.
Visit www.enterprisesg.gov.sg for more information.
View original content to download multimedia:
SOURCE Enterprise Singapore
|
https://www.wibw.com/prnewswire/2022/04/26/slingshot-2022-asias-premier-deep-tech-startup-competition-offers-exclusive-new-singapore-immersion-programme-top-50-global-startups/
| 2022-04-26T05:01:13Z
|
NEW YORK, Aug. 10, 2022 /PRNewswire/ -- Weiss Law is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of CarLotz, Inc. ("CarLotz" or the "Company") (NASDAQ: LOTZ), in connection with the proposed merger of the Company with Shift Technologies, Inc. ("Shift") (NASDAQ: SFT). Under the terms of the merger agreement, Company shareholders will receive 0.692158 shares of Shift common stock for each share of CarLotz common stock, leaving then- current Shift equity holders owning approximately 52.9% and CarLotz then-current equity holders owning approximately 47.1% of the combined company upon closing of the transaction.
If you own CarLotz shares and wish to discuss this investigation or have any questions concerning this notice or your rights or interests, visit our website:
https://www.weisslaw.co/news-and-cases/lotz
Or please contact:
Joshua Rubin, Esq.
Weiss Law
305 Broadway, 7th Floor
New York, NY 10007
(212) 682-3025
(888) 593-4771
stockinfo@weisslawllp.com
Weiss Law is investigating whether (i) CarLotz's board of directors acted in the best interests of Company shareholders in agreeing to the proposed transaction, (ii) the per-share merger consideration adequately compensates CarLotz's shareholders, and (iii) all information regarding the sales process and valuation of the transaction will be fully and fairly disclosed.
Weiss Law has litigated hundreds of stockholder class and derivative actions for violations of corporate and fiduciary duties. We have recovered over a billion dollars for defrauded clients and obtained important corporate governance relief in many of these cases. If you have information or would like legal advice concerning possible corporate wrongdoing (including insider trading, waste of corporate assets, accounting fraud, or materially misleading information), consumer fraud (including false advertising, defective products, or other deceptive business practices), or anti-trust violations, please email us at stockinfo@weisslawllp.com
View original content to download multimedia:
SOURCE Weiss Law
|
https://www.kxii.com/prnewswire/2022/08/11/shareholder-alert-weiss-law-investigates-carlotz-inc/
| 2022-08-11T04:34:19Z
|
(In US Dollars unless otherwise stated)
TORONTO, July 19, 2022 /PRNewswire/ - Superior Gold Inc. ("Superior Gold" or the "Company") (TSXV: SGI) (OTCMKTS: SUPGF) announces detailed production results for the second quarter of 2022 for the Company's 100%-owned Plutonic Gold operations, located in Western Australia.
Second Quarter Highlights
- Safety performance improved during the quarter with a 24% reduction in the total injury frequency rate achieved during the period. Our safety improvement program is progressing and on track.
- Production of 15,196 ounces, a 21% decrease over the comparable prior-year period, primarily as a result of unusually high rainfall for the month of May and the impact of the removal of COVID-19 restrictions in Western Australia in April.
- Sales of 16,726 ounces, a 6% increase over the previous quarter and a 12% decrease over the comparable period.
- Ore milled of 407kt, a 13% increase over the comparable prior-year period following successful shutdowns in Q1 and Q2, now running closer to its capacity.
- An updated Mineral Reserve and Resource statement which incorporated an increase in mineral reserves of 66% and an increase in inferred mineral resources of 29%. The 43-101 Technical Report was also updated and re-issued.
- Cash and cash equivalents totaling $18.2 million at the end of the quarter.
Chris Jordaan, President, and CEO of Superior Gold stated: "The second quarter provided some unexpected challenges on two fronts, unusually high rainfall and increases in COVID-19 cases.
Rainfall events in May were extremely unusual. We received 143 millimetres of rain for the month compared to a long-term average of 15 millimetres and an annual rainfall target of 264 millimetres. With over 50% of the annual expected rainfall falling during May, flooding around the airport runway and Main Pit benches resulted in significant flight disruption and delays in accessing the early entry to the Main Pit development.
Following the removal of a number of COVID-19 restrictions within Western Australia in April, we experienced a surge in COVID-related absenteeism and disruption with realized COVID-19 rates running on average between 3-5% with spikes as high as 13% in May. This had a direct impact on available operators in the underground, impacting our ability to access higher grades, as well as a shortage of specialized technical staff to maintain equipment causing extended downtimes. We continue to mitigate the COVID-19 issues by over manning in critical roles. We observed improvements in COVID-19 rates over the last month.
Both of these issues impacted planned production, particularly in accessing the Main Pit mill feed that was originally planned for Q2. The combined effects delayed flights to the mine site and caused an abnormal shortage of key employees in the mining operations and contractors on-site.
Despite these challenges, we realized significantly improved throughput primarily attributable to the successful 15-day planned mill shut down in Q1 and three additional days in Q2 for relining of all mills. However, the throughput benefit was offset by lower realized tonnes and grades from the underground than planned due to underground operator shortage and the delayed entry into the Main Pit, both of which resulted in the processing of lower grade stockpile material during the quarter.
Looking ahead, the plant is now running closer to its nameplate capacity of 5,000 TPD. This improved rate is also higher than our planned rate for the second half of 2022. As we look ahead to the second half of the year, we are also seeing progress on material deliverables which will help to increase head grades into the plant and continue our trajectory of higher throughput rates. The delivery of an additional jumbo, loader and truck for the underground mine will have a positive impact on development metres and tonnes delivered from the underground in Q4.
We are targeting production and cash flow increases in the second half of 2022, while carefully monitoring for any further disruptions from COVID-19 or other possible situations which could affect production levels."
The Company will be releasing its complete financial and operating results for the second quarter of 2022 in August 2022.
Preliminary production details are summarized in the table below.
Chris Jordaan, President and CEO of Superior Gold will present the highlights of the second quarter production results through a webcast hosted by 6ix. The webcast will take place on Wednesday, July 20, 2022, at 10:00 AM EDT. To join the webcast please click on the attached link to register and listen and ask questions. Webcast Link: https://my.6ix.com/t3IA9ikk
The scientific and technical information in this news release has been reviewed and approved by Ettienne Du Plessis, who is a "qualified person" as defined by NI 43-101. Mr. Du Plessis is not independent of the Company within the meaning of NI 43-101.
Superior Gold is a Canadian-based gold producer that owns 100% of the Plutonic Gold Operations located in Western Australia. The Plutonic Gold Operations include the Plutonic underground gold mine and central mill, numerous open-pit projects including the Plutonic Main Pit push-back project, the Hermes open pit projects, and an interest in the Bryah Basin joint venture. Superior Gold is focused on expanding production at the Plutonic Gold Operations and building an intermediate gold producer with superior returns for shareholders.
Continue to Follow, Like and Watch our progress:
Web: www.superior-gold.com | Twitter: @SuperiorGoldInc | Facebook: SuperiorGoldInc | Instagram: SuperiorGoldInc | LinkedIn: Superior Gold Inc. | YouTube: Superior Gold
This news release contains "forward-looking information" within the meaning of applicable securities laws that are intended to be covered by the safe harbours created by those laws. "Forward-looking information" includes statements that use forward-looking terminology such as "may", "will", "expect", "anticipate", "believe", "continue", "potential" or the negative thereof or other variations thereof or comparable terminology. Forward-looking information includes information with respect to guidance as to projections, outlook, guidance, forecasts, estimates, and other statements regarding future or estimated financial and operational performance, gold production and sales, revenues and cash flows, and capital costs (sustaining and non-sustaining), including projected cash operating costs and all-in sustaining costs) as well as statements with respect to the mine plan, exploration, drilling, operating, and organizational matters and activities relating to the Plutonic Gold Operations and the Company generally, including its liquidity and capital requirements and financial results. By identifying such information in this manner, the Company is alerting the reader that such information is subject to known and unknown risks, uncertainties, and other factors that may cause the actual results, level of activity, performance, or achievements of the Company to be materially different from those expressed or implied by such forward-looking information.
Forward-looking information is not a guarantee of future performance and is based upon a number of estimates and assumptions of management at the date the statements are made. Furthermore, such forward-looking information involves a variety of known and unknown risks, uncertainties, and other factors which may cause the actual plans, intentions, activities, results, performance, or achievements of the Company to be materially different from any future plans, intentions, activities, results, performance or achievements expressed or implied by such forward-looking information. Readers are encouraged to refer to the Annual Information Form of the Company for a discussion of other risks including outbreaks or threats of outbreaks of viruses, other infectious diseases, or other similar health threats, such as the novel coronavirus outbreak, which could have a material adverse effect on the Company by causing operational and supply chain delays and disruptions, labour shortages, shutdowns, inflationary pressures on operating or capital costs, the inability to sell gold, capital markets volatility or other unknown but potentially significant impacts. The Company cannot accurately predict what effects these conditions will have on the Plutonic Gold Operations or the financial results of the Company, including uncertainties relating to travel restrictions to the Plutonic Gold Operations or otherwise and business closures that have been or may be imposed by governments. If an outbreak or threat of an outbreak of a virus or other infectious disease or other public health emergency occurs, it could have a material adverse effect on the Company's business, financial condition, and results of operations.
The Company cautions that there can be no assurance that forward-looking information will prove to be accurate, as actual results and future events could differ materially from those anticipated in such information. Accordingly, investors should not place undue reliance on forward-looking information as no assurance can be given that any of the events anticipated by the forward-looking information will transpire or occur, and if any of them do so, what benefits the Company will derive therefrom. Except as required by law, the Company does not assume any obligation to release publicly any revisions to forward-looking information contained in this news release to reflect events or circumstances after the date hereof.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Exchange) accept responsibility for the adequacy or accuracy of this release.
View original content to download multimedia:
SOURCE Superior Gold
|
https://www.wibw.com/prnewswire/2022/07/19/superior-gold-announces-q2-2022-production-results-cash-position/
| 2022-07-19T10:41:54Z
|
Woman dies after falling into river at Grand Canyon, officials say
(Gray News) - Officials with the National Park Service said a woman visiting the Grand Canyon has died after falling into a river.
The Grand Canyon Regional Communications Center reports a passenger on a commercial river trip fell into the Colorado River on June 11 around 2 p.m. near Pipe Creek Beach.
Officials said commercial guides were able to reach her by boat and began CPR. However, 47-year-old Sheetal Patel was pronounced deceased by rescuers.
The NPS said Patel was cooling off along Pipe Creek Beach when a current caught her in the Colorado River. Patel hiked into the canyon to meet the river trip at Phantom Ranch and was beginning a multi-day boating trip.
The park service is investigating the incident in coordination with the Coconino County Medical Examiner.
Officials reminded all visitors to Grand Canyon to ensure they are drinking plenty of fluids, resting in the shade during the heat of the day, and watching for signs of distress in traveling companions while dressing appropriately for the weather.
The NPS said it does not recommend hiking from the rim to the river and back in one day.
Copyright 2022 Gray Media Group, Inc. All rights reserved.
|
https://www.mysuncoast.com/2022/06/14/woman-dies-after-falling-into-river-grand-canyon-officials-say/
| 2022-06-14T21:04:26Z
|
Demand wavers in some areas as housing costs mount
- Mortgage payments are higher than rent in 45 of the 50 largest U.S. metros, up from 22 in 2019.
- Price appreciation is finally starting to slow, easing slightly from 20.9% annual growth in April to 20.7% in May.
- Inventory continues to recover from February lows, but is still 50% below 2019 levels.
SEATTLE, June 21, 2022 /PRNewswire/ -- Ballooning mortgage costs, driven by skyrocketing prices and interest rates, have made mortgages less affordable than at any time since at least 2007. Demand for homes has pulled back in response, easing price growth, slowing sales and boosting inventory, according to the latest market report1 from Zillow®.
Mortgage rates have shot up in early June, averaging 5.78%2 as of Thursday. A new purchase of a typical U.S. home3 at that rate would mean monthly mortgage payments of $2,127, that's 51% higher than a year ago and up 36% year to date.
"Mortgage rates took an unprecedented leap skyward over the past two weeks and quickly multiplied housing costs as they rose," said Zillow economist Nicole Bachaud. "We are already seeing signs of waning demand, and expect these recent rate hikes to quicken the market's needed rebalancing. While shoppers will likely experience less competition for homes than the frenzied recent months, their purchasing power has dwindled."
Incomes are lagging further behind fast-rising mortgage costs, leading to the most significant affordability challenges in the past 15 years. The latest data available from April shows monthly payments4 taking about 28% of homeowners' monthly income — dangerously close to the 30% threshold, beyond which is considered a cost burden. With rates now far above April's average, that share is at or very near 30% already. Zillow data for this metric is available through 2007; the Atlanta Federal Reserve's Home Ownership Affordability Monitor shows affordability bottoming out in July 2006.
Although rents have soared since the start of 2021, the rapidly rising cost of a mortgage still makes rent the cheaper option nearly everywhere. A typical rent payment in May is more expensive than a mortgage payment (with a 20% down payment), including taxes and insurance, in just five of the 50 largest U.S. metros. In May 2019, rent was more expensive in 28 of those metros.
After annual price appreciation set new record highs for 13 straight months, home values finally turned the corner in May to show a slightly slower pace of annual growth: 20.7%, down from 20.9% in April.
"Arriving in the middle of the spring selling season, this deceleration is a clear signal that buyers are dialing back their demand for homes in the face of daunting affordability challenges," said Jeff Tucker, senior economist at Zillow.
The trend appears to show that the market passed an inflection point for home values between April and May, transitioning from ever hotter to somewhat cooler price growth. The typical U.S. home is now worth $349,816 — nearly $60,000 more than last year and almost $95,000 higher than in May 2020.
Sales are also slowing. The number of for-sale listings that went under contract in May is down nearly 20% from 2021, when that activity was near a four-year peak, and is 2% below that of May 2019. The median time on market for new listings is just seven days — holding steady from April and even with last May.
Share of listings with a price cut is ticking up as well — rising to 11.5% in May from a recent low of 8.5% in February.
Inventory of for-sale listings continued its steady spring climb and now sits just 14.2% below its year-ago level. Still, that leaves buyers with 50% fewer options than they had to choose from in May 2019.
Typical rents are up to $1,979 in the U.S. and still rising fast, with 1.2% monthly growth that slightly edged April's 1.1% month-over month rise. To put this into context, the average monthly May rent growth from 2014 to 2019 was 0.7%. Annual rent appreciation for May is 15.9%, easing off a peak of 17.2% in February.
1 The Zillow Real Estate Market Report is a monthly overview of the national and local real estate markets. The reports are compiled by Zillow Research. For more information, visit www.zillow.com/research.
2 Based on data from Freddie Mac
3 Assuming a new loan on a house priced at Zillow's Home Value Index in May of $349,816, using a 20% down payment and a 30-year fixed-rate mortgage at 5.78%, includes taxes and insurance.
4 Assuming a new loan on a house priced at Zillow's Home Value Index in April of $344,773, using a 20% down payment and a 30-year fixed-rate mortgage at 4.98%, includes taxes and insurance
About Zillow Group
Zillow Group, Inc. (NASDAQ: Z and ZG) is reimagining real estate to make it easier to unlock life's next chapter. As the most visited real estate website in the United States, Zillow® and its affiliates offer customers an on-demand experience for selling, buying, renting or financing with transparency and ease.
Zillow Group's affiliates and subsidiaries include Zillow®,, Zillow Premier Agent®, Zillow Home Loans™, Zillow Closing Services™, Trulia®, Out East®, ShowingTime®, Bridge Interactive®, dotloop®, StreetEasy® and HotPads®. Zillow Home Loans, LLC is an Equal Housing Lender, NMLS #10287 (www.nmlsconsumeraccess.org).
View original content to download multimedia:
SOURCE Zillow
|
https://www.kxii.com/prnewswire/2022/06/21/housing-affordability-hits-15-year-low-prices-mortgage-rates-rise/
| 2022-06-21T12:24:45Z
|
63% combined pathologic response rate for neoadjuvant Libtayo monotherapy in stage II to IV resectable CSCC per primary analysis of a confirmatory Phase 2 trial
TARRYTOWN, N.Y., Sept. 12, 2022 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced positive clinical data for an investigational regimen of PD-1 inhibitor Libtayo® (cemiplimab) as neoadjuvant monotherapy in stage II to IV resectable cutaneous squamous cell carcinoma (CSCC). The data, from the primary analysis of a confirmatory Phase 2 trial, were presented in an oral session at the European Society for Medical Oncology (ESMO) Congress 2022 in Paris and concurrently published in the New England Journal of Medicine (NEJM).
"Regeneron conducted the first pivotal trial of Libtayo in advanced cutaneous squamous cell carcinoma that was unlikely to be curable by surgery or radiation, and we are now studying the utility of Libtayo in earlier stages of this disease. In addition to our neoadjuvant trial, a global Phase 3 trial of Libtayo is ongoing in the adjuvant setting after surgery and radiation for patients at heightened risk for recurrence," said Israel Lowy, M.D., Ph.D., Senior Vice President, Translational and Clinical Sciences, Oncology at Regeneron. "In the neoadjuvant trial in stage II to IV cutaneous squamous cell carcinoma presented at ESMO and published in NEJM, Libtayo demonstrated greater than 60% response rates per both pathologic and imaging measures. Libtayo may therefore have expanded utility in earlier stages of cutaneous squamous cell carcinoma as a monotherapy to potentially help avoid surgery, and as part of a combination approach with surgery to facilitate function-preserving resections and minimize disfigurement."
In the confirmatory, multicenter, single-arm Phase 2 trial, 79 patients received up to four fixed doses of Libtayo every 3 weeks prior to surgery, with 62 receiving all 4 doses and 70 undergoing surgery. Patients experienced the following efficacy:
- 63.3% combined pathologic response rate (50 of 79 patients), with 50.6% (40 patients) achieving the primary endpoint of complete pathologic response (0% viable tumor, excluding a null hypothesis of 25%) and 12.7% (10 patients) experiencing a major pathologic response (>0% and ≤10% viable tumor cells) by independent pathologic review.
- 68% objective response rate (ORR) (54 of 79 patients; 5 complete responses [CR] and 49 partial responses [PR]) per local imaging review.
Adverse events (AE) of any grade occurred in 87% of patients, with 17% considered serious. The most common AE was fatigue (n=24). AEs that were ≥grade 3 occurred in 18% of patients. The treatment discontinuation rate due to AEs was 1%, and there was one death due to worsening congestive heart failure considered related to treatment. There were no new Libtayo safety signals.
Patient follow-up in the trial is ongoing to assess disease-free survival. A separate global Phase 3 trial investigating Libtayo in the adjuvant CSCC setting for patients at heightened risk (i.e., due to involvement of multiple lymph nodes, extension of cancer through the lymph node capsule, perineural invasion) for recurrence is enrolling patients.
The potential use of Libtayo described above is investigational, and its safety and efficacy has not been evaluated by any regulatory authority for this indication.
About Regeneron in Oncology
At Regeneron, we're applying more than three decades of scientific innovation with the goal of developing paradigm-changing therapies for patients with cancer. Our oncology portfolio is built around two foundational approaches – our approved PD-1 inhibitor Libtayo and investigational bispecific antibodies – which are being evaluated both as monotherapies and in combination with emerging therapeutic modalities. Together, they provide us with unique combinatorial flexibility to develop potentially synergistic treatments for a wide range of solid tumors and blood cancers.
If you are interested in learning more about our clinical trials, please contact us (clinicaltrials@regeneron.com or 844-734-6643) or visit our clinical trials website.
About Libtayo
Libtayo is a fully human monoclonal antibody targeting the immune checkpoint receptor PD-1 on T cells and was invented using Regeneron's proprietary VelocImmune technology. By binding to PD-1, Libtayo has been shown to block cancer cells from using the PD-1 pathway to suppress T-cell activation. In the U.S. and other countries Libtayo is indicated in certain patients with advanced basal cell carcinoma (BCC), advanced cutaneous squamous cell carcinoma (CSCC) and advanced non-small cell lung cancer (NSCLC), as well as in advanced cervical cancer in Canada and Brazil. As of July 1, 2022, Libtayo is developed and marketed globally by Regeneron.
In the U.S., the generic name for Libtayo in its approved indications is cemiplimab-rwlc, with rwlc as the suffix designated in accordance with Nonproprietary Naming of Biological Products Guidance for Industry issued by the U.S. Food and Drug Administration (FDA). Outside of the U.S. the generic name of Libtayo in its approved indication is cemiplimab.
The extensive clinical program for Libtayo is focused on difficult-to-treat cancers. Libtayo is currently being investigated in trials as a monotherapy, as well as in combination with either conventional or novel therapeutic approaches for other solid tumors and blood cancers. These potential uses are investigational, and their safety and efficacy have not been evaluated by any regulatory authority.
U.S. FDA-approved Indications Libtayo is a prescription medicine used to treat people with:
- A type of skin cancer called advanced CSCC that has spread or cannot be cured by surgery or radiation.
- A type of skin cancer called BCC:
- A type of lung cancer called NSCLC. Libtayo may be used as your first treatment when your lung cancer has not spread outside your chest (locally advanced lung cancer) and you cannot have surgery or chemotherapy with radiation, or your lung cancer has spread to other areas of your body (metastatic lung cancer), and your tumor tests positive for high "PD-L1" and your tumor does not have an abnormal "EGFR", "ALK "or "ROS1" gene.
It is not known if Libtayo is safe and effective in children.
About Regeneron's VelocImmune Technology
Regeneron's VelocImmune technology utilizes a proprietary genetically engineered mouse platform endowed with a genetically humanized immune system to produce optimized fully human antibodies. When Regeneron's co-Founder, President and Chief Scientific Officer George D. Yancopoulos was a graduate student with his mentor Frederick W. Alt in 1985, they were the first to envision making such a genetically humanized mouse, and Regeneron has spent decades inventing and developing VelocImmune and related VelociSuite® technologies. Dr. Yancopoulos and his team have used VelocImmune technology to create approximately one in five of all original, FDA-approved or authorized fully human monoclonal antibodies. This includes REGEN-COV® (casirivimab and imdevimab), Dupixent® (dupilumab), Libtayo® (cemiplimab-rwlc), Praluent® (alirocumab), Kevzara® (sarilumab), Evkeeza® (evinacumab-dgnb) and Inmazeb™ (atoltivimab, maftivimab and odesivimab-ebgn).
IMPORTANT SAFETY INFORMATION AND INDICATION FOR U.S. PATIENTS
What is the most important information I should know about Libtayo?
Libtayo is a medicine that may treat certain cancers by working with your immune system. Libtayo can cause your immune system to attack normal organs and tissues in any area of your body and can affect the way they work. These problems can sometimes become severe or life-threatening and can lead to death. You can have more than one of these problems at the same time. These problems may happen anytime during treatment or even after your treatment has ended.
Call or see your healthcare provider right away if you develop any new or worsening signs or symptoms, including:
- Lung problems: cough, shortness of breath, or chest pain
- Intestinal problems: diarrhea (loose stools) or more frequent bowel movements than usual, stools that are black, tarry, sticky or have blood or mucus, or severe stomach area (abdomen) pain or tenderness
- Liver problems: yellowing of your skin or the whites of your eyes, severe nausea or vomiting, pain on the right side of your stomach area (abdomen), dark urine (tea colored), or bleeding or bruising more easily than normal
- Hormone gland problems: headache that will not go away or unusual headaches, eye sensitivity to light, eye problems, rapid heartbeat, increased sweating, extreme tiredness, weight gain or weight loss, feeling more hungry or thirsty than usual, urinating more often than usual, hair loss, feeling cold, constipation, your voice gets deeper, dizziness or fainting, or changes in mood or behavior, such as decreased sex drive, irritability, or forgetfulness
- Kidney problems: decrease in your amount of urine, blood in your urine, swelling of your ankles, or loss of appetite
- Skin problems: rash, itching, skin blistering or peeling, painful sores or ulcers in mouth or nose, throat, or genital area, fever or flu-like symptoms, or swollen lymph nodes
- Problems can also happen in other organs and tissues. These are not all of the signs and symptoms of immune system problems that can happen with Libtayo. Call or see your healthcare provider right away for any new or worsening signs or symptoms, which may include: chest pain, irregular heartbeat, shortness of breath or swelling of ankles, confusion, sleepiness, memory problems, changes in mood or behavior, stiff neck, balance problems, tingling or numbness of the arms or legs, double vision, blurry vision, sensitivity to light, eye pain, changes in eyesight, persistent or severe muscle pain or weakness, muscle cramps, low red blood cells, or bruising
- Infusion reactions that can sometimes be severe. Signs and symptoms of infusion reactions may include: nausea, chills or shaking, itching or rash, flushing, shortness of breath or wheezing, dizziness, feel like passing out, fever, back or neck pain, or facial swelling.
- Rejection of a transplanted organ. Your healthcare provider should tell you what signs and symptoms you should report and monitor you, depending on the type of organ transplant that you have had.
- Complications, including graft-versus-host disease (GVHD), in people who have received a bone marrow (stem cell) transplant that uses donor stem cells (allogeneic). These complications can be serious and can lead to death. These complications may happen if you underwent transplantation either before or after being treated with Libtayo. Your healthcare provider will monitor you for these complications.
Getting medical treatment right away may help keep these problems from becoming more serious. Your healthcare provider will check you for these problems during your treatment with Libtayo. Your healthcare provider may treat you with corticosteroid or hormone replacement medicines. Your healthcare provider may also need to delay or completely stop treatment with Libtayo if you have severe side effects.
Before you receive Libtayo, tell your healthcare provider about all your medical conditions, including if you:
- have immune system problems such as Crohn's disease, ulcerative colitis, or lupus
- have received an organ transplant
- have received or plan to receive a stem cell transplant that uses donor stem cells (allogeneic)
- have a condition that affects your nervous system, such as myasthenia gravis or Guillain-Barré syndrome are pregnant or plan to become pregnant. Libtayo can harm your unborn baby
Females who are able to become pregnant:
- Your healthcare provider will give you a pregnancy test before you start treatment.
- You should use an effective method of birth control during your treatment and for at least 4 months after your last dose of Libtayo. Talk with your healthcare provider about birth control methods that you can use during this time.
- Tell your healthcare provider right away if you become pregnant or think you may be pregnant during treatment with Libtayo.
- are breastfeeding or plan to breastfeed. It is not known if Libtayo passes into your breast milk. Do not breastfeed during treatment and for at least 4 months after the last dose of Libtayo.
Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.
The most common side effects of Libtayo include muscle or bone pain, tiredness, rash, and diarrhea. These are not all the possible side effects of Libtayo. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088. You may also report side effects to Regeneron Pharmaceuticals and Sanofi at
1-877-542-8296.
Please see full Prescribing Information, including Medication Guide.
About Regeneron
Regeneron is a leading biotechnology company that invents, develops and commercializes life-transforming medicines for people with serious diseases. Founded and led for nearly 35 years by physician-scientists, our unique ability to repeatedly and consistently translate science into medicine has led to numerous FDA-approved treatments and numerous product candidates in development, almost all of which were homegrown in our laboratories. Our medicines and pipeline are designed to help patients with eye diseases, allergic and inflammatory diseases, cancer, cardiovascular and metabolic diseases, pain, hematologic conditions, infectious diseases and rare diseases.
Regeneron is accelerating and improving the traditional drug development process through our proprietary VelociSuite technologies, such as VelocImmune, which uses unique genetically humanized mice to produce optimized fully human antibodies and bispecific antibodies, and through ambitious research initiatives such as the Regeneron Genetics Center®, which is conducting one of the largest genetics sequencing efforts in the world.
For more information, please visit www.Regeneron.com or follow @Regeneron on Twitter.
Regeneron Forward-Looking Statements and Use of Digital Media
This press release includes forward-looking statements that involve risks and uncertainties relating to future events and the future performance of Regeneron Pharmaceuticals, Inc. ("Regeneron" or the "Company"), and actual events or results may differ materially from these forward-looking statements. Words such as "anticipate," "expect," "intend," "plan," "believe," "seek," "estimate," variations of such words, and similar expressions are intended to identify such forward-looking statements, although not all forward-looking statements contain these identifying words. These statements concern, and these risks and uncertainties include, among others, the impact of SARS-CoV-2 (the virus that has caused the COVID-19 pandemic) on Regeneron's business and its employees, collaborators, and suppliers and other third parties on which Regeneron relies, Regeneron's and its collaborators' ability to continue to conduct research and clinical programs, Regeneron's ability to manage its supply chain, net product sales of products marketed or otherwise commercialized by Regeneron and/or its collaborators or licensees (collectively, "Regeneron's Products"), and the global economy; the nature, timing, and possible success and therapeutic applications of Regeneron's Products and product candidates being developed by Regeneron and/or its collaborators or licensees (collectively, "Regeneron's Product Candidates") and research and clinical programs now underway or planned, including without Libtayo® (cemiplimab); uncertainty of the utilization, market acceptance, and commercial success of Regeneron's Products and Regeneron's Product Candidates and the impact of studies (whether conducted by Regeneron or others and whether mandated or voluntary), including the studies discussed or referenced in this press release, on any of the foregoing or any potential regulatory approval of Regeneron's Products and Regeneron's Product Candidates; the likelihood, timing, and scope of possible regulatory approval and commercial launch of Regeneron's Product Candidates and new indications for Regeneron's Products, such as Libtayo as monotherapy for resectable cutaneous squamous cell carcinoma; safety issues resulting from the administration of Regeneron's Products (such as Libtayo) and Regeneron's Product Candidates in patients, including serious complications or side effects in connection with the use of Regeneron's Products and Regeneron's Product Candidates in clinical trials; determinations by regulatory and administrative governmental authorities which may delay or restrict Regeneron's ability to continue to develop or commercialize Regeneron's Products and Regeneron's Product Candidates; ongoing regulatory obligations and oversight impacting Regeneron's Products, research and clinical programs, and business, including those relating to patient privacy; the availability and extent of reimbursement of Regeneron's Products (such as Libtayo) from third-party payers, including private payer healthcare and insurance programs, health maintenance organizations, pharmacy benefit management companies, and government programs such as Medicare and Medicaid; coverage and reimbursement determinations by such payers and new policies and procedures adopted by such payers; competing drugs and product candidates that may be superior to, or more cost effective than, Regeneron's Products and Regeneron's Product Candidates; the extent to which the results from the research and development programs conducted by Regeneron and/or its collaborators or licensees (including those discussed or referenced in this press release) may be replicated in other studies and/or lead to advancement of product candidates to clinical trials or therapeutic applications; the ability of Regeneron to manufacture and manage supply chains for multiple products and product candidates; the ability of Regeneron's collaborators, licensees, suppliers, or other third parties (as applicable) to perform manufacturing, filling, finishing, packaging, labeling, distribution, and other steps related to Regeneron's Products and Regeneron's Product Candidates; unanticipated expenses; the costs of developing, producing, and selling products; the ability of Regeneron to meet any of its financial projections or guidance and changes to the assumptions underlying those projections or guidance; the potential for any license or collaboration agreement, including Regeneron's agreements with Sanofi, Bayer, and Teva Pharmaceutical Industries Ltd. (or their respective affiliated companies, as applicable), to be cancelled or terminated; and risks associated with intellectual property of other parties and pending or future litigation relating thereto (including without limitation the patent litigation and other related proceedings relating to EYLEA® (aflibercept) Injection, Dupixent® (dupilumab), and Praluent® (alirocumab)), other litigation and other proceedings and government investigations relating to the Company and/or its operations, the ultimate outcome of any such proceedings and investigations, and the impact any of the foregoing may have on Regeneron's business, prospects, operating results, and financial condition. A more complete description of these and other material risks can be found in Regeneron's filings with the U.S. Securities and Exchange Commission, including its Form 10-K for the year ended December 31, 2021 and its Form 10-Q for the quarterly period ended June 30, 2022. Any forward-looking statements are made based on management's current beliefs and judgment, and the reader is cautioned not to rely on any forward-looking statements made by Regeneron. Regeneron does not undertake any obligation to update (publicly or otherwise) any forward-looking statement, including without limitation any financial projection or guidance, whether as a result of new information, future events, or otherwise.
Regeneron uses its media and investor relations website and social media outlets to publish important information about the Company, including information that may be deemed material to investors. Financial and other information about Regeneron is routinely posted and is accessible on Regeneron's media and investor relations website (http://newsroom.regeneron.com) and its Twitter feed (http://twitter.com/regeneron).
View original content:
SOURCE Regeneron Pharmaceuticals, Inc.
|
https://www.mysuncoast.com/prnewswire/2022/09/12/positive-neoadjuvant-libtayo-cemiplimab-monotherapy-data-resectable-cutaneous-squamous-cell-carcinoma-presented-esmo-published-nejm/
| 2022-09-12T08:57:13Z
|
INEO patents the world's first dual screen loss prevention and advertising system
SURREY, BC, June 28, 2022 /PRNewswire/ - INEO Tech Corp. (TSXV: INEO) (OTCQB: INEOF) (the "Company" or "INEO"), the innovative developer and operator of the INEO Media Network, a digital advertising and analytics solution for retailers, is pleased to announce the Company has filed a design patent, entitled "ELECTRONIC ARTICLE SURVEILLANCE PEDESTAL WITH TWO-SIDED DISPLAY", for the dual screen version of its disruptive Welcoming System.
The patent filing protects the unique form factor, design and materials used in INEO's new dual screen product, branded as the INEO Welcoming System DUO. The INEO Welcoming System DUO is also protected by the Company's original utility patents, already granted in the United States and Canada, and pending in Europe. The INEO Welcoming System DUO, which has one LED screen on each side of the pedestal, is ideal for large retailers who have multiple doors at their front entrances. The bright, bold digital signage on the INEO Welcoming System DUO is easily visible to customers on either side of the pedestal.
The Company's recent premier of the new INEO Welcoming System DUO at the NRF Protect 2022 Conference in Cleveland, OH garnered tremendous interest and was a resounding success in landing pilot system installations with several large retail chains.
"The launch of the INEO Welcoming System DUO is a significant milestone for the company, and we are very pleased to file for the patent which will help provide a level of protection against competitors as we continue to expand our footprint globally," said Greg Watkin, Founder and Chairman of INEO. "The combination of two LED screens and an EAS pedestal within one device is a unique invention which required critical design and innovative engineering by INEO's R&D team. We are excited to begin showcasing the INEO Welcoming System DUO and are confident retailers will love the new capabilities of the dual screens integrated within one system."
Traditional loss-prevention systems typically consisted of a standalone tag-detection system known as an Electronic Article Surveillance ('EAS') pedestal located at the retailers' front door. EAS systems incorporate security tags or labels which are attached to merchandise and must be removed or deactivated prior to leaving the retail store. INEO's new Welcoming System DUO product builds upon the Company's previous patented combination media display and electronic surveillance pedestal by adding a second LED screen to the EAS system. The INEO Welcoming System DUO is a remarkable product given the complexity in designing and housing an RF security tag system in close proximity to two LED screens without degradation of the RF signal required for the operation of the EAS system.
The INEO Welcoming System DUO utilizes the same technology the Company has originally designed for the INEO Welcoming System which allows it to operate in both the Accousto-Magnetic (AM) 58KHz frequency spectrum and the 8.2MHz frequency spectrum. Digital display screens are inherently "noisy" as they cause electromagnetic interference which hinders the detection of loss prevention tags in a retail store; however, INEO has developed technology which allows the EAS loss prevention aspect of the system to still operate effectively with two large digital display screens located within the detection field.
The INEO Welcoming System DUO preserves the same base form factor of the original INEO Welcoming System allowing for visual uniformity within the retail store. The INEO Welcoming System DUO is the same height and width as the standard INEO Welcoming System and is only 2.3 centimeters (1 ¼ inches) thicker. The sleek design is a function of the proprietary technology INEO has developed and patented.
INEO Tech Corp.
Per: "Kyle Hall"
Kyle Hall, Chief Executive Officer and Director
INEO Tech Corp., through its wholly owned subsidiary, INEO Solutions Inc., operates the INEO Media Network, a digital advertising and analytics solution for retailers. INEO's patented technology integrates and monetizes digital screens with theft detection sensor gates at the entrance of retail stores. The Company's cloud-based platform uses IoT (Internet of Things) and AI (Artificial Intelligence) technology to deliver customized digital advertising to each retail location based on the demographic mix, such as age and gender, of customer traffic at each location. The Company also deploys the INEO Welcoming Network technology through a SaaS-based solution to larger retail chains. INEO is headquartered in Surrey, Canada and publicly traded on the TSX-Venture Exchange under the symbol "INEO" and on the OTCQB-Venture Market under the symbol "INEOF".
For more information please visit:
Website: www.ineosolutionsinc.com
LinkedIn: https://www.linkedin.com/company/ineosolutions
Facebook: https://www.facebook.com/ineosolutionsinc
Instagram: https://www.instagram.com/ineosolutionsinc
Twitter: https://twitter.com/INEOsolutions
Investors are cautioned that, except as disclosed in the disclosure document, any information released or received with respect to the Company may not be accurate or complete and should not be relied upon. Trading in securities of the Company should be considered highly speculative.
This news release contains statements and information that, to the extent that they are not historical fact, may constitute "forward-looking information" within the meaning of applicable securities legislation. Forward-looking information may include financial and other projections, as well as statements regarding future plans, objectives or economic performance, or the assumption underlying any of the foregoing. This news release uses words such as "may", "would", "could", "likely", "expect", "anticipate", "believe", "intend", "plan", "forecast", "project", "estimate", "outlook", and other similar expressions to identify forward-looking information. Forward-looking information involves significant risks, assumptions, uncertainties and other factors that may cause actual future results or anticipated events to differ materially from those expressed or implied in any forward-looking statements and accordingly, should not be read as guarantees of future performance or results. There are a number of important factors that could cause the Company's actual results to differ materially from those indicated or implied by forward-looking statements and information. Other factors that could cause actual results to differ materially from the Company's expectations are disclosed in the Company's documents filed on SEDAR, including the Company's most recent annual and interim Management Discussion and Analysis and Financial Statements. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release. The Company disclaims any intention or obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, except to the extent required by law.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
View original content to download multimedia:
SOURCE INEO Tech Corp.
|
https://www.mysuncoast.com/prnewswire/2022/06/28/ineo-files-design-patent-dual-screen-ineo-welcoming-system/
| 2022-06-28T12:04:25Z
|
PHOENIX, Aug. 25, 2022 /PRNewswire/ -- Intelemark, a national leader in the outbound calling and lead generation/appointment setting industry for more than 20 years is pleased to be recognized as one of Arizona's top voice and call center service providers for 2022 by Clutch.
For more than two decades Intelemark has helped companies grow their business by putting our clients in front of their desired buyers. We have been successful in this business and continue to grow because Intelemark has the experience to do it right and produce quantitative results. Intelemark's differentiation is our technology, experienced calling agents and management team, and our ability to build a partnership with each client.
We proudly share this achievement as Clutch officially announced their Leaders Awards, naming Intelemark a leading B2B service provider in the voice and call center services industry. Clutch is a B2B ratings and reviews platform based in Washington, DC. They evaluate technology service and solutions companies based on the quality of work, thought leadership, and client reviews.
Every year, Clutch honors the highest-performing B2B companies across industries. The top service providers exhibit deep knowledge in their field and a solid commitment to high-quality customer service. Receiving this award is no small feat, and we appreciate this recognition.
"As a top B2B Appointment Setting and Lead Generation company that has helped clients grow their businesses for 22+ years, we are humbled to be recognized as a leader in the industry." – Murray Goodman, CEO at Intelemark.
We appreciate the incredible support our clients have shown us. Our clients' success is our primary motivation to continue providing top-tier services. Take a look at the reviews we've received.
If you have any questions about our services, contact us to discuss how we can help your business grow.
Headquartered in Scottsdale, AZ, Intelemark is a national leader in the appointment setting/lead generation industry for more than 20 years. We design highly customized, well-crafted B2B demand generation, lead generation and appointment setting campaigns to connect companies with high-quality targets within their prospect audience. Intelemark's proprietary software application, a virtual and a highly experienced English-speaking agent colony, and a senior management team have helped clients drive revenue and growth for more than two decades.
For Press Inquiries Contact:
Anna Brice, Director of Marketing
Intelemark
Email: annab@intelemark.com
Phone: (602) 943-7111
View original content to download multimedia:
SOURCE Intelemark
|
https://www.kxii.com/prnewswire/2022/08/25/intelemark-recognized-among-arizonas-top-voice-call-center-services-providers-2022/
| 2022-08-25T12:59:49Z
|
SAN FRANCISCO , June 29, 2022 /PRNewswire/ -- Hagens Berman urges Inotiv, Inc. (NASDAQ: NOTV) investors who suffered significant losses to submit your losses now.
Class Period: Sept. 21, 2021 – June 13, 2022
Lead Plaintiff Deadline: Aug. 22, 2022
Visit: www.hbsslaw.com/investor-fraud/NOTV
Contact An Attorney Now: NOTV@hbsslaw.com
844-916-0895
Inotiv, Inc. (NASDAQ: NOTV) Securities Fraud Class Action:
The litigation challenges Inotiv's claims regarding its Envigo business, which the company acquired in Sept. 2021, including that Envigo maintained "high standards of animal welfare" at its Cumberland, Virginia facility and other animal testing sites.
Defendants misrepresented and concealed that: (1) the Cumberland facility engaged in widespread and flagrant violations of the Animal Welfare Act ("AWA"); (2) Envigo and the Cumberland facility continuously violated the AWA; (3) Envigo and Inotiv didn't properly remedy issues with regard to animal welfare at Cumberland; (4) as a result, Inotiv was likely to face increased scrutiny and government action; (5) Inotiv would imminently shut down Cumberland; and, (6) Inotiv didn't perform proper due diligence of Envigo.
On May 20, 2022, Inotiv announced that on May 18 federal and state law enforcement conducted a search and seizure warrant on the Cumberland facility. The company also announced the DOJ sued Envigo for violations of the ACA.
On May 21, 2022, the court in the DOJ's case ordered a halt to violations of the AWA at Cumberland. The court's order observed that hundreds of beagle puppies died in the Cumberland facility (many of which were not given anesthesia before they were euthanized by intracardiac injection), nursing female beagles were denied food, and many puppies died from cold exposure. About 3 weeks later, Inotiv announced it was closing Cumberland.
These events sent the price of Inotiv shares crashing lower.
"We're focused on investors' losses and proving Inotiv misled investors about its adherence to animal welfare standards," said Reed Kathrein, the Hagens Berman partner leading the investigation.
If you invested in Inotiv and have significant losses, or have knowledge that may assist the firm's investigation, click here to discuss your legal rights with Hagens Berman.
Whistleblowers: Persons with non-public information regarding Inotiv should consider their options to help in the investigation or take advantage of the SEC Whistleblower program. Under the new program, whistleblowers who provide original information may receive rewards totaling up to 30 percent of any successful recovery made by the SEC. For more information, call Reed Kathrein at 844-916-0895 or email NOTV@hbsslaw.com.
About Hagens Berman
Hagens Berman is a global plaintiffs' rights complex litigation law firm focusing on corporate accountability through class-action law. The firm is home to a robust securities litigation practice and represents investors as well as whistleblowers, workers, consumers and others in cases achieving real results for those harmed by corporate negligence and fraud. More about the firm and its successes can be found at hbsslaw.com. Follow the firm for updates and news at @ClassActionLaw.
FOR IMMEDIATE RELEASE
Contact:
Reed Kathrein, 844-916-0895
View original content to download multimedia:
SOURCE Hagens Berman Sobol Shapiro LLP
|
https://www.kxii.com/prnewswire/2022/06/29/notv-alert-hagens-berman-national-trial-attorneys-encourages-inotiv-inc-notv-investors-with-significant-losses-contact-firms-attorneys-securities-fraud-case-filed/
| 2022-06-29T13:54:51Z
|
Fact check: Misleading claims in attack ads against Pennsylvania GOP Senate candidates Oz and McCormick
By Daniel Dale, CNN
Pennsylvania’s television viewers have been inundated with attack ads in the state’s Republican primary for the US Senate. And some of those attack ads have featured misleading claims.
The fiercest ad battle has been between the primary’s two leading candidates and outside groups targeting them: Mehmet Oz, a surgeon and former television show host, and David McCormick, a former hedge fund chief executive and economic official in the George W. Bush administration.
Here’s a look at one of the attacks on Oz and one of the attacks on McCormick.
Oz and ‘defund the police’
Two television ads from a super PAC called Pennsylvania Conservative Fund try to portray Oz as a phony who is merely pretending to be a conservative. Each of the ads features a narrator who claims Oz “was a spokesman for a group who wanted to defund the police.”
Facts First: This claim is misleading. Oz opposes the concept of defunding the police. His brief affiliation with the “group” these ads were referring to, a health-focused foundation called The California Endowment, had nothing at all to do with policing. Rather, Oz appeared in one health care ad for the foundation — in which he urged Californians to visit the foundation’s website to learn how to take advantage of the benefits offered by the Affordable Care Act, also known as Obamacare. The ad came out in 2010, roughly a decade before the “defund the police” movement rose to prominence.
Sarah Reyes, spokesperson for The California Endowment, said in an email that Oz had no involvement with the foundation beyond the ad. “Dr. Oz has never been employed by us or been a ‘spokesperson’ for our organization,” Reyes said.
The California Endowment did comment supportively in 2020 about protesters who were calling to defund the police in the wake of the murder of George Floyd, and its chief executive spoke favorably in 2021 about the idea of reducing the number of police officers on the street and instead improving health, jobs and housing programs. (This week, Reyes would not answer directly when CNN asked if the foundation supports defunding the police, saying, “As a private foundation we are prohibited from taking stands on policy issues. We do support prevention and healing.”)
Regardless, The California Endowment’s stance on defunding the police in the 2020s is beside the fact-check point here. The key fact is that the super PAC ads attempt to use Oz’s appearance in a single health care ad in 2010, years before most Americans had even heard the phrase “defund the police,” to hint that Oz supports police defunding. That’s deceptive.
Oz campaign spokesperson Brittany Yanick said in an email: “Claiming that Dr. Oz’s participation in a single advertisement for the California Endowment fund constitutes Dr. Oz’s endorsement of a position the organization took 10 years later is both misleading and wrong.”
CNN could not reach the super PAC behind the ad for comment. This claim about Oz and defunding the police was previously fact-checked by FactCheck.org.
McCormick and the 2016 election
An ad from Oz’s campaign claims that McCormick “paid for attacks on Donald Trump.”
Facts First: This claim is misleading. While McCormick did donate in early 2015 to a political action committee that supported Republican presidential candidate Jeb Bush, there is no indication that McCormick’s money was spent on attacks on Trump or intended for attacks on Trump — especially because McCormick made his $5,000 donation five months before Trump even began his candidacy for president.
Yanick, the Oz campaign spokesperson, said in an email that this claim in the ad was referring to the fact that “McCormick hosted one of the FIRST fundraisers” for Right to Rise, an arm of the pro-Bush operation that spent money attacking Trump. That’s true — McCormick was a member of the host committee for that January 2015 fundraiser — and the Oz campaign is entitled to criticize McCormick for it.
But it’s still a big stretch to claim that McCormick himself paid for any attacks on Trump.
First and foremost, that early Bush fundraiser happened more than five months before Trump launched his candidacy in a speech in June 2015. McCormick’s own $5,000 donation was recorded exactly five months before Trump’s announcement event. At the time, many observers scoffed at the idea that Trump was actually going to run.
Second, even after Trump did announce his run, Bush’s allies were reluctant for months to attack him. While the pro-Bush super PAC Right to Rise USA was funding attack ads against Trump by late 2015, there was a whole lot of elapsed time between those ads and McCormick’s donation at the beginning of the year. (In addition, McCormick’s January 2015 donation was to the pro-Bush leadership PAC with a similar name, not the super PAC that raised far more money and led the advertising effort.)
McCormick also donated $2,700 to Bush’s own campaign in June 2015, the month that Bush announced his candidacy. A McCormick campaign official, speaking on condition of anonymity, said this week that McCormick had gone on to support Trump in the general election, to vote for Trump in both 2016 and 2020 and to serve on the Trump administration’s Defense Policy Board.
McCormick did say at a Duke University event in early 2017, however, that “I wasn’t particularly involved with the Trump camp — I wasn’t a Trump supporter — but I wanted that president to be successful,” adding that he also would’ve wanted success for Hillary Clinton if she had won.
This claim about McCormick funding attacks on Trump was previously fact-checked by FactCheck.org and PolitiFact.
The-CNN-Wire
™ & © 2022 Cable News Network, Inc., a WarnerMedia Company. All rights reserved.
|
https://localnews8.com/politics/cnn-us-politics/2022/04/08/fact-check-misleading-claims-in-attack-ads-against-pennsylvania-gop-senate-candidates-oz-and-mccormick-2/
| 2022-04-08T14:36:01Z
|
Laszlo Bock, co-founder of Humu, steps into a new role as Executive Chairman with Scott Chancellor succeeding him as CEO.
MOUNTAIN VIEW, Calif., Aug. 24, 2022 /PRNewswire/ -- Humu, an HR technology company that uses science-backed nudges to help managers develop high-performing teams, today announced that Scott Chancellor will join as Chief Executive Officer (CEO), starting August 29. Chancellor succeeds Laszlo Bock, who co-founded Humu and served as its CEO since 2017. Bock will be stepping into an Executive Chairman role, presiding over Humu's Board of Directors.
Chancellor joins Humu from Apptio where he spent the past three years in the role of Chief Product & Technology Officer. During his time there, he oversaw a period of rapid product and revenue growth for the company, leading its expansion into the Cloud Financial Management and Enterprise Agile Planning markets, while modernizing and revitalizing Apptio's core product offering.
Prior to joining Apptio, Chancellor spent over seven years at Amazon Web Services, where he founded and led the company's AWS Insights organization as General Manager and was responsible for several of AWS's most used services, including all of its cloud financial management services.
Chancellor has also held roles at Hewlett-Packard, Wachovia Securities, and the United States Department of Defense. He earned a bachelor's degree from the University of Washington, where he studied accounting and computer science, and a Master of Business Administration from Harvard Business School.
"As a leader, I am excited by opportunities for spectacular growth—through building exceptional products that enable organizations to live up to their values," said Chancellor. "I am inspired by Humu's mission to make work better and by the chance to guide the team in helping the world's largest companies empower their managers and accelerate their employees' success."
"It's rare to find a leader who excels in business growth and product innovation, and deeply values shaping a great organizational culture," said TCV Venture Partner Jessica Neal and board member at Humu. "After running an extensive search process, we are thrilled to have Scott join as CEO and believe he is the best possible person to lead Humu into this next chapter."
With Chancellor leading the company as CEO, Laszlo Bock will still play an active role in Humu as the board's Executive Chairman, and as an advisor and spokesperson. "Over the past five years, it's been a privilege to build the foundation of Humu and lead it through transformational growth," said Bock. "I'm excited for my new role in the company and this next chapter under Scott's leadership. His track record of scaling user and revenue growth will bring us even closer to achieving the mission that we set five years ago: make work better."
About Humu
Humu works with the world's largest companies to deliver timely, personalized coaching that makes it easy for managers to improve team performance, retention, and employee experience. For more information or to view open positions, visit humu.com.
Media Contact
Lucy Stenzel-Poore
Mission North for Humu
humu@missionnorth.com
View original content:
SOURCE Humu
|
https://www.kxii.com/prnewswire/2022/08/24/humu-announces-scott-chancellor-its-new-chief-executive-officer/
| 2022-08-24T20:10:31Z
|
Pascal Siakam has triple-double, Raptors beat 76ers 119-114
By IAN HARRISON
Associated Press
TORONTO (AP) — Pascal Siakam had 37 points, 12 assists and 11 rebounds for his third career triple-double, Gary Trent Jr. scored 30 points and the Toronto Raptors beat the Philadelphia 76ers 119-114 on Thursday night. Siakam shot 14 for 28, going 1 for 7 from 3-point range. He made 8 for 10 free throws. Precious Achiuwa scored 20 points and made a career-high five 3-pointers, and Scottie Barnes had 13 points and 10 rebounds to help the Raptors win for the seventh time in eight games. Joel Embiid had 30 points and 10 rebounds, and James Harden had 13 points and 15 assists for the 76ers, whose hopes of winning the Atlantic Division title took a hit.
|
https://localnews8.com/news/2022/04/07/pascal-siakam-has-triple-double-raptors-beat-76ers-119-114/
| 2022-04-08T05:29:00Z
|
AUGUSTA, Ga. (AP) — Rory McIlroy was sounding like an old man.
He reminisced about his first Masters — just 13 years ago — like it was ancient history. He conceded that golf is no longer the be-all and end-all in his life. His voice rose with excitement as he talked of playing in the par-3 contest with young daughter Poppy in tow.
“It’s funny. When you don’t have children, the par-3 seems like a bit of an afterthought,” he mused. “Then, once kids arrive, it sort of becomes the highlight of the week in a way.”
Should we book you a table for the early bird special, Mr. McIlroy?
Not so fast. Sure, he’s no longer the youngest guy on the course, but at 32 he’s far from the oldest.
“I still feel like time’s on my side,” McIlroy said Tuesday, snapping back to reality. “I’ve got a few more gray hairs than I used to, but I’m still young at heart.”
Yet, with each passing year, he seems a little further away from one of golf’s greatest achievements, a capper to his career that once seemed as sure a thing as the azaleas blooming during Masters week.
McIlroy hasn’t won a major championship in nearly eight years. More than a decade has passed since he threw away his best chance to win the Masters with a horrific back nine on Sunday.
A career Grand Slam?
That’s no longer an obsession, not like it was for the cherub-faced, moppy-haired phenom from Holywood (Northern Ireland, that is), turning up for his first Masters at the age of 19.
“I would say less pressure,” McIlroy said. “I’m maybe at a different stage of my life where back then golf was everything. Obviously, look, it’s still very, very important, but maybe back then I would think that, I don’t know, like I was unfulfilled if I didn’t win one.”
The Masters remains the only missing link on his majors resume. He won his first U.S. Open in 2011 just two months after his Augusta meltdown. In 2012, he claimed the first of two PGA Championships. In 2014, the greatest year of his career, he won the British Open and another PGA.
Funny how it worked out.
Back in the spring of 2011, it sure looked like the Masters would be the first of his major titles.
McIlroy dominated over the first three days, leading after every round and going into Sunday with a commanding four-stroke advantage. He got off to a shaky start that day but was still ahead as he made the turn.
Just nine holes to go.
Then, everything fell apart. He hit his tee shot at No. 10 so far left they’re probably still looking for it. He made a four-putt double bogey at 12. He finished with an 8-over 80, barely visible in the rearview mirror of winner Charl Schwartzel.
McIlroy shrugged off that huge disappointment in the best way possible. Over the 2 1/2 years that followed, he fully lived up to the greatness that was predicted of him.
And, yet, the green jacket has eluded him.
It’s a glaring hole in his record, but he’s not discouraged.
“I know if I play well,” McIlroy said, “I’ll give myself chances to win this golf tournament.”
He has finished in the top 10 at Augusta National a half-dozen times, not really close to winning most of those years but always in the mix.
McIlroy’s first shot at the career Grand Slam came at the 2015 Masters, but he ran into Jordan Spieth during a virtually unbeatable stretch in his career. Four rounds under par, including a 68 and 66 on the weekend, was only good enough to finish six strokes behind the Texan.
Four years ago, McIlroy played in the final group on Sunday with Patrick Reed and came out aggressive, hoping to wipe out a three-stroke deficit. The result was a 74 that left him six shots behind Reed.
McIlroy learned a painful lesson that day, one that he’s still struggling to apply at the Masters.
“Patience, discipline, don’t make big numbers.,” he said. “For me anyway, it feels like a very negative way to think, but it’s the way to play around this place. You don’t have to do anything spectacular.”
If McIlroy can put together four unspectacular rounds, he might be wearing a green jacket come Sunday evening.
The one everyone thought he would surely have by now.
___
Follow Paul Newberry on Twitter at https://twitter.com/pnewberry1963
___
More AP golf: https://apnews.com/hub/golf and https://twitter.com/AP_Sports
|
https://cw33.com/sports/ap-sports/the-quest-continues-mcilroy-still-chasing-career-grand-slam/
| 2022-04-05T18:56:35Z
|
TSX.V: EU
OTCQB:ENCUF
www.encoreuranium.com
CORPUS CHRISTI, Texas, June 23, 2022 /PRNewswire/ - enCore Energy Corp. ("enCore" or the "Company") (TSXV: EU) (OTCQB: ENCUF) announced today the results from the 2022 Annual General Meeting of Shareholders held on June 22nd, 2022. A total of 92,710,149 of common shares were voted in connection with the meeting, representing approximately 28.9% of the issued and outstanding common shares of the company. Shareholders approved all motions including the re-election of directors as follows: William M. Sheriff, William B. Harris, Mark S. Pelizza, Richard M. Cherry, Dennis E. Stover, W. Paul Goranson, Nathan A. Tewalt. Shareholders also approved the appointment of auditors and the Company's stock option plan.
Following the vote, the Board approved Nathan Tewalt's resignation from the Board of Directors and approved the re-appointment of Susan Hoxie-Key as a director of the Board, all effective immediately. Mr. Tewalt will continue to serve the Company as the Chair of the Technical Advisory Committee.
enCore Energy is rapidly advancing towards becoming the next producer of American uranium. With approximately 90 million pounds of U3O8 estimated in the measured and indicated categories and 9 million pounds of U3O8 estimated in the inferred category1, enCore is the most diversified in-situ recovery uranium development company in the United States. enCore is focused on becoming the next uranium producer from its licensed and past-producing South Texas Rosita Processing Plant by 2023. The South Dakota-based Dewey Burdock and Wyoming Gas Hills projects offer mid-term production opportunities with significant New Mexico uranium resource endowments providing long-term opportunities. The enCore team is led by industry experts with extensive knowledge and experience in all aspects of ISR uranium operations and the nuclear fuel cycle.
NEITHER THE TSX VENTURE EXCHANGE NOR ITS REGULATION SERVICES PROVIDER (AS THAT TERM IS DEFINED IN THE POLICIES OF THE TSX VENTURE EXCHANGE) ACCEPTS RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.
CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS: Certain information in this news release constitutes forward-looking statements under applicable securities laws. Any statements that are contained in this news release that are not statements of historical fact may be deemed to be forward-looking statements. Forward-looking statements are often identified by terms such as "may", "should", "anticipate", "expect", "potential", "believe", "intend" or the negative of these terms and similar expressions. Forward-looking statements in this news release include, but are not limited to, statements relating to the intended use of the net proceeds of the Offering and the completion of any capital project or property acquisitions. Forward-looking statements necessarily involve known and unknown risks, including, without limitation, risks associated with general economic conditions; adverse industry events; future legislative and regulatory developments; inability to access additional capital; the ability of enCore to implement its business strategies; and other risks. Readers are cautioned not to place undue reliance on forward-looking statements as there can be no assurance that the plans, intentions or expectations upon which they are placed will occur. Such information, although considered reasonable by management at the time of preparation, may prove to be incorrect and actual results may differ materially from those anticipated. Forward-looking statements contained in this news release are expressly qualified by this cautionary statement.
View original content to download multimedia:
SOURCE enCore Energy Corp.
|
https://www.kxii.com/prnewswire/2022/06/23/encore-energy-announces-results-2022-annual-general-meeting/
| 2022-06-23T11:35:38Z
|
NEW DELHI (AP) — Just hours before news of Queen Elizabeth II’s death spread, Prime Minister Narendra Modi delivered a fiery speech urging India to shed its colonial ties in a ceremony to rename a boulevard that once honored King George V.
Rajpath, formerly called Kingsway, was a “symbol of slavery” under the British Raj, he said. Instead, under the newly named Kartavya Path that leads to the iconic India Gate, “a new history has been created,” Modi beamed.
His speech last Thursday was the latest in a concerted drive to purge India of its colonial relics. It was also a clear sign that the country, once the largest of Britain’s colonies that endured two centuries of imperial rule, has moved on.
The renovated avenue now boasts a black granite statue of Indian freedom fighter Subhas Chandra Bose, in the place where a mold of King George V, Elizabeth’s grandfather, once stood.
The queen’s death provoked sympathies to a deeply respected figure from some while for a few others, it jogged memories of a bloody history under the British crown. But among most regular Indians, the news was met with an indifferent shrug.
The British monarchy “holds precisely zero relevance to Indians today — they are of no importance,” said Kapil Komireddi, author of “Malevolent Republic: A Short History of the New India.”
British rule shaped the country in significant ways, but India has since overtaken the British economy in size.
“The country has come into its own … As a rising power, India can gain a lot from the U.K. but the U.K. can gain a whole lot more from India,” Komireddi added.
On Thursday, Modi penned a heartfelt note, calling the queen “a stalwart of our times,” while the government declared a day of mourning. But for most Indians born a generation after independence from the British in 1947, there is little attachment to the queen or the royal family.
Sankul Sonawane, 20, was at home when he heard the news, which had “no impact” on him. “We have no sense of emotional connection with the queen. She was a monarch and I don’t believe in the idea of a monarchy.”
Dhiren Singh, a 57-year-old entrepreneur in New Delhi, felt the same way. “I do not think we have any place for kings and queens in today’s world, because we are the world’s largest democratic country,” he said.
Elizabeth visited India three times during her reign and was the first monarch to tour the newly freed country, cementing the start of fresh ties with Britain. After her coronation in 1953, she arrived in the capital New Delhi in 1961, where she addressed a massive crowd and nearly a million people lined up along streets to catch a glimpse of her and her husband, Prince Philip.
Darshan Paul was 10 or 11 years old when she stood along a road in New Delhi and waved an Indian flag at the queen. “I remember her gloved hand waving back at me and was so impressed,” Paul, now 71, said.
There was abundant excitement and curiosity around her visit, Paul recalled, as she and her friends poured over newspaper photos of the queen and were dazzled by the gowns she wore.
But it was a different time then, Paul said, as she acknowledged that the traditional bond some Indians once held with the royal family has morphed dramatically since.
“To young Indians today, they seem like any other high-profile celebrity family – you might follow news of them because you want to know what is happening behind closed doors. But beyond the glamor and celebrity allure, they don’t hold any significance any more.”
If her son, who was formally proclaimed King Charles III over the weekend, were to make an official visit to India, “it will certainly not matter as much,” Paul added.
The queen’s last visit in 1997 was tinged with controversy when she traveled to a memorial dedicated to hundreds of unarmed Indians who were killed by British colonial forces in 1919, amid calls for an apology over the Jallianwala Bagh massacre.
For many, the royal family remains a hallmark of a deeply painful history. Colonial rule is still remembered for the extraordinary violence and suffering it spawned, from numerous famines and economic exploitation to ultimately an unprecedented level of bloodshed in the partition of India and Pakistan.
Scrolling through social media after the news, 25-year-old Sumedha Chatterjee said the tweets in support of the queen felt almost like people had forgotten about all the “loot and plunder” the British monarchy oversaw. “They built their empire on the backs of the so-called third world,” she added.
Just hours after her death, Indian social media lit up with renewed calls for the return of the famous Koh-i-Noor, the 106-carat diamond discovered in India that is part of the British crown jewels.
“If the king is not going to wear (the) Koh-i-Noor, give it back,” quipped one user.
Ever since gaining independence, India has moved to shed its colonial ties, including changing back the names of a clutch of cities that were renamed during British rule. In the 1960s, officials removed figures of British officials and royalty from public view — the statue of King George V, which stood tall under the canopy of India Gate, was moved to Coronation Park, a graveyard or final resting place for imperial symbols in the capital.
And under Modi, there has been renewed vigor to reclaim India’s past, which has seen the government scrub away colonial-era street names, some laws and even flag symbols.
Such gestures “represent a new India” which has nothing to do with the monarchy, said Archana Ojha, a professor of history at Delhi University. She added, though, that the country’s imperial history can’t be hidden away.
“We may not need to cherish some of the legacies, but we need to preserve them to teach our future generations. We cannot just erase it completely,” she said.
___
Associated Press journalist Rishi Lekhi contributed to this report.
|
https://cw33.com/news/international/ap-international/ap-anger-over-past-indifference-meets-queens-death-in-india/
| 2022-09-13T23:48:32Z
|
Rudy Giuliani has been told he’s the target of a Georgia special grand jury investigating attempts by former President Trump and his allies to overturn the 2020 election results in the state, his lawyer confirmed to The Hill Monday.
Giuliani’s testimony is expected before the special grand jury this week.
The New York Times first reported on Thursday that Giuliani had been informed of being targeted by the grand jury. Robert Costello, an attorney representing the former New York City mayor, confirmed the Times’s reporting in an email to The Hill.
Giuliani was ordered last week to appear in person after attempts by his lawyers to delay his testimony.
In the subpoena, shared by The Atlanta Journal-Constitution, Giuliani is noted as “both a personal attorney for former President Donald Trump and a lead attorney for the Trump Campaign’s legal efforts seeking to influence the results of the November 2020 election in Georgia and elsewhere.”
Giuliani will likely invoke attorney-client privilege to avoid answering questions about his conversations with the former president, his lawyer told the Times.
Fulton County District Attorney Fani Willis (D) subpoenaed Giuliani along with several other Trump allies, including Sen. Lindsey Graham (R-S.C.), Rep. Jody Hice (R-Ga.), Georgia Gov. Brian Kemp (R) and conservative lawyers John Eastman, Jenna Ellis and Cleta Mitchell.
A judge recently quashed efforts by Graham to challenge his subpoena after Willis argued Graham’s resistance was “built on the shifting sands of erroneous legal arguments, inapplicable legal principles, and citations to caselaw that fail to support any legal point being made.”
|
https://cw33.com/hill-politics/giuliani-told-hes-a-target-of-georgia-probe/
| 2022-08-15T21:15:13Z
|
Tesla CEO Elon Musk has subpoenaed his friend and former Twitter CEO Jack Dorsey as part of an effort to back out of his $44 billion agreement to acquire the company Dorsey helped found, according to court documents.
Twitter and Musk are headed for an Oct. 17 trial in Delaware that should determine whether or not Twitter can force the billionaire to go through with the acquisition.
Twitter has subpoenaed a host of tech investors and entrepreneurs connected to Musk, including prominent venture capitalist Marc Andreessen and David Sacks, the founding chief operating officer of PayPal.
Musk has claimed that Twitter failed to provide adequate information about the number of fake, or “spam bot,” Twitter accounts, and that it has breached its obligations under the deal by firing top managers and laying off a significant number of employees. Musk’s team expects more information about the bot numbers to be revealed in the trial court discovery process, when both sides must hand over evidence.
Twitter argues that Musk’s reasons for backing out are just a cover for buyer’s remorse. Shortly after Musk agreed to pay 38% above Twitter’s stock price, the stock market stumbled and shares of the electric-car maker Tesla, where most of Musk’s personal wealth resides, lost more than $100 billion of their value.
The subpoena was served last week. It asks Dorsey for documents and communications related to the acquisition, as well as information on the effect of fake or spam accounts on Twitter’s business and its measurement of daily active users.
A lawyer representing Dorsey did not immediately respond to a message for comment on Monday.
|
https://cw33.com/technology/ap-technology/musk-subpoenas-former-twitter-ceo-and-friend-jack-dorsey/
| 2022-08-23T13:04:46Z
|
NEW YORK, June 2, 2022 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in International Business Machines Corporation ("IBM" or the "Company") (NYSE: IBM) of a class action securities lawsuit.
CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of IBM investors who were adversely affected by alleged securities fraud between April 4, 2017 and October 20, 2021. Follow the link below to get more information and be contacted by a member of our team:
IBM investors may also contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or by telephone at (212) 363-7500.
CASE DETAILS: The filed complaint alleges that defendants made false statements and/or concealed that: (i) Strategic Imperatives Revenue and growth, CAMSS and CAMSS Components' revenue and growth, and the Company's Segments' revenue and growth were artificially inflated as a result of the wrongful reclassification of revenues from non-strategic to strategic to make those revenues eligible for treatment as Strategic Imperatives Revenue; (ii) the Company's present success and positive future growth prospects concerning its Strategic Imperative business strategy were being fueled by the wrongful reclassification of revenues from non-strategic to strategic to make those revenues eligible for treatment as Strategic Imperative Revenue and, as a result (iii) the Company misled the market by portraying the Company's Strategic Imperative's financial performance and future prospects more favorable than they actually were as a result of the wrongful reclassification of revenues from non-strategic to strategic to make those revenues eligible for treatment as Strategic Imperatives.
WHAT'S NEXT? If you suffered a loss in IBM during the relevant time frame, you have until June 6, 2022 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.
NO COST TO YOU: If you are a class member, you may be entitled to compensation without payment of any out-of-pocket costs or fees. There is no cost or obligation to participate.
WHY LEVI & KORSINSKY: Over the past 20 years, the team at Levi & Korsinsky has secured hundreds of millions of dollars for aggrieved shareholders and built a track record of winning high-stakes cases. Our firm has extensive expertise representing investors in complex securities litigation and a team of over 70 employees to serve our clients. For seven years in a row, Levi & Korsinsky has ranked in ISS Securities Class Action Services' Top 50 Report as one of the top securities litigation firms in the United States.
CONTACT:
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
Ed Korsinsky, Esq.
55 Broadway, 10th Floor
New York, NY 10006
jlevi@levikorsinsky.com
Tel: (212) 363-7500
Fax: (212) 363-7171
www.zlk.com
View original content to download multimedia:
SOURCE Levi & Korsinsky, LLP
|
https://www.kxii.com/prnewswire/2022/06/02/ibm-lawsuit-alert-levi-amp-korsinsky-notifies-international-business-machines-corporation-investors-class-action-lawsuit-upcoming-deadline/
| 2022-06-02T19:02:02Z
|
NEW YORK, Sept. 1, 2022 /PRNewswire/ --
WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of Azure Power Global Limited (NYSE: AZRE) between June 15, 2021 and August 26, 2022, both dates inclusive (the "Class Period"). If you wish to serve as lead plaintiff, you must move the Court no later than October 31, 2022.
SO WHAT: If you purchased Azure Power securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
WHAT TO DO NEXT: To join the Azure Power class action, go to https://rosenlegal.com/submit-form/?case_id=8433 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email pkim@rosenlegal.com or cases@rosenlegal.com for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than October 31, 2022. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.
WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources or any meaningful peer recognition. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs' Bar. Many of the firm's attorneys have been recognized by Lawdragon and Super Lawyers.
DETAILS OF THE CASE: According to the lawsuit, defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose material adverse facts about the Company's business operations and prospects. Specifically, defendants failed to disclose to investors: (1) there were procedural irregularities, including deviations from safety and quality standards, at one of Azure Power's plants; (2) certain project data was manipulated; (3) as a result of the foregoing, the Company's internal controls and procedures were not effective; (4) Azure Power had received a credible whistleblower report alleging such misconduct; and (5) as a result of the foregoing, defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis. When the true details entered the market, the lawsuit claims that investors suffered damages.
To join the Azure Power class action, go to https://rosenlegal.com/submit-form/?case_id=8433 mailto:or call Phillip Kim, Esq. toll-free at 866-767-3653 or email pkim@rosenlegal.com or cases@rosenlegal.com for information on the class action.
No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor's ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.
Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.
Attorney Advertising. Prior results do not guarantee a similar outcome.
Laurence Rosen, Esq.
Phillip Kim, Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 40th Floor
New York, NY 10016
Tel: (212) 686-1060
Toll Free: (866) 767-3653
Fax: (212) 202-3827
lrosen@rosenlegal.com
pkim@rosenlegal.com
cases@rosenlegal.com
www.rosenlegal.com
View original content to download multimedia:
SOURCE Rosen Law Firm, P.A.
|
https://www.mysuncoast.com/prnewswire/2022/09/02/rosen-leading-longstanding-firm-encourages-azure-power-global-limited-investors-secure-counsel-before-important-deadline-securities-class-action-azre/
| 2022-09-02T01:52:07Z
|
SREBRENICA, Bosnia-Herzegovina (AP) — They were the ones who lived in a world in which their husbands, sons, brothers, uncles and nephews were massacred. They were the ones who fought to make sure that world would neither deny nor forget the truth of what happened in Srebrenica.
As thousands converge on the eastern Bosnian town to commemorate the 27th anniversary Monday of Europe’s only acknowledged genocide since World War II, the crucial role women have played in forging a global understanding of the 1995 massacre also is getting recognized.
A permanent photo exhibition of portraits of the women of Srebrenica opened Saturday in a memorial center dedicated to the massacre’s more than 8,000 victims. The center in Potocari, just outside the town, is set to host an international conference of women discussing how they found strength to fight for justice after being driven from their homes and witnessing their loved ones being taken away to be killed.
“After I survived the genocide in which my most beloved child and my husband were killed, it was the injustice of their killers, their refusal to acknowledge what they did and to repent, that pushed me to fight for truth and justice,” said Munira Subasic.
Subasic’s relatives were among more than 8,000 men and boys from the Bosniak ethnic group, which is made up primarily of Muslims, who perished in 10 days of slaughter after the town was overrun by Bosnian Serb forces in the closing months of Bosnia’s 1992-95 fratricidal war.
Bosnian Serb soldiers plowed the victims’ bodies into hastily made mass graves, and then later dug up the sites with bulldozers and scattered the remains among other burial sites to hide the evidence of their crimes.
Bosniak women and children were packed onto buses and expelled from the town.
But as soon as the war was over, Subasic and other women who had shared her fate vowed to find the remains of their loved ones, bring them back to their town and bury them there.
To do that, they created an organization, Mothers of Srebrenica, which engaged in street protests and other actions to stay in the public eye. They demanded that the mass graves be found, the remains identified and those responsible for the massacre punished. To date, almost 90% of those reported missing from the fall of Srebrenica have been accounted for.
“People often ask us who supported us, who had our back early on. But it was no one, we did it on our own,” said Sehida Abdurahmanovic.
“The pain is the best and the most difficult education, but also the most honest, because it comes directly from the heart,” she added.
Since the end of the war, Srebrenica has been located in the Serb-run Bosnian entity of Republika Srpska, while many of its pre-war inhabitants live in the country’s other entity, the Bosniak-Croat Federation.
In the immediate post-war years, crowds of angry Bosnian Serbs did their best to prevent women who had lived through the bloodshed from visiting the newly found mass graves to search for items that once belonged to their loved ones. To intimidate them, crowds would line up along the streets, shouting and throwing stones at buses carrying the women.
But the women kept returning. For a long time, they had to be escorted by the NATO-led peacekeepers, but still they refused to bury their identified dead anywhere else but in Srebrenica.
Finally, in 2003, Bosnian Serb authorities relented under pressure and allowed the survivors to inaugurate the memorial cemetery for the victims in the town.
So far, the remains of more than 6,600 people have been found and buried at the cemetery. The remains of 50 more victims, recently found in mass graves and identified through DNA analysis, will be put to rest there on Monday.
Dozens of Srebrenica women testified before the U.N. war crimes tribunal for the former Yugoslavia, helping put behind bars close to 50 Bosnian Serb wartime officials, collectively sentenced to over 700 years in prison.
“After my husband was killed and I stayed alone with our two children, I thought I will not be able to function, but the pain kept us going,” Abdurahmanovic said.
Brought up in a patriarchal society, Srebrenica women were expected to suffer in silence and not confront Serb leaders, who continue to downplay or even deny the 1995 massacre. Instead, they changed their lives, setting up support groups, commemorating the victims and re-telling their trauma to everyone willing to listen, including queens, presidents, prime ministers, diplomats and journalists.
“The history of what happened in Srebrenica has been written in white marble headstones in the memorial cemetery, which would not have existed had we not insisted,” said Suhra Sinanovic, who lost her husband and 23 other close male relatives in the massacre.
She said Bosnian Serb authorities had underestimated the Srebrenica women.
“If, God forbid, a war was to break out in Bosnia again, maybe (the Serbs) would do things differently by letting the men live and killing the women,” she said.
|
https://cw33.com/news/international/ap-international/srebrenica-women-honored-for-highlighting-1995-massacre/
| 2022-07-09T16:29:29Z
|
NEW YORK, June 23, 2022 /PRNewswire/ -- In a recently published annual report on the best workplaces for legal industry associates, Chambers Associate endorsed Stroock for high associate satisfaction based on direct, anonymously conducted interviews with associates at the firm.
Chambers also noted the firm's strong performance when it comes to maintaining associates' quality of life.
Here's some of what Stroock's associates had to say about life at the firm:
- "Stroock is a smaller law firm with big-law-firm work – you get the ability to work with top clients while experiencing a cozy, close-knit culture."
- "Everyone is very familiar with each other, even partners are happy to chat or answer any of our questions."
- "The firm does a good job with diversity, we have a number of committees, groups, events and resources."
- "The firm's pro bono commitment is second to none, especially for a firm of our size."
- "Stroock does a good job at making sure everyone's workloads are manageable."
Click here to read the full report.
View original content to download multimedia:
SOURCE Stroock & Stroock & Lavan LLP
|
https://www.kxii.com/prnewswire/2022/06/23/stroock-endorsed-by-chambers-2022-associate-satisfaction-report/
| 2022-06-23T19:16:44Z
|
Delta Air Lines to Present at the Morgan Stanley Laguna Conference
Published: Sep. 7, 2022 at 8:30 AM EDT|Updated: 55 minutes ago
ATLANTA, Sept. 7, 2022 /PRNewswire/ -- Delta Air Lines (NYSE:DAL) will present at the Morgan Stanley Laguna Conference at 10:35 a.m. ET on Wednesday, September 14th, 2022.
A live webcast of this event will be available at ir.delta.com. An online replay will be available at the same site shortly after the webcast is complete.
The above press release was provided courtesy of PRNewswire. The views, opinions and statements in the press release are not endorsed by Gray Media Group nor do they necessarily state or reflect those of Gray Media Group, Inc.
|
https://www.mysuncoast.com/prnewswire/2022/09/07/delta-air-lines-present-morgan-stanley-laguna-conference/
| 2022-09-07T13:25:40Z
|
Company to host conference call and webcast on Monday, August 15, 2022, at 8:00am ET
BOSTON and ATLANTA, Aug. 12, 2022 /PRNewswire/ -- Inhibikase Therapeutics, Inc. (Nasdaq: IKT) ("Inhibikase" or "Company"), a clinical-stage pharmaceutical company developing therapeutics with the potential to modify the course of Parkinson's disease ("PD") and related disorders, today reported financial results for the second quarter ended June 30, 2022 and highlighted recent developments.
"In the second quarter, we continued to make progress across our entire portfolio. We recently opened enrollment in our Phase 2a '201' trial for IkT-148009 for the treatment of Parkinson's disease. We have now opened nearly a quarter of all sites for the study and we are actively screening patients. In addition, we have submitted our Investigational New Drug (IND) application for IkT-001Pro for patients with chronic myelogenous leukemia to the U.S. Food and Drug Administration (FDA), and expect to initiate our '501' bioequivalence study of IkT-001Pro following FDA review and concurrence," commented Milton Werner, Ph.D., President and Chief Executive Officer of Inhibikase. "Looking ahead, we also expect to share Parkinson's assessment data from our Phase 1/1b '101' clinical trial of IkT-148009 at the Movement Disorders Society Congress in September and are continuing to advance our regulatory activities in the U.S. and the EU27 as we plan a Phase 2 trial in Multiple System Atrophy. Taken together, we believe that these activities lay the groundwork for continued momentum across our business as we seek to deliver on our mission of bringing novel, disease-modifying treatments to patients suffering from devastating diseases."
Recent Developments and Upcoming Milestones:
- Phase 2a '201' Trial of IkT-148009 Open for Enrollment: In May 2022, Inhibikase opened enrollment for its Phase 2a study ('201 trial') evaluating IkT-148009 for the treatment of Parkinson's disease. The Company has opened 11 of 40 planned sites and is actively screening patients. The 201 trial is a 1:1:1:1 randomized, double-blind, twelve-week dosing trial, designed to measure the safety, tolerability and steady-state pharmacokinetics (PK) of three doses of IkT-148009 in up to 120 untreated Parkinson's patients. The trial will further measure the potential for IkT-148009 to impact the disease globally in the body using a hierarchy of Parkinson's-related disease assessments in the brain and gut as secondary or exploratory endpoints.
- The advancement of IkT-148009 into Phase 2a followed a review of the study protocol, as well as the safety, tolerability and PK data from the 101 clinical trial by the FDA. In the 101 trial, the clinical pharmacology of IkT-148009 in patients paralleled the clinical pharmacology of IkT-148009 in older heathy volunteers. IkT-148009 also demonstrated a favorable safety and tolerability profile up to a dose of 325 mg, with no clinically-significant adverse events observed. Inhibikase plans to present additional data from the 101 trial at the Movement Disorders Society Congress in Madrid, Spain, in September 2022.
- Filed IND Application for IkT-001Pro for Stable-Phase Chronic Myelogenous Leukemia (CML): On June 29, 2022, Inhibikase filed its IND application with the FDA for IkT-001Pro, the Company's prodrug of imatinib mesylate to treat Stable-phase Chronic Myelogenous Leukemia (SP-CML). A clerical error delayed the review of the IND, however the Division of Hematological Malignancies I confirmed that FDA review of the IND should be completed no later than August 26, 2022. Following clearance by the FDA, the Company expects to initiate bioequivalence studies in accordance with the 505(b)(2) regulatory pathway. IkT-001Pro will be evaluated in a two-part dose finding/dose equivalence study in up to 62 healthy volunteers. The study is designed to evaluate the steady-state pharmacokinetics of IkT-001Pro and determine the dose of IkT-001Pro equivalent to 400 mg imatinib mesylate, the standard-of-care dose for SP-CML. Inhibikase expects to initiate this two-part bioequivalence study in the normal course following review of the proposed clinical study by the FDA. Inhibikase will confer with the FDA once bioequivalence is established to begin the New Drug Application, or NDA, process on the proposed approval path for IkT-001Pro under the 505(b)(2) statute. The Company plans to simultaneously pursue a superiority study comparing the selected dose of IkT-001Pro to standard-of-care 400 mg imatinib mesylate in SP-CML patients using a novel two-period, wait-list-crossover-switching study.
- Evaluating ongoing studies of IkT-148009 in Animal Models of Multiple System Atrophy (MSA): Inhibikase continues to advance regulatory activities IkT-148009 in both the U.S. and EU27 for the treatment of MSA. The Company is preparing regulatory filings in the US and EU27 to enable the planned Phase 2 MSA trial if IkT-148009 is validated to be active in MSA in animal model studies. Execution of this trial will require the Company to raise additional working capital. Two animal model studies are ongoing and a preliminary assessment in one of the two studies demonstrated an apparent functional benefit following treatment.
- Receipt of new patent # 11,407,747 entitled Compositions and methods for inhibiting kinases: This patent was issued August 9, 2022 for the application of the Company's c-Abl kinase inhibitor portfolio to the treatment of cancer or bacterial or viral infections. This patent is the fifth U.S. patent issued for our portfolio of compounds that inhibit Abelson Tyrosine Kinases for a therapeutic purpose.
Second Quarter 2022 Financial Results
Net Loss: Net loss for the second quarter ended June 30, 2022, was $4.6 million, or $0.18 per share, compared to a net loss of $ 2.6 million, or $0.22 per share for the second quarter in 2021.
Net loss for the six months ended June 30, 2022, was $9.3 million or $0.37 per share, compared to a net loss of $5.3 million, or $0.47 per share in the six months ended June 30, 2021.
R&D Expenses: Research and development expenses were $3.0 million for the second quarter ended June 30, 2022, compared to $2.4 million in the second quarter of 2021. The increase of $0.6 million was driven by a $2.1 million increase in non-grant related research offset by a decrease of $1.4 million in grant related research expenditures and a decrease of $0.1 million in non-cash stock compensation expense. The non-grant related research was expended primarily in connection with the Company's PD clinical trials.
Research and development expenses were $6.0 million for the six months ended June 30, 2022 compared to $4.8 million in the comparable period in 2021. The $1.2 million increase was driven by a $4.3 million increase in non-grant related research offset by a decrease of $2.7 million in grant related research expenditures and a decrease of $0.4 million in non-cash stock compensation expense. The non-grant related research was expended primarily in connection with the Company's PD clinical trials.
SG&A Expenses: Selling, general and administrative expenses for the quarter ended June 30, 2022 were $1.7 million compared to $1.6 million for the second quarter in 2021. The increase was primarily from increased headcount resulting in increased compensation expense of $0.1 million, increased legal fees, board fees, investor relation and consulting fees of $0.3 million and a net increase of $0.1 million for other normal operating expenses offset by decreased non-cash stock based compensation expense of $0.4 million.
Selling, general and administrative expenses for the six months ended June 30, 2022 were $3.3 million compared to $3.2 million for comparable period in 2021. The increase was primarily from increased headcount resulting in increased compensation expense of $0.3 million, increased legal fees, board fees, investor relation and consulting fees of $0.6 million and a net decrease of $0.1 million for other normal operating expenses offset by decreased non-cash stock based compensation expense of $0.7 million.
Cash Position: Cash and cash equivalents were $32.2 million as of June 30, 2022. The Company expects that existing cash and cash equivalents will be sufficient to fund its normal operations and capital expenditure requirements through December 31, 2023.
Conference Call Information
The conference call is scheduled to begin at 8:00am ET on Monday, August 15, 2022. Participants should dial 844-825-9789 (United States) or 412-317-5180 (International) with the conference code 10169366. A live webcast may be accessed using the link here, or by visiting the investors section of the Company's website at www.inhibikase.com. After the live webcast, the event will be archived on Inhibikase's website for approximately 90 days after the call.
About Inhibikase (www.inhibikase.com)
Inhibikase Therapeutics, Inc. (Nasdaq: IKT) is a clinical-stage pharmaceutical company developing therapeutics for Parkinson's disease and related disorders. Inhibikase's multi-therapeutic pipeline focuses on neurodegeneration and its lead program IkT-148009, an Abelson Tyrosine Kinase (c-Abl) inhibitor, targets the treatment of Parkinson's disease inside and outside the brain. Its multi-therapeutic pipeline is pursuing Parkinson's-related disorders of the brain and GI tract, orphan indications related to Parkinson's disease such as Multiple System Atrophy, and drug delivery technologies for kinase inhibitors such as IkT-001Pro, a prodrug of the anticancer agent Imatinib that the Company believes will provide a better patient experience with fewer on-dosing side-effects. The Company's RAMP™ medicinal chemistry program has identified a number of follow-on compounds to IkT-148009 to be potentially applied to other cognitive and motor function diseases of the brain. Inhibikase is headquartered in Atlanta, Georgia with offices in Boston, Massachusetts.
Social Media Disclaimer
Investors and others should note that the Company announces material financial information to investors using its investor relations website, press releases, SEC filings and public conference calls and webcasts. The Company intends to also use Twitter, Facebook, LinkedIn and YouTube as a means of disclosing information about the Company, its services and other matters and for complying with its disclosure obligations under Regulation FD.
Forward-Looking Statements
This press release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking terminology such as "believes," "expects," "may," "will," "should," "anticipates," "plans," or similar expressions or the negative of these terms and similar expressions are intended to identify forward-looking statements. These forward-looking statements are based on Inhibikase's current expectations and assumptions. Such statements are subject to certain risks and uncertainties, which could cause Inhibikase's actual results to differ materially from those anticipated by the forward-looking statements. Important factors that could cause actual results to differ materially from those in the forward-looking statements are set forth in Inhibikase's filings with the SEC, including its annual report on Form 10-K for the year ended December 31, 2021, including under the caption "Risk Factors" and its quarterly report on Form 10-Q for the quarter ended June 30, 2022 filed with the Securities and Exchange Commission. Any forward-looking statement in this release speaks only as of the date of this release. Inhibikase undertakes no obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future developments or otherwise, except as may be required by any applicable securities laws.
Contacts:
Company Contact:
Milton H. Werner, Ph.D.
President & CEO
678-392-3419
info@inhibikase.com
Investor Relations:
Alex Lobo
SternIR, Inc.
alex.lobo@sternir.com
View original content to download multimedia:
SOURCE Inhibikase Therapeutics, Inc.
|
https://www.wibw.com/prnewswire/2022/08/12/inhibikase-therapeutics-reports-second-quarter-2022-financial-results-highlights-recent-period-activity/
| 2022-08-12T22:04:26Z
|
Future applications for the early, preventative use of amniotic membrane allografts in addition to the current standard of care for DFUs present a novel opportunity to reduce long-term morbidity and amputation risk in diabetic patients.
PENSACOLA, Fla., Aug. 8, 2022 /PRNewswire/ -- A new MDPI study, co-authored by Regenative Labs signifies a huge win for patients suffering from diabetic foot ulcers (DFUs). DFUs are debilitating for an individual. They are painful, long lasting, and, even with proper care, can lead to amputation. The current standard of care for DFUs is debridement, the medical removal of dead, damaged, or infected tissue to improve the healing potential of the remaining healthy tissue. The increased healing time and augmented risk of amputation associated with the current standard of care only solidifies the need for new DFU treatment alternatives. Regenerative medicine is such an alternative.
With approximately 37.3 million diabetic adults in the United States, physicians are faced with an epidemic. Given the projected increase of 1.4 million new diagnoses of diabetes mellitus each year, advancing knowledge and care for the disease and its related conditions is especially relevant.
Regenative Labs' AmnioText™, a dehydrated amniotic membrane allograft, was used to close a grade 5 wound according to the Curative Health Services (CHS wound grade scale), described as full thickness and subcutaneous tissues, exposed tendons, ligaments, and/or joints, plus necrotic tissue in the wound, in 7 weeks. Grade 5 wounds have a 91.5% rate of not healing at all. This unsettling outcome emphasizes the efficacy and importance of amniotic membrane allografts in revolutionizing the standard of care for DFUs.
The inability to heal DFUs presents a severe danger to patients as anywhere from 5 to 24% of untreated DFUs can lead to limb amputation within 6–18 months. These infections can lead to long-term impairment and possible lower-limb amputation without timely and correct management.
"Regenative Labs and our products are focused on ameliorating this problem with our outcomes-based approach. We provide the highest quality amniotic membrane allograft to allow doctors to provide predictable outcomes for their patients," shared Regenative Labs CEO, Tyler Barrett.
Amniotic membrane allografts, such as those provided by Regenative Labs, have proven to augment the body's ability to regenerate the structural tissue defects associated with DFUs; they are also comparable in cost to the standard of care, which averages about USD 17,245. Not only is the current standard of care for DFUs less effective, but it is also high in cost and typically relies on inpatient expenditures.
Medicare now recognizes the medical necessity of amniotic membrane allografts in the treatment of both DFUs and venous stasis ulcers. Consequently, many patients rely on Medicare to assist with the costs associated with DFU treatment. This presents the opportunity for human amniotic membrane allografts to be utilized in rural and underserved communities where DFU treatment is typically delayed due to high costs and a lack of supplies associated with traditional treatment. This could exponentially decrease the risk of amputations in diabetic patients in these rural and underserved communities.
About Regenative Labs: Regenative Labs produces regenerative medicine products to address the root cause of a patient's conditions using Wharton's Jelly innovations rather than masking the pain with other treatments. Regenative Labs works closely with scientists, physicians, hospitals, and surgery centers to constantly monitor and improve patient progress and outcomes for new product development. Formed by veteran industry professionals familiar with daily challenges of innovations in healthcare, the company provides effective, non-addictive, non-invasive options for patients. Regenative Labs has a laser-focused, expert product research and development team which follows FDA guidelines of minimal manipulation for homologous use. The company adheres to AATB and FDA guidelines.
Learn more at Regenative's website: www.regenativelabs.com
View original content to download multimedia:
SOURCE Regenative Labs
|
https://www.wibw.com/prnewswire/2022/08/08/regenative-labs-releases-new-study-revolutionize-treatment-patients-with-diabetic-foot-ulcers/
| 2022-08-08T13:55:01Z
|
IRVINE, Calif., Aug. 1, 2022 /PRNewswire/ -- Wheel Pros' brand, Rotiform wheels, today announced its continued partnership with Ferrari as the official wheel provider of the most recent factory race car to come out of Maranello, the Ferrari 296 GT3. Rotiform has developed an all-new, forged wheel homologated specifically for the 296 GT3 factory racecar. The car will make its display debut with the bespoke Rotiform wheels for the first time at the 2022 24 Hours of Spa and will begin competing in 2023.
Encompassed in the partnership, the new Rotiform design will be the exclusive wheel offered for all factory Ferrari 296 GT3 professional level racecars, which will compete in multiple championships spanning across the globe. The factory supported GT cars are competing in the World Endurance Championship (WEC), IMSA, and GT World Challenge Series and others.
"We are excited to continue the partnership with Ferrari as we progress even further into professional motorsports with Rotiform wheels," said Brian Henderson, CSO and cofounder of Rotiform. "By continuing the technical partnership with Ferrari, we can showcase the performance accolades that this brand has been working tirelessly to achieve over the past few years. The 296 GT3 is the perfect platform for us to show the automotive world what Rotiform can produce in the motorsports space."
Rotiform has served as technical partner since 2021, previously supplying Rotiform branded race wheels for the world-renowned Ferrari Challenge Championship and GT Racing Series 2020 488 GTE and 2020 488 GT3 EVO cars.
Rotiform wheels are continuously proving to be an integral addition to the Wheel Pros brand family since 2019. See the all-new Rotiform wheels on the 296 GT3 at the 2022 24 Hours of Spa at the world-famous Circuit de Spa-Francorchamp in Stavelot, Belgium, July 28-31, 2022.
About Rotiform:
Rotiform, founded in 2009, is a US-based wheel manufacturer known for its industry-leading innovation and forward-thinking designs. The technical partnership with Ferrari GT factory racing has allowed Rotiform to showcase its engineering and performance potential in competitive motorsports and instills a lasting reputation as a championship-winning brand.
View original content to download multimedia:
SOURCE Rotiform
|
https://www.mysuncoast.com/prnewswire/2022/08/01/rotiform-wheels-is-official-wheel-provider-ferrari-296-gt3/
| 2022-08-01T15:34:36Z
|
New partnership empowers operators to navigate the rapidly changing 5G, IoT, and OpenRAN ecosystem for better service performance
CUPERTINO, Calif., May 24, 2022 /PRNewswire/ -- Mobileum Inc. ("Mobileum"), a leading global provider of analytics solutions for roaming and network services, security, risk management, testing and service assurance, and subscriber intelligence, and Digis Squared, a market leader in network services and AI-assisted tools, announced today that the companies have entered a strategic partnership to bring a comprehensive set of network testing and cognitive optimization solutions to market.
The collaboration brings together Digis Squared's deep expertise in developing cognitive tools to automate and analyze radio network and edge-to-edge performance, and optimizing networks and capacity management to benefit the customer experience, and Mobileum, whose highly scalable and flexible telecom analytics portfolio enables operators to improve business performance, monitor customer experience, and access new monetization opportunities.
Ron Haberman, Mobileum Chief Product Officer, commented:
"Finding meaning in data is what we do. Mobileum's Active Intelligence platform enables Communications Service Providers (CSPs) to connect deep network and operational intelligence with real-time actions to increase revenue, enhance the customer experience, reduce costs, and streamline operations. The partnership with Digis Squared extends the edge-to-edge network testing, optimization, planning, and management capabilities we can deliver. In addition, the in-house expertise and capabilities that the Digis Squared team brings in machine learning analytics is a great fit with our predictive analytics and automated actions approach."
Abdel Rahman Fady, Digis Squared CTO, commented:
"Digis Squared is pleased to partner with Mobileum to provide a more comprehensive testing solution across legacy 2G and 3G technologies through 4G to 5G, Private Networks and OpenRAN. With 5G, IoT, and OpenRAN deployments already underway, this new ecosystem will see CSPs working with a distributed value-chain of stakeholders and information silos that require a new approach to monitoring digital risk and analysing data. AI tools that can swiftly identify issues and automatically solve known problems will be vital to ensure the smooth operations of the highly complex multi-technology, multi-vendor systems, which CSPs rely on today."
Mobileum's Active Intelligence platform provides the actionable insights today's communications service providers require to unleash the power of 5G and next-generation networks. Powering Mobileum's roaming and network services, risk management, testing and monitoring, and customer engagement and experience solutions, the Active Intelligence platform delivers the advanced analytics, AI/ML, and DPI capabilities carriers need to enhance the customer experience, increase revenue, cut costs, reduce losses, and streamline operations.
The Digis Squared INOS solution provides Single Site Verification, network benchmarking, and optimization capabilities and is fully configurable live in the field. Fully customizable reports are delivered within 15 minutes of completion of data receipt, with access to 200 different network KPIs, network QoS, and customer QoE analysis. In addition to 5G analysis, there is considerable interest in Digis Squared's OpenRAN
capability as optimization, interoperability testing, and benchmarking with legacy systems begin to move from PoCs toward commercial deployment.
About Mobileum
Mobileum is a leading provider of Telecom analytics solutions for roaming, core network, security, risk management, domestic and international connectivity testing, and customer intelligence. More than 1,000 customers rely on its Active Intelligence platform, which provides advanced analytics solutions, allowing customers to connect deep network and operational intelligence with real-time actions that increase revenue, improve customer experience, and reduce costs. Headquartered in Silicon Valley, Mobileum has global offices in Australia, Germany, Greece, India, Portugal, Singapore, UK, and United Arab Emirates.
Learn more in https://www.mobileum.com/ and follow @MobileumInc on Twitter
About Digis Squared
Managed Services, System Integration & Consulting. We transform telecom networks, deploy new technologies, and manage vendors, for network operators, service providers and regulators.
Apply our vendor-agnostic expertise, automated AI-led tools and processes to transform your technical and commercial capabilities. We work with agility, deep experience, and our in-house cognitive tools to optimise and manage multi-vendor networks across all technologies.
Headquartered in the UK, Digis Squared has offices in Angola, Egypt and UAE.
Digis Squared ◦ Enabling smarter networks.
Follow us on LinkedIn and Twitter @DigisSquared, and discover more at Digis2.com
View original content:
SOURCE Mobileum
|
https://www.mysuncoast.com/prnewswire/2022/05/24/mobileum-digis-squared-announce-partnership-provide-comprehensive-edge-to-edge-network-testing-analytics/
| 2022-05-24T09:38:22Z
|
Which pellet grill is best?
Pellet grills are often overlooked in favor of gas and charcoal grills. However, a pellet grill’s ability to maintain a temperature automatically and impart a delicious smoky flavor is hard to beat. Most can also smoke foods without needing any additional equipment.
The best pellet grill is the Traeger Grills Pro Series 22 Electric Wood Pellet Grill And Smoker. It can easily feed a family of four and offers expert assembly if you can’t, or don’t want to, build it yourself.
What to know before you buy a pellet grill
Benefits of a pellet grill
Pellet grills have several benefits that make them stand out from the crowd.
- Easy: Much of a pellet grill’s operation is handled automatically by its computer system. This includes setting and maintaining the temperature as well as starting the grill.
- Consistent: By maintaining a temperature automatically, often to within 15 degrees of what’s set, your meals will turn out perfectly with far less variation.
- Versatile: You can cook just about anything with a pellet grill, and you can even mix and match the types of pellets you use to impart different flavors of smoke to your foods.
Size and cooking area
When shopping for a pellet grill, it’s important to consider how much space it takes up and how much food it can cook at once.
- Size varies greatly, and larger sizes don’t always mean larger cooking areas. Just make sure the pellet grill isn’t so big that there’s no room around it where you intend to put it.
- Cooking area is typically given as the sum total of the main rack and additional smaller racks. A family of four typically needs 300-500 square inches of cooking area, with group gatherings needing 600-plus. A one-person household shouldn’t need any more than 300 square inches.
What to look for in a quality pellet grill
Temperature range
The temperature range of a pellet grill is paramount, as temperatures below the range aren’t possible and temperatures above it often automatically shut down the grill for safety reasons. Most offer a range of 180-425 degrees, with better models being able to reach 500-700.
Temperature controller
Pellet grills use a variety of temperature control systems.
- Three-position controllers only have three settings — low, medium and high. They have no system for choosing a specific temperature.
- Multi-position controllers let you set a temperature in 5- or 10-degree intervals, but they struggle to operate correctly in inclement weather.
- Proportional-integrative-derivative controllers let you set a precise temperature, but they can be a little pricey.
How much you can expect to spend on a pellet grill
Pellet grills typically cost $200-$2,500. Budget models cost $350 or less while the better midrange models run $350-$750. The best and biggest grills start around $800 and can cost several thousand dollars.
Pellet grill FAQ
Why do pellet grills need electricity?
A. Pellet grills need electricity to do things such as monitoring the temperature to feed pellets into the flames as needed, as well as running optional parts like an automatic ignition. Luckily, they don’t require any special gear — they just plug into any old outlet.
What can I cook with a pellet grill?
A. You can cook anything a gas and charcoal grill can, as well as anything a smoker can. This includes all manner of meats, vegetables and cheese. You can even bake foods such as cobblers and pizzas.
Does it matter what pellets I use with my grill?
A. Yes. You should use food-grade pellets, as non-food-grade pellets can contain filler materials that add an odd flavor at best or can be hazardous to your health at worst. Look for pellets marketed as “barbecue” or “smoker.”
What’s the best pellet grill to buy?
Top pellet grill
Traeger Grills Pro Series 22 Electric Wood Pellet Grill And Smoker
What you need to know: It’s roomy and effective.
What you’ll love: The small-sized 572-square-inch model can cook up to 24 burgers at once, but if you need more space there’s a larger 884-square-inch model. It has a digital control that can keep temperatures within 15 degrees of what’s desired. Several accessory bundles are available.
What you should consider: A handful of consumers had issues with parts arriving damaged from shipping. Others had problems with the smoker portion maintaining the desired temperature.
Where to buy: Sold by Amazon and Home Depot
Top pellet grill for the money
Z Grills ZPG-550B Wood Pellet Grill And Smoker
What you need to know: This is no less efficient for its lower price.
What you’ll love: It has a digital controller for the temperature and an automatic pellet igniter. It has 538 square inches of cooking space — more than enough to feed a family of four — and a temperature range of 180-450 degrees. The steel construction is durable and powder coated.
What you should consider: A few customers had issues with faulty ignitions or controlling the temperature. Others found the hopper would sometimes stop feeding in pellets.
Where to buy: Sold by Amazon and Home Depot
Worth checking out
Camp Chef SmokePro XT Wood Pellet Grill And Smoker
What you need to know: This is another excellent grill that’s just a touch cheaper than the Traeger.
What you’ll love: It has a temperature range of 160-500 degrees and a digital controller for simplicity. It has an internal food temperature monitor and a bright LED screen. It uses a patented system to make cleaning out ash quick and easy. It comes in black or bronze.
What you should consider: Some purchasers reported struggling to cook effectively at first while they adjusted to the new grill. Others had trouble maintaining a temperature.
Where to buy: Sold by Amazon and Home Depot
Want to shop the best products at the best prices? Check out Daily Deals from BestReviews.
Sign up here to receive the BestReviews weekly newsletter for useful advice on new products and noteworthy deals.
Jordan Woika writes for BestReviews. BestReviews has helped millions of consumers simplify their purchasing decisions, saving them time and money.
Copyright 2022 BestReviews, a Nexstar company. All rights reserved.
|
https://cw33.com/reviews/br/patio-br/grilling-outdoor-cooking-br/best-pellet-grill/
| 2022-05-19T08:52:24Z
|
FAYETTEVILLE, Ark. (AP) — Former reality TV star Josh Duggar will return to federal court on Wednesday, where a judge could sentence him to up to 20 years in prison for receiving and possessing child pornography.
Prosecutors are seeking a maximum sentence for Duggar, whose large family was the focus of TLC’s “19 Kids and Counting” reality show. His lawyers have asked the court in Fayetteville, about 140 miles (225 kilometers) northwest of Little Rock, to send him to prison for five years.
Duggar was arrested in April 2021 after a Little Rock police detective found child porn files were being shared by a computer traced to Duggar. Investigators testified that images depicting the sexual abuse of children, including toddlers, were downloaded in 2019 onto a computer at a car dealership Duggar owned.
TLC canceled “19 Kids and Counting” in 2015 following allegations that Duggar had molested four of his sisters and a babysitter years earlier. Authorities began investigating the abuse in 2006 after receiving a tip from a family friend but concluded that the statute of limitations on any possible charges had expired.
Duggar’s parents said he had confessed to the fondling and apologized. After the allegations resurfaced in 2015, Duggar apologized publicly for unspecified behavior and resigned as a lobbyist for the Family Research Council, a conservative Christian group.
Months later, he publicly apologized for cheating on his wife and a pornography addiction, for which he then sought treatment.
In seeking a 20-year sentence, prosecutors cited the graphic images — and the ages of the children involved — as well as court testimony about the alleged abuse of Duggar’s sisters.
Duggar’s past behavior “provides an alarming window into the extent of his sexual interest in children that the Court should consider at sentencing,” federal prosecutors wrote in their sentencing memorandum.
“This past conduct, when viewed alongside the conduct for which he has been convicted, makes clear that Duggar has a deep-seated, pervasive, and violent sexual interest in children, and a willingness to act on that interest” the court filing said.
Prosecutors also noted that Duggar’s computer had been partitioned to evade accountability software that had been installed to report to his wife activity such as porn searches, according to experts.
“There is simply no indication that Duggar will ever take the steps necessary to change this pattern of behavior and address his predilection for minor females,” prosecutors wrote.
Duggar has maintained that he’s innocent and that he intends to appeal, his attorneys wrote in their sentencing memorandum.
“Duggar accepts that he is before this Court for sentencing and that this Court must impose a penalty,” his attorneys wrote. “That is justice. But Duggar also appeals to this Court’s discretion to temper that justice with mercy.”
On Tuesday, U.S. District Judge Timothy Brooks — who will sentence Duggar on Wednesday — denied Duggar’s request for an acquittal or a new trial.
|
https://cw33.com/news/u-s-news/ap-u-s-headlines/ex-reality-star-josh-duggar-to-be-sentenced-for-child-porn/
| 2022-05-25T08:07:41Z
|
LOS ANGELES, Aug. 4, 2022 /PRNewswire/ -- Leading luxury tequila company, Casa Del Sol, today announced the hiring of beverage industry veteran, Scott Blazek, as their new Chief Growth Officer.
Blazek served as Executive Vice President of Breakthru Beverage for Nevada for seven years where he oversaw the entire NV operation, including the Las Vegas and Reno markets. Prior to his time at Breakthru, Scott worked for Heineken USA where he served as Senior Vice President of Sales as well as with Diageo, serving in several capacities across the organization.
"I am excited to be joining Casa Del Sol at such a pivotal moment in time," Blazek comments. "The time is now for a company like Casa Del Sol who is garnering significant consumer and trade excitement to catapult the tequila industry into uncharted territory, and I look forward to being part of the thrilling journey ahead."
Scott will be leading the company's commercial organization; including all sales and distribution, strategy and analytics as well as working as a critical partner on the executive team reporting to CEO Steph Sebbag and Colbi Corbett, President & COO.
"Scott's extensive experience across the wider beverage alcohol industry as well as his deep understanding of the space makes him a true value add for Casa Del Sol," states Colbi Corbett, President & COO of Casa Del Sol. Corbett continues, "We are building a world-class team rooted in values, quality and authenticity and look forward to Scott helping us build on the national momentum and high revenue velocity we are experiencing as a brand and company."
Casa Del Sol is available nationwide through Southern Glazer's Wine and Spirits in partnership with Shaw-Ross International Importers.
Casa Del Sol is a luxurious, award-winning ultra premium tequila unlike any other. Casa Del Sol tequila is uniquely aged in heritage Cognac barrels made of French Limousin Oak in partnership with the Martell family and using only the finest 100% Blue Weber agave. With a vision to redefine the tequila category, Casa Del Sol tastefully brings together aesthetic design, sustainability, social change and quality. 100% Mexican owned distillery proudly awarded the ESRⓇ distinction for sustainability and social responsibility. Each bottle of Casa Del Sol is inspired by the golden hour of the setting sun and the legend of Mayahuel, the Goddess of Tequila.
For more information visit: www.casadelsoltequila.com and @casadelsoltequila on Instagram.
Communications Contact:
Taylor Foxman
The Industry Collective
Taylor@TheIndustryCollective.org
View original content to download multimedia:
SOURCE Casa Del Sol
|
https://www.kxii.com/prnewswire/2022/08/04/leading-luxury-tequila-company-casa-del-sol-appoints-beverage-industry-veteran-scott-blazek-chief-growth-officer/
| 2022-08-04T20:15:18Z
|
Foundries.io delivers a consistent cloud-native software experience for developers building IoT and Edge devices
LONDON, June 22, 2022 /PRNewswire/ -- Foundries.io, the leader in cloud native development and deployment solutions for secure IoT and Edge devices, today announced it is the first Linux distribution to fully integrate and provide commercial support for Project Cassini, an open, collaborative, standards-based initiative from Arm. The FoundriesFactory Edge Platform-as-a-Service (EPaaS) will accelerate the adoption and deployment of Cassini platforms by providing safe and secure updates as the Cassini specifications expand and evolve.
Project Cassini focuses on compatibility, security and reference implementations for a cloud-native ecosystem. FoundriesFactory Linux microPlatform delivers on each of these areas, enabling Arm® SystemReady™-IR and -ES certification, PSA Certified Level 1 and the Parsec security services enablement.
The result is a Project Cassini-aligned platform that is standardized and secure with application portability that will aid the proliferation of IoT and Edge devices by allowing developers to focus on their value-added applications instead of undifferentiated platform software. Several major Original Design Manufacturers (ODMs) are already implementing the Project Cassini requirements using FoundriesFactory, including AAEON, ADLINK, Advantech, ASUS and Nexcom.
"Project Cassini and FoundriesFactory enables the same kind of application portability in embedded development that mobile phone users have come to expect." said George Grey, co-founder and CEO at Foundries.io. "This collaboration between our FoundriesFactory Edge Platform-as-a-Service and Arm really marks a major milestone in the way we build, test and deploy IoT and Edge devices, and signals to the market where embedded development is headed."
When using a Project Cassini-aligned platform, enabled by FoundriesFactory, the developer experience will not vary from platform to platform regardless of whether the underlying hardware configurations or even the system CPU is different from one platform to another. Retargeting containerized workloads and applications becomes very straightforward.
"Developers need to build, test and deploy IoT devices more quickly and securely than ever before," said Mohamed Awad, vice president, IoT and Embedded at Arm. "Arm's collaboration with FoundriesFactory will push Project Cassini forward, laying the foundation for a cloud-native developer experience across a diverse and secure edge ecosystem."
Foundries.io helps organizations bring IoT and Edge devices to market faster. The FoundriesFactory subscription service reinvents IoT by delivering a secure, customizable, Linux platform with fleet management services for the world's connected devices. Now, product teams gain enhanced data security while reducing the cost of developing, testing, deploying and maintaining devices across their installed lifetime. Our open-source Linux microPlatform interfaces to any cloud and supports market leading microprocessors, SBCs and SoMs, enabling developers to focus on their applications, and not have to worry about the firmware platform and operating system. For more information, visit https://foundries.io/
Media Contact
Astrid Hörnlein
ah@astridhoernlein.de
View original content:
SOURCE Foundries.io
|
https://www.wibw.com/prnewswire/2022/06/22/foundriesfactory-supports-arms-project-cassini-secure-production-edge-deployments/
| 2022-06-22T08:04:24Z
|
Bouncy, customizable Brown Sugar Jelly unveiled nationwide as a permanent menu addition for cold beverages
EMERYVILLE, Calif., June 8, 2022 /PRNewswire/ -- Today, Peet's Coffee introduces its Summer of Jelly menu celebrating the refreshing taste, vibrant colors and unique customization of boba-inspired coffee and tea beverages. As younger U.S. consumers drive demand for boba-inspired specialty drinks1, Peet's debuts a new line of plant-based coffee and tea customized beverages featuring Brown Sugar Jelly for refreshing flavor and texture. Sweet and bouncy Jelly are fully plant-based and can now be added to any cold beverage at Peet's as a permanent menu option. From the new Brown Sugar Cold Brew Oat Latte to a Citrus Green Tea Shaker with Brown Sugar Jelly, Peet's summer menu offers the customization and bright layers that fans of Jelly and boba crave, matched with Peet's aromatic, freshly roasted coffee and tea selections.
"Jelly beverages are a refreshing treat that can be dreamed up and enjoyed with endless flavor and color combinations, especially during summer," said Patrick Main, Senior Beverage Innovator. "At Peet's, our Brown Sugar Jelly is fully plant-based and can be added to any cold drink for refreshing sweetness, irresistible texture and luscious layers that look and taste delicious."
Peet's Summer of Jelly products include:
- Brown Sugar Jelly – Permanent addition
- Brown Sugar Cold Brew Oat Latte – Permanent addition
- Iced Brown Sugar Matcha Oat Latte – Permanent addition
- Citrus Green Tea Shaker with Brown Sugar Jelly – Summer feature
- Strawberry Lemon Tea Shaker with Brown Sugar Jelly – Summer feature
- Brown Sugar Oat Latte (Hot or Iced) – Summer feature
Peet's Coffee is offering an exclusive promotion for all new Peetnik Rewards Members2 who will receive $3 off a Jelly beverage when they download the Peet's App and enter promo code JELLY3 at registration from June 8-22, 2022. Download the Peet's app here.
Also, this summer, coffee drinkers are invited to soak in the sunshine with Peet's Zenith Summer Blend. This sweet and easy-drinking medium roast coffee invokes lighthearted summer vibes whether brewed hot or cold. Guatemala's sweet chocolate-caramel notes are at the forefront, with New Guinea giving the blend some heft, balanced by Rwanda's juicy cherry cola notes. The blend is available in retail stores and online for a limited time.
Peet's Coffee honors Pride Month with the return of Peet's Rainbow Sugar Cookie, available now through June 30. As part of the company's longtime community commitment, Peet's is providing a $20,000 donation to SF LGBT Center, a non-profit organization fostering resources, support, and a safe space for LGBTQ individuals in San Francisco.
To learn more about Peet's Summer of Jelly menu and to find a Coffeebar location near you, visit www.peets.com.
- Source Bloomberg.
- $3 off a Jelly beverage when you download the Peet's app, 6/8 - 6/22/2022
Offer valid for $3 off your purchase of a Jelly Beverage, any size, at participating Peetnik Rewards locations. Offer valid for 7 days from issuance. Transaction must include one (1) bar-made beverage with Jelly. Offer valid for one-time use only. Must apply offer at checkout to redeem. Offer not valid on previous purchases. May not be combined with other Peetnik Rewards offers. Only transactions more than $0 will qualify for points. Taxes, surcharges, or fees may apply. No cash value, substitutions, or rainchecks. This offer is exclusive to you and your Peetnik Rewards account, and cannot be reproduced, transferred, or used by any else. Peet's reserves the right to withdraw or change the offer terms at any time, at its discretion, without notice.
When Alfred Peet founded Peet's Coffee® in Berkeley, California in 1966, he introduced an artisan movement creating the U.S. specialty coffee industry. Considered the "Big Bang of coffee," Peet's legacy – sourcing the world's best beans, artisan roasting for rich, premium taste and crafting beverages by hand – lives on today in every cup, whether ordered online, selected at a grocery store then brewed at home or served in any one of over 270 Peet's Coffee locations in the U.S and China. Peet's Coffee is committed to the welfare of people and the planet, with 100 percent of its coffee purchases verified as responsibly sourced per Enveritas standards. The company operates the first LEED® Gold certified roastery in the United States. Visit www.peets.com and connect @peetscoffee.
Images can be downloaded here
View original content to download multimedia:
SOURCE Peet's Coffee Inc.
|
https://www.wibw.com/prnewswire/2022/06/08/peets-coffee-introduces-summer-jelly-with-plant-based-boba-inspired-coffee-tea-menu/
| 2022-06-08T13:12:39Z
|
A Global Pitch Competition for Blockchain Startups with Prize Pool up to $300,000
NEW YORK, Aug. 29, 2022 /PRNewswire/ -- VietChallenge (a non-profit startup accelerator focused on supporting emerging technologies and entrepreneurs of diverse backgrounds) is partnering with Hectagon (the world's first DAO-governed Web3 Venture Capital platform) and HUB Global (one of the most established blockchain investment funds in Southeast Asia) to launch Block Champion, a new blockchain start-up competition for emerging Web3 entrepreneurs and developers from around the globe. The competition discovers the most innovative blockchain solutions and foster their growth through mentorship, networking and access to funding.
The event was conceived at the heels of VietChallenge's Blockchain Roundtable in December 2021, a private gathering of blockchain experts, founders, and investors, that counted in its attendance the leadership of prominent names in the space such as Sky Mavis/Axie Infinity, CoinList, Republic, Kyber Network, DelChain, among others. Through this gathering, VietChallenge formed an alliance with Hectagon and HUB Global, together joining resources to meet the appetite for access to funding and mentorship of the world's best blockchain projects.
[https://www.youtube.com/watch?v=oapmVFa-SHQ&t=3s]
[The "Cross-Pacific Blockchain Roundtable" in NYC last year set the foundation for Block Champion, a global blockchain startup competition]
All blockchain projects are welcome to apply with no preferences for where the companies are located or what stage they have reached. Finalists will be eligible for the following benefits:
- Investment commitments in exchange for a security stake in each finalist or the equivalence in terms of token assets or stablecoins (USDT, USDC, or BUSD). A prize pool of $300,000 (US) has been established for these investments.
- The opportunity to travel to New York City, USA for in-person accelerator programs and a one-on-one mentorship program, prior to the Grand Finale event in December 2022.
- Access to an extensive network of 100+ industry experts, international investors, VC firms, and like-minded entrepreneurs.
"HUB Global is beyond thrilled to be a part of organizing Block Champion Global Start-up Competition. Our mission to discover and incubate rising Web3 start-ups is in perfect alignment with that of the team at VietChallenge. We can't wait to welcome start-ups and founders to this competition."- Henry Tran, Co-Founder, HUB Global.
"As a Venture Capital Funding Platform for Web3 projects, joining hands with VietChallenge and HUB Global to organize BlockChampion is a significant movement of Hectagon to expand our investment portal and to reach more potential Web3 projects. We are proud to have respected advisors and investors such as Japanese billionaire and serial entrepreneur Mr.Taizo Son, founder and CEO of Mistletoe to be part of Hectagon and our Investment Council. We believe with the successful launch of our TGE and a strong community of over 50,000 members, we can be a great support to the most promising Web3 startups in the space." - Linh Han, CEO of Hectagon Finance. Read more about recent successful TGE events of Hectagon in the news.
"After 7 years of successfully connecting entrepreneurs of diverse backgrounds and start-ups with funding and mentorship through our regular track competition, we're tremendously excited to partner with Hectagon and HUB Global to add a new global blockchain competition to the VietChallenge ecosystem. With Block Champion, we aim to bring together the most promising Web3 start-ups from all around the world and to connect them with some of the best industry experts as well as ample funding opportunities and network connections."- Mai Zymaris, Founder and President of VietChallenge.
Block Champion Global Start-Up Competition will accept applications from August 25, 2022 to September 30, 2022. Interested blockchain start-ups and developers can submit their applications at blockchampion.network. All related questions and press inquiries can be directed to contact@blockchampion.network.
About us
Emmerse is the blockchain division of VietChallenge, Inc, a 501(c)(3) nonprofit headquartered in Boston, USA. Founded in 2015, VietChallenge has attracted over 800+ global startups from 20+ countries to compete in its flagship startup pitching competitions and awarded $300,000+ in cash with no strings attached. Since inception, VietChallenge helped raise $60M+ for its contestants and connected them with a global network of hundreds of experts, mentors, and prominent entrepreneurs across all industries.
Hectagon is the world's first DAO-governed web3 venture capital funding platform for everyone. Founded by Linh Han, a Forbes 30 Under 30 nominee, Hectagon decentralizes venture capital investing for the average investors, allowing anyone to participate in early web3 start-up investments and to obtain governance power in their protocol by owning its native Hecta tokens.
HUB Global is one of the most established blockchain venture capital in Southeast Asia. Besides being an investment fund, Hub Global dedicates itself to building the startup community by hosting an accelerator program and organizing 2 hackathons for community-driven blockchain projects and NFT games. Through its broad network, Hub Global has invested in Southeast Asia start-ups across a range of verticals such as GameFi, social NFT, Metaverse, DeFi, Infrastructure, Marketplace, and Game Guild
View original content to download multimedia:
SOURCE Hectagon Finance
|
https://www.kxii.com/prnewswire/2022/08/29/vietchallenge-hectagon-hub-global-announce-block-champion/
| 2022-08-29T14:36:29Z
|
Implemented by the Centers for Disease Control and Prevention, the diagnosis code will accurately identify US patients with APDS, supporting care and research efforts
LEIDEN, Netherlands, Aug. 2, 2022 /PRNewswire/ -- Pharming Group N.V. ("Pharming" or "the Company") (EURONEXT Amsterdam: PHARM/Nasdaq: PHAR) announces that a new diagnosis code for reporting cases of activated phosphoinositide 3-kinase delta syndrome (APDS), a rare primary immunodeficiency, will be added to the International Classification of Diseases, 10th Revision, Clinical Modification (ICD-10-CM) by the US Centers for Disease Control and Prevention (CDC). The diagnosis code, D81.82 ‒ Activated Phosphoinositide 3-kinase Delta Syndrome (APDS), will be effective starting October 1, 2022.
Anurag Relan, Chief Medical Officer of Pharming, commented:
"By assigning this ICD-10-CM code, the CDC is formally recognizing APDS as a discrete immunological disease, and that will make a life-altering difference for people affected by the condition. By using the unique diagnostic code to identify both established and new patients with APDS, physicians will increase care options for affected individuals while helping to boost the world's understanding of the prevalence, mechanisms, and outcomes of this progressively debilitating disease. For healthcare practitioners, this milestone marks an opportunity to make a big difference by taking a simple action."
The assignment of the ICD-10-CM code will, for the first time, enable physicians and payors in the US to add a diagnosis of APDS to patients' health records, which will help connect these individuals with researchers studying the prevalence and course of the disease. In addition, by allocating a specific diagnosis, the new ICD-10-CM code may help confirm medical necessity in individual patients, thus improving their access to relevant care options through US health insurance plans.
Caused by genetic variants affecting approximately one to two people per million, APDS causes significant lymphoproliferation and immune dysfunction, as well as an increased risk of lymphoma. There is no approved therapy for the disease and treatment is generally limited to supportive care, such as antibiotics and immunoglobulin replacement therapy. Physician and patient advocacy groups specializing in immunodeficiency disorders, along with Pharming, expect the decision to raise awareness about this rare disease.
Vicki and Fred Modell, co-founders of the Jeffrey Modell Foundation, commented:
"We are excited that US regulatory authorities have assigned APDS an ICD-10-CM code. As a foundation dedicated to early diagnosis, meaningful treatments, and cures for primary immunodeficiency, we are aware of the physical and emotional challenges people with APDS face due to misdiagnosis of their disease. By increasing recognition of the condition, we expect the new diagnostic code to help ensure that every patient is included when it comes to the delivery of appropriate and meaningful treatments for APDS."
About Activated Phosphoinositide 3-Kinase δ Syndrome (APDS)
APDS is a rare primary immunodeficiency that affects approximately one to two people per million. Also known as PASLI, it is caused by variants in either of two genes, PIK3CD or PIK3R1, that regulate maturation of white blood cells. Variants of these genes lead to hyperactivity of the PI3Kδ (phosphoinositide 3-kinase delta) pathway.1,2 Balanced signaling in the PI3Kδ pathway is essential for physiological immune function. When this pathway is hyperactive, immune cells fail to mature and function properly, leading to immunodeficiency and dysregulation.1,3 APDS is characterized by severe, recurrent sinopulmonary infections, lymphoproliferation, autoimmunity, and enteropathy.4,5 Because these symptoms can be associated with a variety of conditions, including other primary immunodeficiencies, people with APDS are frequently misdiagnosed and suffer a median 7-year diagnostic delay.6 As APDS is a progressive disease, this delay may lead to an accumulation of damage over time, including permanent lung damage and lymphoma.4-7 The only way to definitively diagnose this condition is through genetic testing.
About Pharming Group N.V.
Pharming Group N.V. (EURONEXT Amsterdam: PHARM/Nasdaq: PHAR) is a global biopharmaceutical company dedicated to transforming the lives of patients with rare, debilitating, and life-threatening diseases. Pharming is commercializing and developing an innovative portfolio of protein replacement therapies and precision medicines, including small molecules, biologics, and gene therapies that are in early to late-stage development. Pharming is headquartered in Leiden, Netherlands, and has employees around the globe who serve patients in over 30 markets in North America, Europe, the Middle East, Africa, and Asia-Pacific.
For more information, visit www.pharming.com.
About the Jeffrey Modell Foundation
Vicki and Fred Modell established the Jeffrey Modell Foundation (JMF) in 1987, in memory of their son Jeffrey, who died at the age of 15, from complications of Primary Immunodeficiency (PI) — a genetic condition that is chronic, serious, and often fatal. JMF is a global nonprofit organization dedicated to early diagnosis, meaningful treatments and, ultimately, cures through research, physician education, public awareness, advocacy, patient support, newborn screening, and genetic sequencing. For more information, visit https://www.info4pi.org/.
Forward-Looking Statements
This press release contains forward-looking statements, including with respect to timing and progress of Pharming's preclinical studies and clinical trials of its product candidates, Pharming's clinical and commercial prospects, Pharming's ability to overcome the challenges posed by the COVID-19 pandemic to the conduct of its business, and Pharming's expectations regarding its projected working capital requirements and cash resources, which statements are subject to a number of risks, uncertainties and assumptions, including, but not limited to the scope, progress and expansion of Pharming's clinical trials and ramifications for the cost thereof; and clinical, scientific, regulatory and technical developments. In light of these risks and uncertainties, and other risks and uncertainties that are described in Pharming's 2021 Annual Report and the Annual Report on Form 20-F for the year ended December 31, 2021 filed with the US Securities and Exchange Commission, the events and circumstances discussed in such forward-looking statements may not occur, and Pharming's actual results could differ materially and adversely from those anticipated or implied thereby. Any forward-looking statements speak only as of the date of this press release and are based on information available to Pharming as of the date of this release.
Inside Information
This press release relates to the disclosure of information that qualifies, or may have qualified, as inside information within the meaning of Article 7(1) of the EU Market Abuse Regulation.
References
1. Lucas CL, et al. Nat Immunol. 2014;15:88-97.
2. Elkaim E, et al. J Allergy Clin Immunol. 2016;138(1):210-218.
3. Nunes-Santos C, Uzel G, Rosenzweig SD. J Allergy Clin Immunol. 2019;143(5):1676-1687.
4. Coulter TI, et al. J Allergy Clin Immunol. 2017;139(2):597-606.
5. Maccari ME, et al. Front Immunol. 2018;9:543.
6. Jamee M, et al. Clin Rev Allergy Immunol. 2019;May 21.
7. Condliffe AM, Chandra A. Front Immunol. 2018;9:338.
Logo - https://mma.prnewswire.com/media/1454235/Pharming_Group_NV_Logo.jpg
View original content to download multimedia:
SOURCE Pharming Group N.V.
|
https://www.wibw.com/prnewswire/2022/08/02/pharming-announces-new-icd-10-cm-code-apds-rare-primary-immunodeficiency/
| 2022-08-02T06:02:37Z
|
NEW YORK, May 17, 2022 /PRNewswire/ – The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Lilium N.V. f/k/a Qell Acquisition Corp. (NASDAQ: LILM) alleging that the Company violated federal securities laws.
Class Period: March 30, 2021 to March 14, 2022
Lead Plaintiff Deadline: June 17, 2022
No obligation or cost to you.
Learn more about your recoverable losses in LILM:
https://www.kleinstocklaw.com/pslra-1/lilium-n-v-f-k-a-qell-acquisition-corp-loss-submission-form?id=27275&from=4
Lilium N.V. f/k/a Qell Acquisition Corp. NEWS - LILM NEWS
CLASS ACTION CASE DETAILS: The filed complaint alleges that Lilium N.V. f/k/a Qell Acquisition Corp. made materially false and/or misleading statements and/or failed to disclose that: (1) Lilium materially overstates the design and capabilities of the Lilium Jet, an electric vertical take-off-and-landing aircraft for use in a new type of high-speed air transport system for people and goods; (2) Lilium materially overstates the likelihood for the Lilium Jet's timely certification; (3) Lilium misrepresents its ability to obtain or create the necessary batteries for the Lilium Jet; (4) the special purpose acquisition company merger would not and did not generate enough cash to commercially launch the Lilium Jet; (5) Qell Acquisition Corp. did not engage in proper due diligence regarding its merger with Lilium GmbH; and (6) as a result, Defendants' public statements and statements to journalists were materially false and/or misleading at all relevant times.
WHAT THIS MEANS TO YOU AS A SHAREHOLDER: If you have suffered a loss in Lilium N.V. f/k/a Qell Acquisition Corp. you have until June 17, 2022 to petition the court for lead plaintiff status. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.
NO COST TO YOU: If you purchased Lilium N.V. f/k/a Qell Acquisition Corp. securities during the relevant period, you may be entitled to compensation without payment of any out-of-pocket fees.
HOW TO PROTECT YOUR FINANCIAL INTERESTS: For additional information about the LILM lawsuit, please contact J. Klein, Esq. by telephone at 212-616-4899 or click this link: https://www.kleinstocklaw.com/pslra-1/lilium-n-v-f-k-a-qell-acquisition-corp-loss-submission-form?id=27275&from=4.
ABOUT KLEIN LAW FIRM
J. Klein, Esq. represents investors and participates in securities litigations involving financial fraud throughout the nation. The Klein Law Firm is a boutique litigation firm with experience in a wide range of areas including securities law, corporate finance and commercial litigation. Since 2011, our experienced attorneys have achieved superior results for our clients with a personalized focus. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT:
J. Klein, Esq.
Empire State Building
350 Fifth Avenue
59th Floor
New York, NY 10118
jk@kleinstocklaw.com
Telephone: (212) 616-4899
www.kleinstocklaw.com
View original content:
SOURCE The Klein Law Firm
|
https://www.wibw.com/prnewswire/2022/05/17/lilm-alert-klein-law-firm-announces-lead-plaintiff-deadline-june-17-2022-class-action-filed-behalf-lilium-nv-fka-qell-acquisition-corp-shareholders/
| 2022-05-17T10:37:09Z
|
Revenge travel: How vacation vengeance became a thing
By Lilit Marcus, CNN
As more and more countries reopen their borders to eager tourists, a trendy new phrase has emerged on social media: revenge travel.
The term has been used to describe trips as varied as family reunions, big splurge vacations and re-visits to favorite places, which leads to one question: so, what is it?
“Revenge” generally has a negative connotation, which contradicts the joyful, excited feeling so many people have about making their first vacation in two-plus years.
But the idea of “revenge travel” seems to be more about loving to travel rather than expecting a specific destination to make amends. Unless, say, Romania stole your girlfriend or Peru got you fired from your job, it sounds strange to take revenge on a place.
Perhaps “revenge travel” can be interpreted as getting revenge against the pandemic, or against Covid itself.
No. Really. What is it?
“Revenge travel is a media buzzword that originated in 2021 when the world began to reopen, and people decided to make up for lost time,” says Erika Richter, vice president of the American Society of Travel Advisors (ASTA).
Part of the problem is that there isn’t one good way to describe the current mood of travel around the globe. “Post-pandemic travel” isn’t quite accurate, since the pandemic isn’t over in many places. Different countries and regions are operating on different timelines, with some eliminating all barriers to entry while others remain strictly controlled or even closed to foreign visitors.
Richter agrees with the overall sentiment behind the concept, even if she doesn’t use the term “revenge travel.”
“It’s another way of saying, “Hey, life is short. I want to book that trip. I want to spend more time with family. I want to connect with humanity and with nature. I want to explore the world and seek experiences that make me feel alive.”
She isn’t the only one in the tourism industry struggling to figure out how to talk about “revenge travel” as a trend.
“I don’t think the prefix ‘revenge’ is appropriate to what travel should be about,” Rory Boland, editor of Which? magazine, tells CNN Travel. He calls “revenge travel” an “ugly term.”
However, he acknowledges that the phrase has clearly connected with people.
“What it is trying to capture, I think, is the desire many people have to travel again, to see new places and meet new people, after a period that has felt static and dreary.”
The people who are doing it
Whether they use the term “revenge travel” or not, many travelers report that they’re taking their first big trip since the beginning of the pandemic.
Deborah Campagnaro, who lives in British Columbia, Canada, is one of them.
She retired from her investment services job of 30-plus years during the pandemic and looked forward to going on a big celebratory vacation with her husband. The couple went on a group trip to Nepal in 2016 to hike the Annapurna Circuit, a challenging trek through some of the country’s highest peaks.
They loved the trip so much they had planned to go back to Nepal, this time on a custom itinerary. Pandemic related closures and weather difficulties meant they had to postpone multiple times. Finally, they have confirmed tickets and bookings for September 2022.
Campagnaro and her husband are indulging in additional time and experiences instead of fancy resort stays. They will be staying in Nepal for an entire month and have added on a few days in the lakeside town of Pokhara as a treat.
“That wouldn’t have happened before,” she says about the side trip. “We’re just doing it now because we can. it’s very, very nice to have some downtime there after a trek.”
Rhode Island resident Brittney Darcy is also looking forward to a trip that was scuttled by the pandemic.
The 26-year-old has dreamed of going to Paris since she was a little girl watching her favorite movie, “Sabrina.” But the planned summer 2020 trip with her boyfriend was called off when Covid broke out.
Now, she has finally rescheduled her dream vacation — but with more stops and some upgrades. Instead of five days in Paris, she will be spending two weeks abroad in France and Italy.
“I went on a cross-country trip during Covid, but it wasn’t enough and I’ve always wanted to go to Paris and Italy and I’ve never been. We’re young and why not?” she told CNN.
The money she saved from not traveling for two years is being put toward some vacation upgrades. Instead of having a layover in Iceland or Ireland, Darcy and her boyfriend paid more for a direct flight from Boston.
Darcy admits that she had never heard the term “revenge travel,” but once she did it was a perfect term to apply to her Europe trip.
“Covid has made me less frugal. We only live once, so I might as well spend my money on experiences.”
Making up for lost time
One thing is clear: as vaccines roll out and doors reopen, people around the world are eager to get back out on the road again.
Travel booking company Expedia tracks online search data related to travel and tourism. In 2021, the single highest increase in average travel search traffic — 10% — was in May, the week after the European Union voted to extend their contract with Pfizer and approve the vaccine for use on adolescents.
Expedia’s survey found that 60% of consumers had plans to travel domestically and 27% to travel internationally in 2022.
And many of these travelers are willing to spend more money on a vacation than they would have in the past.
Two-ish years of staying home means that some people have saved up money and can now splurge on a fancier hotel, a first-class airplane ticket or a spendy once-in-a-lifetime experience.
On top of that, more and more companies have permanently changed their remote work policies post-pandemic.
A Pew survey published in February showed that 60% of workers with jobs that can be done from home said they’d like to work from home all or most of the time when the pandemic is over if given the choice.
For some people, working from home doesn’t necessarily mean from home — it could mean trying out an Airbnb in another country and spending several weeks there combining work and travel.
Some destinations are openly courting remote workers. Caribbean islands like Barbados and Anguilla have offered visas specifically for remote workers or “digital nomads” as a way to boost tourism.
So call it “revenge travel” or don’t. Either way, it’s apparent that people have changed their travel mindsets since the pandemic began, and that feeling of “oh, finally!” has a lot of power to sell airline tickets and hotel packages.
One of the people taking part in the trend is Christie Hudson, Expedia’s head of public relations, who worked on the company’s travel survey.
“Honestly, I wasn’t very surprised [by the survey results] simply because the findings resonated so strongly with the way I feel personally,” she says. “During my last weekend getaway, I booked multiple spa appointments and upgraded our flights to first class. I felt like I deserved it.”
The-CNN-Wire
™ & © 2022 Cable News Network, Inc., a WarnerMedia Company. All rights reserved.
Seychelles image via Getty
|
https://localnews8.com/entertainment/cnn-style/2022/05/15/revenge-travel-how-vacation-vengeance-became-a-thing/
| 2022-05-16T09:50:26Z
|
CEDARHURST, N.Y., April 20, 2022 /PRNewswire/ -- The securities litigation law firm of Kuznicki Law PLLC issues this alert to shareholders of Telefonaktiebolaget LM Ericsson ("Ericsson" or the "Company") (NasdaqGS: ERIC), if they purchased the Company's securities between April 27, 2017 and February 25, 2022, inclusive (the "Class Period"). Shareholders have until May 2, 2022 to file lead plaintiff applications in the securities class action lawsuit.
Shareholders are encouraged to contact us at https://kclasslaw.com/cases/securities/nasdaqgs-eric/https://kclasslaw.com/cases/securities/nyse-hmlp/, by calling toll-free at 1-833-835-1495 or by email (dk@kclasslaw.com).
Kuznicki Law PLLC is committed to ensuring that companies adhere to responsible business practices and engage in good corporate citizenship. The firm seeks recovery on behalf of investors who incurred losses when false and/or misleading statements or the omission of material information by a Company lead to artificial inflation of the Company's stock. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT:
Kuznicki Law PLLC
Daniel Kuznicki, Esq.
445 Central Avenue, Suite 344
Cedarhurst, NY 11516
Email: dk@kclasslaw.com
Phone: (347) 696-1134
Cell: (347) 690-0692
Fax: (347) 348-0967
https://kclasslaw.com
View original content to download multimedia:
SOURCE Kuznicki Law PLLC
|
https://www.wibw.com/prnewswire/2022/04/21/filing-deadline-kuznicki-law-pllc-announces-class-action-behalf-shareholders-telefonaktiebolaget-lm-ericsson-eric/
| 2022-04-21T04:25:53Z
|
KOKOMO, Ind. (AP) — A joint venture between Stellantis and Samsung plans to build an electric vehicle battery factory in Indiana that will employ up to 1,400 workers and become the company’s second such factory in North America.
The venture announced Tuesday plans to spend more than $2.5 billion on the plant in Kokomo that will supply electric battery modules for a range of vehicles produced at Stellantis’ North American assembly plants.
Construction of the plant is expected to start later this year, with the facility expected to open in early 2025 in the city about 60 miles (97 kilometers) north of Indianapolis.
The venture’s investment in the plant could gradually increase up to $3.1 billion, Mark Stewart, the chief operating officer of Stellantis North America, said at the announcement at Ivy Tech Community College in Kokomo.
Samsung SDI will use its PRiMX technology to produce electric vehicle battery cells and modules for the North American market at the Kokomo plant, the companies said in a statement.
Stellantis, formed last year with the merger of Fiat Chrysler and France’s PSA Peugeot, had said it would build two electric vehicle battery factories in North America. The Kokomo plant would be the second of those plants and the first in the United States.
In March, it announced plans to spend $4.1 billion in a joint venture with LG Energy Solution of Korea to build one of the plants in Windsor, Ontario. That plant will employ about 2,500 people.
Stellantis, the world’s fourth-largest automaker, has announced plans to sell 5 million electric vehicles by 2030, with 50% of its North American passenger car and light truck sales going fully electric by 2030. Stellantis plans to sell only electric passenger cars in Europe by 2030.
Stellantis in October announced plans to spend nearly $230 million to retool three Kokomo-area factories so they can produce transmission systems that work with both traditional gasoline-powered vehicles and gas-electric hybrid versions.
In 2020 it announced spending of $400 million to convert its Indiana Transmission Plant II in Kokomo into an engine factory.
“Today’s announcement is another step toward positioning Indiana as a leader in the future of mobility, battery technology and clean energy,” Indiana Gov. Eric Holcomb said in a statement.
Indiana is offering the planned electric battery factory an incentive package of up to about $186.5 million in conditional tax credits, training grants and investments, including funding that would offset the costs of the plant’s infrastructure, the Indiana Economic Development Corporation said.
|
https://cw33.com/business/ap-business/stellantis-samsung-plan-indiana-electric-car-battery-plant/
| 2022-05-25T07:59:41Z
|
‘It caught me totally off guard’: Oklahoma restaurant staff gets $4,500 tip from couple
LAWTON, Okla. (KSWO/Gray News) - The staff at an Oklahoma restaurant is counting their blessings after a mysterious couple left them a few thousand dollars as a tip.
Mitchell Rhoades, the owner of Leo and Ken’s Truck Stop and Restaurant, told KSWO a couple came in to eat breakfast Sunday morning.
Before they left, they paid for everyone’s meal and gave the cashier about $4,500 to split between the on-duty servers.
“They dropped off the money, and I, of course, tried to refuse it at first, you know that was way too much money,” he said. “But they weren’t hearing it, and they said, ‘Man, we’re just trying to bless people the way we’ve been blessed.’ So, they handed me the money and walked out the door. It was the first time it’s ever happened like that. I mean, it’s a cool deal, and it caught me totally off guard.”
Rhoades said before the couple left, they told him it was only fair that they pay their blessing forward.
Rhoades said he hopes the next time he or his staff sees someone in need of a helping hand, they also rise to the occasion.
“This world would be a whole lot of a better place if we tried to help each other out rather than stepping on or stepping over somebody else to get what we need or what we want,” he said. “There’s always plenty enough to go around, and we can always help somebody out that’s maybe in need or less fortunate; it’d make the world a better place. Put out good in the world, and the good will come back to you.”
The couple left without telling them who they were, but Rhoades said he wants them to know they are all very thankful, and “God bless.”
Copyright 2022 KSWO via Gray Media Group, Inc. All rights reserved.
|
https://www.kxii.com/2022/04/05/it-caught-me-totally-off-guard-oklahoma-restaurant-staff-gets-4500-tip-couple/
| 2022-04-07T11:19:59Z
|
PHOTOS: San Diego Zoo Safari Park welcomes ‘significant’ birth of baby white rhino
SAN DIEGO (Gray News) - The San Diego Zoo Safari Park announced this week the arrival of a male white rhino born to a first-time mother.
According to the park, the unnamed calf was conceived through natural breeding with the mother, Livia, and the father, J Gregory, and was born on Aug. 6.
Wildlife care specialists report the calf is healthy, confident and full of energy. They said Livia is an excellent mother, being very attentive and protective.
Representatives with the park said, “all rhino births are significant,” and the calf’s birth represents an essential step with Livia carrying a calf to term, as she could serve as a surrogate mother in the future.
Livia and her calf are expected to remain in a private habitat to allow time for bonding at the Nikita Kahn Rhino Rescue Center within the San Diego Zoo Safari Park.
Copyright 2022 Gray Media Group, Inc. All rights reserved.
|
https://www.mysuncoast.com/2022/08/23/photos-san-diego-zoo-safari-park-welcomes-significant-birth-baby-white-rhino/
| 2022-08-23T19:07:52Z
|
MONTEREY PARK, Calif., Aug. 30, 2022 /PRNewswire/ -- Blue Shield of California Promise Health Plan adamantly disagrees with the Department of Health Care Services' (DHCS) failure to issue a notice of intent to award to Blue Shield Promise a managed care plan contract to serve Medi-Cal beneficiaries in San Diego County and other bid markets.
This decision is not consistent with the stated goals of the procurement and therefore is not in the best interest of Medi-Cal beneficiaries and their communities. Blue Shield Promise is evaluating all avenues to appeal this decision as it continues its commitment as a nonprofit managed care plan to serve its members and provide them with access to quality care.
Blue Shield Promise (formerly Care1st Health Plan) has been serving Medi-Cal beneficiaries in San Diego and Los Angeles counties for more than 25 years, and its parent company, Blue Shield of California has been serving the state's residents for more than 80 years. Together, they are tax-paying, mission-driven nonprofit health plans operating exclusively in California.
About Blue Shield of California Promise Health Plan
Blue Shield of California Promise Health Plan is a managed care organization, wholly owned by Blue Shield of California, offering Medi-Cal and Cal MediConnect. It is led by healthcare professionals with a "members-first" philosophy and committed to building a quality network of providers and partnering with community organizations for more than 400,000 members. For more information about Blue Shield of California Promise Health Plan, please visit www.blueshieldca.com/promise.
For more news about Blue Shield of California, please visit https://news.blueshieldca.com/. Or follow the health plan on LinkedIn, Twitter, or Facebook.
View original content to download multimedia:
SOURCE Blue Shield of California Promise Health Plan
|
https://www.kxii.com/prnewswire/2022/08/30/blue-shield-california-promise-health-plan-statement-department-health-care-services-decision-medi-cal-contract-award-is-disservice-vulnerable-californians/
| 2022-08-30T16:22:41Z
|
Current CFO and Board Member, Tom Casey, to Retire After Transition Period
SAN FRANCISCO, July 27, 2022 /PRNewswire/ -- LendingClub Corporation (NYSE: LC), the parent company of LendingClub Bank, America's leading digital marketplace bank, today announced that Drew LaBenne has been named LendingClub's next Chief Financial Officer (CFO). To ensure a seamless transition, he will assume the responsibilities on September 1, 2022, from current CFO, Tom Casey, who will be retiring but will continue to support LendingClub in a non-executive capacity through the end of 2022. Mr. Casey will also be retiring from LendingClub's Board of Directors.
As CFO, LaBenne will lead LendingClub's finance organization and financial activities including accounting, financial planning and analysis, treasury, tax, and investor relations.
"Drew has extensive retail and commercial banking experience at some of the largest and most well-respected banks in the world. He is also completely aligned with the multiple ways we can use technology to deliver better outcomes for consumers in managing their money," said LendingClub CEO, Scott Sanborn. "His acumen and experience make him uniquely qualified to help lead LendingClub as we combine the innovation of a fintech with the operating discipline of a digital bank."
Mr. LaBenne was previously the CFO of Bakkt (NYSE: BKKT), a digital asset marketplace. Prior to that he was CFO of Amalgamated Bank and Managing Director and CFO of JP Morgan Chase's Business Banking division. LaBenne also spent 17 years at Capital One Financial where he held numerous positions including CFO of Retail Banking and played a key role in growing the banking franchise.
"I have been watching LendingClub's ongoing and very successful transformation from afar since it became a national digital bank last year," added Mr. LaBenne. "The company is combining the best of both worlds – the growth and agility of a fintech with the profitability and resilience of a bank. I am excited to be joining a company that is redefining what banking can do for its customers."
LendingClub's current CFO and member of the Board of Directors, Tom Casey, will be retiring from both positions effective August 31, 2022, after a well-planned transition process. Sanborn added, "In his six years at the Club, Tom has captained our return to profitability and scale, helped our transformation to a digital bank, built an incredible finance model and organization and helped shape the strategy that the company will build on for many years to come. I would like to thank Tom both personally and on behalf of the company for his incredible contributions to LendingClub."
LendingClub Corporation (NYSE: LC) is the parent company of LendingClub Bank, National Association, Member FDIC. LendingClub Bank is the leading digital marketplace bank in the U.S., where members can access a broad range of financial products and services designed to help them pay less when borrowing and earn more when saving. Based on more than 150 billion cells of data and over $75 billion in loans, our advanced credit decisioning and machine-learning models are used across the customer lifecycle to expand seamless access to credit for our members, while generating compelling risk-adjusted returns for our loan investors. Since 2007, more than 4 million members have joined the Club to help reach their financial goals. For more information about LendingClub, visit https://www.lendingclub.com.
CONTACT:
For Investors: IR@lendingclub.com
Media Contact: Press@lendingclub.com
View original content to download multimedia:
SOURCE LendingClub Corporation
|
https://www.wibw.com/prnewswire/2022/07/27/lendingclub-names-drew-labenne-new-chief-financial-officer/
| 2022-07-27T21:43:46Z
|
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.